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SUMMARY 
Over the years, studies have demonstrated the emerging roles of the superoxide anion 
(O2.-) as an essential signalling molecule. The involvement of O2.- in cell proliferation 
and cell growth and has been demonstrated in different systems. Moreover, there are 
accumulating evidence pointing to the anti-apoptotic role of O2.-. Our group has 
shown that an increase in intracellular O2.- endows tumour cells with a survival 
advantage against a variety of apoptotic triggers. In line with the pro-survival role of 
O2.-, our group recently demonstrated the role of O2.- in regulating the survival kinase 
Akt via an oxidative inhibition of PTEN by S-nitrosylation. During the course of this 
study, it was noticed that in mouse embryonic fibroblasts that do not express the 
tumour suppressor PTEN (MEFPTEN-/- cells), a decrease in the intracellular level of 
O2.- abrogated the hyperphosphorylation of Akt that was observed in these cells. 
Therefore, we hypothesize that O2.- may regulate the PI3K-Akt pathway not only 
through the inhibition of PTEN but also through a novel pathway that may be critical 
for the maintenance of the hyperphosphorylated Akt observed in  MEFPTEN-/- cells.  
 
In the current project, the PTEN-independent pathways involved in the regulation of 
Akt phosphorylation by O2.- in MEFPTEN-/- cells is investigated. Using 
diphenyleneiodonium chloride (DPI), the inhibitor for the O2.--producing NADPH 
oxidases and silencing of the Nox4 isoform by small interference RNA, we show that 
the reduction of intracellular level of O2.- in MEFPTEN-/- cells results in a decrease in 
the phosphorylation level of the otherwise hyperphosphorylated Akt kinase.  
 
In investigating how O2.- regulates Akt phosphorylation level in MEFPTEN-/- cells, we 
provide evidence that the dephosphorylation of Akt is not dependent on any 
 viii
alterations in the level of PIP3, an important secondary messenger regulating Akt 
phosphorylation. Instead, the Akt molecules present in the cytosol are the primary 
target of this O2.- -mediated regulation, which is achieved via PP2A-dependent 
dephosphorylation. Furthermore, we also show that Akt oxidation status is inversely 
correlated with the level of intracellular O2.-. The proposed regulation of Akt 
phosphorylation by O2.- is possibly dependent on the shift between reduced-Akt and 
oxidized-Akt, which is associated with the susceptibility of Akt to the PP2A 
phosphatase. 
 
In addition to the cytosolic regulation of Akt phosphorylation by O2.-, we have also 
reported NHE1 as a regulator of Akt phosphorylation at the membrane. We showed 
for the first time that NHE1 interacts directly with Akt. This interaction allows NHE1 
to serve as an additional anchor point for Akt recruitment to the membrane. Moreover, 
complex formation between NHE1 and Akt is disrupted by a reduction in intracellular 
O2.- level, which further illustrates the importance of O2.- in regulating Akt 
phosphorylation.  
 
Taken together, our data show that O2.- can regulate the level of Akt phosphorylation 
in various ways in MEFPTEN-/- cells. This suggests that in addition to be due to the 
elevated level of PIP3, hyperphosphorylation of Akt in PTEN-defective cells could be 
dependent on intracellular O2.- level as well.  
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Chapter 1: Introduction 1
CHAPTER 1 INTRODUCTION 
 
1.1 Reactive oxygen species in cell signalling 
 
1.1.1 Overview of free radicals  
 
A free radical can be defined as “any species capable of independent existence that 
contains one or more unpaired electrons” (Halliwell and Gutteridge, 2007). In living 
systems, there are many types of free radicals with different chemical reactivity.  
Although most molecules in the living system are non-radicals, radicals can be 
formed from a non-radical by losing or gaining a single electron. Radicals can also be 
formed from a process called homolytic fission, in which a covalent bond is broken 
with one electron remaining on each atom. The opposite process, heterolytic fission, 
in which one atom receives both electrons of the bonding pair, produces radicals as 
well (Halliwell and Gutteridge, 2007). The major types of free radicals in living 
systems include the simplest free radical hydrogen atom (H.), the oxygen-centred 
radicals (when the unpaired electron resides on oxygen) like superoxide (O2.-) and 
hydroxyl (OH.), the carbon-centred radical thrichloromethyl (CCl3.) and some oxides 
of nitrogen (NO., NO2.) (Halliwell and Gutteridge, 2007).  
 
1.1.2 Reactive oxygen species 
 
Reactive oxygen species (ROS) are oxygen-derived molecules that include both 
oxygen radicals as well as non-radicals that are oxidizing agents and/or easily 
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converted into radicals (Halliwell and Gutteridge, 2007). A list of the major types of 











Carbon dioxide, CO2.- 
 
Hydrogen peroxide, H2O2 
Ozone, O3 
Peroxynitrite ONOO- 
Table 1: Examples of reactive oxygen species including radicals and non-radicals 
Adapted from (Halliwell and Gutteridge, 2007). 
 
The evolution of life in an oxygen-containing environment makes the production of 
oxygen-derived species inevitable to living organisms. Most organisms have evolved 
antioxidant systems to defend against ROS and have also developed ways to utilize 
ROS for cellular signalling or as defence mechanisms against foreign organisms. The 
primary reactive oxygen species is the superoxide anion (O2.-), which is generated 
from one-electron reduction of O2. The major intracellular source of O2.-  includes the 
mitochondria, the NADPH oxidase (Nox) complex and xanthine oxidase (Dröge, 
2002; Halliwell and Gutteridge, 2007). Superoxide anion is produced by the 
mitochondrial respiratory chain when the oxygen accepts a single electron leaking 
from the respiratory chain during electron transfer. Mitochondrial O2.- production is 
detected from seven separate sites in mammalian mitochondria, and is considered as 
an important source of ROS in cells (Brand, 2010). The NADPH oxidase represents 
another major source of O2.- production. The NADPH oxidase-generated O2.- is 
initially reported in phagocytic cells as a defence mechanism against invading 
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organisms. However, later findings suggest that a similar system exists in non-
phagocytic cells for ROS generation, which functions in cell signalling (Jones, 1994; 
Meier, 2001; Quinn and Gauss, 2004; Babior et al., 2002). Superoxide production by 
another source, xanthine oxidase, is minimal at basal level but is important in disease 
conditions such as ischemia and reperfusion (Chance et al., 1979; Granger, 1988).  
 
Upon further reduction of O2.- , a non-radical ROS hydrogen peroxide (H2O2) is 
produced. The conversion of O2.- to H2O2 can be achieved either spontaneously, or by 
an enzymatic reaction catalyzed by the superoxide dismutase (SOD) (McCord and 
Fridovich, 1969; Hodgson and Fridovich, 1975). Although O2.- and H2O2 are not 
highly reactive, they are able to give rise to the highly reactive hydroxyl radical (.OH) 
in the presence of transition metals like iron or copper, via the Fenton reaction or the 
Haber-Weiss reaction (Halliwell and Gutteridge, 2007). Having strong reactivity 
towards other bio-molecules, .OH is one of the major causes of ROS-related oxidative 
damages. Another important route of reaction for O2.- is its reactivity with the reactive 
nitrogen species nitric oxide (NO) to form the highly reactive peroxynitrite (ONOO-), 
a potent nitrosating agent. When NO and O2.- are produced simultaneously, this 
reaction occurs quickly at a diffusion-controlled rate of approximately (1.6+0.3)x1010 
M–1 s–1. The reported reaction rate for CuZnSOD to scavenge O2.- , on the other hand, 
is about 2 x109 M–1 s–1. It is therefore proposed that formation of peroxynitrite could 
not be competed off by SOD when NO reaches micromolar concentrations (Kissner et 
al., 2003). Therefore, the indirect cellular effect of O2.- is dependent on the types of 
secondary ROS generated such as  H2O2 or ONOO-.  
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1.1.3 Redox homeostasis 
 
Regulation of ROS level in the cellular system is critical in maintaining normal 
cellular function, because ROS are produced constantly as products of normal cellular 
metabolism, or as a defence mechanism against foreign organisms. Therefore, 
antioxidant systems have been developed to control the ROS level in cells. An 
antioxidant is defined as “any substance that, when present at low concentrations 
compared with those of an oxidizable substrate, significantly delays or prevents 
oxidation of that substrate” (Halliwell and Gutteridge, 2007). Cellular antioxidants 
fall into two major groups, antioxidant enzymes and non-enzymatic substances. 
Important antioxidant enzymes include glutathione peroxidise (GPx), catalase, 
superoxide dismutase (SOD), and thioredoxin peroxidase. The non-enzymatic 
antioxidant compounds include α-tocopherol (vitamin E), β-carotene, ascorbic acid 
(vitamin C) and glutathione (Halliwell and Gutteridge, 2007).  
 
Cellular redox homeostasis is achieved by tightly regulating the balance between ROS 
production and ROS elimination. Disrupted ROS balance is observed when there is an 
increase in ROS production or a decrease in antioxidant capacity. The resultant 
accumulation of ROS leads to oxidative stress, a condition that is deleterious to the 
cellular system. The term oxidative stress is used to describe an imbalance between 
the level of oxidants and antioxidants in favour of the oxidants, which potentially 
produces damage (Sies, 1997). The impact of ROS on the cellular system under 
oxidative stress has been extensively reported in many pathological conditions such as 
rheumatoid arthritis, cardiovascular diseases, neurodegenerative diseases, diabetes 
mellitus, cancer and the aging process (Dalle-Donne et al., 2006; Mirshafiey and 
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Mohsenzadegan, 2008; Dhalla et al., 2000; Sayre et al., 2001; Roberts and Sindhu, 
2009; Klaunig et al., 2010; Benz and Yau, 2008). 
 
1.1.4 Redox signalling 
 
Despite historically implicated deleterious effects of ROS, more and more evidence 
suggest that ROS serve as secondary messengers for the physiological cellular process 
termed redox signalling. The term redox signalling is used to describe the tightly 
regulated signal delivering process through redox reactions (Valko et al., 2007). The 
regulated increase in ROS or decrease in antioxidant activity leads to a temporary 
imbalance towards more oxidising conditions. The shift in the intracellular redox state 
results in redox-mediated modifications or activity changes of cellular molecules such 
as proteins and lipids in a controlled manner, which is the physiological basis of redox 
signalling. As such, ROS are utilized in the signal transduction pathways for many 
physiological processes such as cell growth and proliferation, gene expression, cell 
adhesion, and programmed cell death (Valko et al., 2007; Dröge, 2002).   
 
Early findings showed that exogenous addition of low concentrations of O2.- and H2O2 
(10nM-1µM) was growth stimulatory to a variety of cultured mammalian cell types 
including hamster and rat fibroblasts, human fibroblasts and human histiocytic 
leukeamia cells (Burdon, 1995). This effect was attributed to the stimulation of 
expression of the early growth related genes like c-fos and c-jun.   
Endogenous production of ROS was later observed in non-phagocytic cells triggered 
with extracellular signals such as cytokines and growth factors, which bind to 
different classes of receptors. This type of ligand-induced ROS production is closely 
Chapter 1: Introduction 6
related to cell growth and proliferation as well. Examples of the ROS inducing ligands 
include tumour necrosis factor alpha (TNFα), platelet-derived growth factor (PDGF), 
epidermal growth factor (EGF) and angiotensin II (Ang II) (Dröge, 2002). 
 
1.1.4.A   TNFα-induced ROS production  
Primary human fibroblast cells were reported to release ROS, primarily O2.- , when 
cells were stimulated with TNFα (Meier et al., 1989). A similar observation was made 
in rat pulmonary artery endothelial cells (RPAEC), which generated O2.- in response 
to TNFα treatment (Murphy et al., 1992). A further study on primary cultures of 
bovine articular chondrocytes showed ROS production after TNFα stimulation as well 
(Lo and Cruz, 1995). The induction of ROS production was blocked when cells were 
pre-treated with diphenyleneiodonium (DPI), a potent inhibitor of ROS- producing 
NADPH oxidase. Concurrently, DPI could reduce TNFα-induced expression of c-fos, 
supporting the involvement of ROS as a mediator of the induction of c-fos expression 
by TNFα (Lo and Cruz, 1995). The physiological relevance of TNFα-induced ROS 
production was further elucidated in a model using wild type (WT) murine embryonic 
fibroblasts (MEFs), TNF receptor-associated factor (TRAF) 2 and TRAF5 double 
knockout (DKO) MEFs and p65 NF-kappaB (NF-κB) subunit single knockout 
(p65KO) MEFs. While ROS induction was not detected in WT MEFs, ROS 
accumulation was increased in DKO or p65KO MEFs and was associated with the 
prolonged activation of c-Jun N-terminal kinase (JNK) in these cells. Moreover, 
ectopic expression of TRAF2 and TRAF5 or p65 in the respective knockout cell lines 
inhibited TNFα-induced ROS production as well as prolonged JNK activation, 
indicating that TRAF-mediated NF-κB activation might be a negative regulator of 
ROS generation upon TNFα stimulation (Sakon et al., 2003). Sustained JNK 
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activation in response to TNFα-induced ROS was then attributed to the oxidation and 
inhibition of JNK-inactivating phosphatases upon ROS accumulation (Kamata et al., 
2005). In addition to the widely reported effect on the MAPK, TNFα was also shown 
to induce the unfolded protein response (UPR) in a ROS-dependent manner in murine 
fibrosarcoma L929 cells (Xue et al., 2005). The elevated Akt phosphorylation by 
TNFα in glioma cells was also dependent on TNFα-induced oxidative stress, 
supported by the observation that the increase in Akt phosphorylation was prevented 
by the antioxidant N-acetylcysteine (NAC) and potentiated by siSOD1 (Ghosh et al., 
2010).   
 
1.1.4.B   PDGF-induced ROS production  
PDGF has been shown to generate ROS, which is essential for mitogenic signalling. 
Sundaresan et al. showed in rat vascular smooth muscle cells (VSMCs) that PDGF 
stimulation led to a transient increase in intracellular H2O2, and the increase was 
blunted by catalase and NAC in a concentration-dependent manner. PDGF-induced 
H2O2 production was further demonstrated to be essential for PDGF-stimulated 
phosphorylation of extracellular-signal-regulated kinases (ERK1/2) and cell migration, 
both of which were inhibited when the rise in H2O2 was blocked by catalase or NAC 
(Sundaresan et al., 1995). PDGF-induced ROS production, as indicated by a transient 
increase in DCFDA fluorescence, was reported in human lens epithelial cells HLE B3. 
In this system, PDGF-stimulated cell proliferation, as well as ERK1/2 or JNK 
activation, was inhibited in the presence of catalase or mannitol, which suppressed the 
generation of ROS by PDGF (Chen et al., 2004). PDGF was also found to increase 
O2.-  production shortly after ligand binding in normal human fetal lung fibroblasts 
IMR-90. The resultant PDGF-induced cell growth was inhibited by pre-treatment with 
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SOD, indicating the requirement for ROS in cell growth simulated by PDGF 
(Thannickal et al., 2000). Moreover, intracellular generation of O2.-  and extracellular 
release of H2O2 was reported in PDGF-treated TSC2-/- cells, where O2.- but not H2O2 
was shown to be essential for PDGF-induced cell proliferation and ERK1/2 activation 
(Finlay et al., 2005). A similar requirement of ROS in PDGF-induced cell 
proliferation was observed in the human hepatic stellate cell line LI-90 (Adachi et al., 
2005) and in primary cell cultures of leiomyoma smooth muscle cells (Mesquita et al., 
2010). 
 
1.1.4.C   EGF-induced ROS production  
The role of ROS in receptor signalling pathways is also widely investigated in EGF 
signalling. EGF-induced ROS production measured by DCFDA fluorescence was 
reported in the human epidermoid carcinoma cells A431. The ROS generated was 
proposed to be H2O2, as introduction of catalase could abolish the increase in DCFDA 
fluorescence induced by EGF. The EGF-induced tyrosine phosphorylation was 
inhibited by catalase as well, indicating a role for H2O2 in EGF signalling (Bae et al., 
1997). Furthermore, in human ovarian cancer cells OVCAR-3, H2O2 production upon 
EGF stimulation was shown to be essential for EGF-induced Akt activation, p70S6K1 
activation, and HIF-1α expression (Liu et al., 2006). The role of ROS generation upon 
EGF stimulation was further revealed in corneal epithelial cells, where ROS was 
involved in EGF-induced Akt and ERK1/2 activation, cell proliferation, cell adhesion, 
cell migration and wound healing (Huo et al., 2009). Furthermore, NADPH oxidase-
dependent ROS generation induced by EGF in pancreatic cancer cells PANC-1was 
associated with the secretion and activation of MMP-2, which was essential for EGF-
stimulated cell invasion (Binker et al., 2009).  
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1.1.4.D   Angiotensin II-induced ROS production  
Angiotensin II (Ang II) is a G protein-coupled receptor binding ligand that has been 
shown to generate ROS in various cell types such as cultured vascular smooth muscle 
cells (VSMCs), mesangial cells, proximal tubular epithelial (MCT) cells, and 
cardiomyocytes. Prolonged incubation of VSMCs with Ang II resulted in sustained 
generation of O2.-, which is dependent on the activation of NADPH and NADH 
oxidases (Griendling et al., 1994) and the functional expression of  p22phox (Ushio-
Fukai et al., 1996). On the other hand, Ang II could induce a rapid increase in 
DCFDA fluorescence, which was dramatically prohibited in cells overexpressing 
catalase and was therefore postulated to be due to H2O2 production (Ushio-Fukai et al., 
1998). In VSMCs, Ang II-induced p38MAPK activation and Akt activation was 
prevented in the catalase overexpressing system where H2O2 production by Ang II 
was blunted, indicating a role of H2O2 in p38MAPK and Akt signalling pathways 
(Ushio-Fukai et al., 1999; Ushio-Fukai et al., 1998). Later reports suggested that Akt 
activation by Ang II was dependent on the Nox4-derived ROS downstream of Rac1 
activation in mesangial cells (Pedruzzi et al., 2004). Interestingly, a p38MAPK 
inhibitor was shown to inhibit Ang II-induced O2.-  generation in the rat aorta after 
infusion with Ang II, indicating a possible two-way relationship between ROS 
production and p38MAPK activation upon Ang II stimulation (Bao et al., 2007). In 
addition, the involvement of ROS in Ang II-mediated ERK1/2 activation was 
supported by the ability of DPI  or the natural antioxidants α-tocopherol and NAC to 
inhibit ERK1/2 activation in response to Ang II stimulation (Frank et al., 2000; Frank 
et al., 2001). Other ROS-mediated physiological actions of Ang II include activation 
of activator protein-1 (AP-1) (Wu et al., 2005), stimulation of vascular endothelial 
growth factor (VEGF) mRNA translation (Feliers et al., 2006), induction of insulin-
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like growth factor-1 receptor transcription (IGF-1R)  (Du et al., 1999), and 
stimulation of interleukin-6 (IL-6) production (Kranzhöfer et al., 1999).  
 
Taken together, studies on ROS production by physiological ligands have revealed the 
importance of redox signalling in cellular systems. The physiological implications of 
ROS function have been demonstrated in the major survival pathways such as the 
MAPK pathway and the Akt pathway (Kamata et al., 2005; Ghosh et al., 2010; 
Sundaresan et al., 1995; Chen et al., 2004; Liu et al., 2006; Huo et al., 2009; Ushio-
Fukai et al., 1998; Ushio-Fukai et al., 1999; Pedruzzi et al., 2004; Frank et al., 2000; 
Frank et al., 2001). These studies also suggest that NADPH oxidase, which functions 
as a major source of ROS generation, plays an essential role in redox signalling 
pathways such as in the ROS-mediated signalling induced by TNFα, PDGF, EGF, and 
Ang II (Lo and Cruz, 1995; Adachi et al., 2005; Mesquita et al., 2010; Huo et al., 
2009; Griendling et al., 1994; Ushio-Fukai et al., 1996; Frank et al., 2000; Pedruzzi et 
al., 2004; Binker et al., 2009; Svegliati et al., 2005). The interaction between the 
ligands and the corresponding receptors leads to activation of NADPH oxidase and, 
thus, production of ROS (Dröge, 2002).  
 
1.2 Nox family 
 
NADPH oxidase (Nox) proteins are enzymes that catalyze the production of O2.-   by 
using NADPH as the electron donor. The Nox family members are transmembrane 
proteins with conserved structures. They all have six transmembrane domains and the 
C-terminal NADPH- and FAD-binding regions. Additional features are found in some 
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but not all family members, such as the EF hand domain present in Nox5 and Duox 
isoforms (Bedard and Krause, 2007). 
 
1.2.1 Nox isoforms 
 
There are seven members in the Nox protein family, Nox1, Nox2, Nox3, Nox4, Nox5, 
Duox 1 and Duox 2. The different isoforms of Nox proteins exhibit distinct tissue 
distributions. A brief summary of the reported tissue distribution for each isoform is 
shown in Table 2 (Bedard and Krause, 2007; Brown and Griendling, 2009). It is noted 
that the tissue distribution of Nox isoforms can be species-specific. For example, 
expression of Nox1 is reported in rodent stomach but its expression is not confirmed 
in human stomach. Moreover, Nox5 is not found in rodents. It is also noted that the 
subcellular localization of Nox proteins is cell type-specific, and the expression level 
of the Nox isoforms is different among the tissues (summarised in Table 2). 
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Nox isoform Tissue distribution Intracellular localization 
Nox1 
 
High expression: colon epithelia 
Expressed: VSMCs, endothelial cells, uterus, placenta, 
prostate, osteroclasts, retinal pericytes, neurons, astrocytes 
microglia, colon tumour cell lines 
Keratinocyte: weak in cytoplasm and strong in nucleus;  





High expression: phagocytes 
Expressed: CNS, endothelial cells, VSMCs, fibroblasts, 
cardiomyocytes, skeletal muscle, hepatocytes, 
hematopoietic stem cells 
Neutrophils: submembranous phagosomes 
Endothelial cells: caveolae 
Transfected HEK293 cells: plasma membrane 
Smooth muscle cells: perinuclear cytoskeleton 
Hippocampal neurons: membranes of synaptic sites 
Nox3 Transfected HEK293 cells: cytoplasm, plasma membrane 
 
High expression: Inner ear 
Expressed: fetal spleen, kidney, lung, skull  
Nox4  
 
High expression: kidney 
Expressed: mesangial cells, smooth muscle cells, 
endothelial cells, fibroblasts, keratinocytes, osteoclasts, 
neurons, hepatocytes, melanoma cells 
VSMCs: focal adhesions, nucleus, endoplasmic reticulum 
HEK293 and endothelial cells: nucleus, endoplasmic 
reticulum 
Nox5 Lymphatic tissues, testis, VSMCs, endothelial cells, spleen, 
uterus, bone marrows, pancreas, ovary, stomach, prostate 
cancer cells 
Transfected HEK293 cells: plasma membrane 
DUOX1/2 Thyroid, epithelial cells, lung, colon, respiratory tract, 
salivary gland, prostate 
Plasma membrane, endoplasmic reticulum 
DUOX1/2 Thyroid, epithelial cells, lung, colon, respiratory tract, 
salivary gland, prostate 
Plasma membrane, endoplasmic reticulum 
Table 2: Tissue distribution and intracellular localization of Nox proteins  
Summarized from (Bedard and Krause, 2007; Brown and Griendling, 2009).  
Abbreviations: CNS, central nervous system; VSMCs, vascular smooth muscle cells
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In addition to the differences in tissue distribution and subcellular localization, Nox 
proteins also have different requirements for additional components for their 
enzymatic activity. As the first discovered Nox protein, Nox2 is the most extensively 
studied isoform. Activation of Nox2 requires at least five additional components to 
co-assemble. This includes the membrane subunit p22phox, the organizer subunit 
p47phox, the activator subunit p67phox, the GTPase Rac and p40phox. The 
membrane bound p22phox interacts with Nox2 for its stabilization (DeLeo et al., 2000; 
Parkos et al., 1988) and at the same time serves as a docking site for the rest of the 
cytosolic subunits such as p47phox (Heyworth et al., 1991; Kawahara et al., 2005). 
The organizer subunit p47phox interacts with p22phox and translocates to the 
membrane upon activation, thus bringing the subsequent activator subunit p67phox 
into close proximity with Nox2. This allows p67phox to interact with and to activate 
Nox2 (Clark et al., 1990; Leto et al., 1994; El-Benna et al., 2009; Maehara et al., 
2009). Rac1 and Rac2 are also important cytosolic components for Nox2 (Abo et al., 
1991; Knaus et al., 1991; Knaus et al., 1992). Rac1 and Rac2 either function as 
adaptors for the formation of the complex or directly regulate the activity of the 
complex (Quinn et al., 1993; Sarfstein et al., 2004; Diebold and Bokoch, 2001; 
Bokoch and Zhao, 2006). The p40phox was reported as a positive regulator for the 
formation of the complex (Cross, 2000; Kuribayashi et al., 2002; Ueyama et al., 2007; 
Tamura et al., 2007). However, it was also reported that p40phox could downregulate 
the activity of the complex (Sathyamoorthy et al., 1997; Lopes et al., 2004).  
 
Activation of other Nox isoforms requires fewer additional components as compared 
to Nox2. Notably, Nox4 only needs the membrane subunit p22phox to work together 
for activation. All other cytosolic subunits are dispensable for Nox4. On the other 
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hand, Nox1 and Nox3 share a similar activation mechanism with Nox2, while Nox5 
and Duox1/2 can be activated by Ca2+.  A summary of the membrane topology and 






Figure A: Regulatory subunits for Nox proteins   
Diagram is taken from (Brown and Griendling, 2009). 
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1.2.2 Nox-mediated ROS production 
 
Upon activation, the Nox proteins produce O2.-   as the primary ROS. The superoxide 
anion is a very short lived ROS. It quickly dismutates to H2O2 either spontaneously or 
enzymatically by superoxide dismutase (SOD) (McCord and Fridovich, 1969; 
Hodgson and Fridovich, 1975). Superoxide also reacts with nitric oxide (NO) to form 
another highly reactive ROS called peroxynitrite (OONO-). Moreover, O2.-  bears a 
negative charge and, thus, cannot diffuse across the membranes. As such, O2.-  is less 
mobile than H2O2. Due to its short-lived nature and its poor diffusibility, the 
downstream signalling effect of O2.- is dependent on the subcellular localization of 
O2.-  production. Therefore, the signal transduction pathways downstream of each Nox 
isoform are also determined by the subcellular localizations of the Nox proteins. A 
summary of the subcellular localizations for each Nox protein is shown in Table 2. 
The topology of the Nox proteins suggests that the electron is transferred from the 
cytosolic NADPH to the acceptor oxygen on the opposite side of the membrane. The 
O2.-  producing site is, thus, either in the extracellular space or in the intraorganellar 
space (Lambeth, 2004). Therefore, the cytosolic effect of Nox-generated O2.-  in cell 
signalling is mostly attributed to H2O2, which is more stable and can penetrate 
through the lipid bilayer of biological membranes. 
 
However, several studies have shown a distinct mechanism of O2.-  passing through 
anion channels, in particular the chloride channel-3 (ClC-3). Extracellular application 
of a bolus of O2.-  to pulmonary microvascular endothelial cells resulted in an increase 
in the oxidation of the pre-loaded O2.- -sensitive fluorophore hydroethidine (HE). The 
fluorescent change could be blocked by the anion channel blocker 4,4’-
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diisothiocyanostilbene-2,2’-disulfonic acid stilbene (DIDS) or by knockdown of 
chloride channel-3 (ClC-3), suggesting that the anion channel such as CIC-3 might be 
involved in the transmembrane flux of O2.- (Hawkins et al., 2007). The requirement of 
CIC-3 was also indicated in vascular smooth muscle cells for Nox1-dependent ROS 
generation and NF-κB activation upon cytokine stimulation (Miller et al., 2007). 
Generation of O2.- in the endosome was detected upon stimulation of TNFα and IL-1β. 
Nox1 was found to be localized in the endosomes, and is responsible for ROS 
production and the subsequent activation of NF-κB. Such Nox1-dependent signalling 
required the presence of CIC-3, as shown by the anion channel inhibitor niflumic acid 
(NFA) and by the use of ClC-3–null SMCs (Miller et al., 2007). A further study 
showed that O2.-  movement out of the IL-1β-stimulated endosome was dependent on 
anion channels. By using the membrane-permeable luminol and membrane-
impermeable isoluminol probes for O2.-  detection, the authors managed to distinguish 
the O2.-  anion outside and inside the isolated endosomes. The efflux of O2.- out of the 
endosomes was blocked by the anion channel blockers, DIDS or NFA. The 
dependence on anion channels for O2.- permeability was also evidenced by the 
accumulation of ROS inside the endosomes in intact cells after blockage of the anion 
channel by DIDS (Mumbengegwi et al., 2008). Taken together, these reports suggest 
that O2.- is able to pass through biological membranes via an anion channel. This 
model of O2.- translocation across membranes provides another possible mode of 
reaction for O2.-  to elicit its signalling function in the cytosol.    
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1.2.3 Nox in cell signalling 
 
1.2.3.A  MAPK pathway 
Nox-derived ROS, including the primary ROS O2.-  and the indirect product H2O2, 
have been shown to be involved in different cellular signalling pathways. Activation 
of the MAPK system by Nox proteins has been shown for different components in the 
MAPK pathways. Nox1 was suggested to play a role in p38MAPK phosphorylation in 
Angiotensin II-stimulated cells (Lassègue et al., 2001) as well as in basic fibroblast 
growth factor (bFGF)-activated JNK signalling for cell migration (Schröder et al., 
2007). Nox4-dependent signalling upstream of p38MAPK and ERK1/2 in the context 
of cell differentiation promoted by Nox4-mediated ROS production were 
demonstrated in embryonic stem cells and adipocytes, respectively (Schröder et al., 
2009; Li et al., 2006).            
   
1.2.3.B  Akt pathway 
Akt, another important molecule central to many signalling pathways, is also under 
the regulation of Nox-derived ROS, as reported for several Nox isoforms. Nox1 was 
shown to be involved in Ang II–induced redox signalling. In vascular smooth muscle 
cells, knockdown of Nox1 by expressing antisense Nox1 mRNA abolished 
Angiotensin II-induced Akt phosphorylation as well as O2.-  production (Lassègue et 
al., 2001; Tabet et al., 2008). In addition, Nox4 was also proposed to be the NADPH 
oxidase responsible for the ROS dependent Akt activation induced by Angiotensin II 
or arachidonic acid (AA) (Gorin et al., 2003). Regulation of Akt activation by Nox4 
was further evidenced in unstimulated pancreatic cancer PANC-1 cells, in which 
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suppression of ROS production by siRNA-mediated Nox4 downregulation resulted in 
a reduction in Akt phosphorylation (Mochizuki et al., 2006).  
 
A more general mode of Akt regulation by Nox proteins is achieved by targeting the 
membrane subunit p22phox, which is shared by most Nox isoforms. In human lens 
epithelium HLE B3 cells, overexpression of p22phox showed a higher level of Akt 
phosphorylation in both unstimulated and PDGF- or AA-stimulated conditions, while 
p22phox knockdown showed the opposite effect (Wang and Lou, 2009). Knockdown 
of p22phox in the model of von Hippel-Lindau (VHL)-deficient renal carcinoma RCC 
786-O cells showed the similar effect of a reduction in Akt phosphorylation (Block et 
al., 2007; Block et al., 2010). Alternative to targeting p22phox, DPI treatment, which 
inhibits general Nox activity, is another widely used approach to elucidate the role of 
Nox proteins in regulating the Akt pathway (Kumar et al., 2008; Block et al., 2010; 
Mochizuki et al., 2006; Block et al., 2007; Ushio-Fukai et al., 1999).    
 
1.3 Akt  
 
Akt (also known as protein kinase B) is a serine/threonine kinase with large varieties 
of substrates. It was first identified as an oncogene within the transforming retrovirus, 
AKT8. The AKT8 murine retrovirus was isolated from an AKR thymoma cell line in 
1977 (Staal et al., 1977). Ten years later, Staal successfully cloned the akt oncogene 
and the human homologues of the akt gene, AKT1 and AKT2 (Staal, 1987). 
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1.3.1 Structure  
 
There are three Akt isoforms in mammals, Akt1, Akt 2 and Akt3 (or PKBα, PKBβ, 
and PKBγ). The sequence similarity between rat, mouse and human is greater than 
95% for all the three isoforms. In humans, Akt1, Akt2 and Akt3 share a sequence 
similarity of more than 75% (77% between Akt2 and Akt3; 81% between Akt1 and 
Akt2; 82% between Akt1 and Akt3). In mice, the sequence similarity between the 
three isoforms is more than 75% as well (76% between Akt2 and Akt3; 82% between 
Akt1 and Akt2 or Akt1 and Akt3). All three isoforms of Akt contain three important 
domains, the N-terminal pleckstrin homology (PH) domain, the kinase domain and 
the C-terminal hydrophobic motif. The PH domain is involved in the interaction with 
the membrane D3-phosphorylated phosphoinositides. For Akt, interaction with 
phosphatidylinositol-3,4,5-trisphosphate (PIP3) via the PH domain is important for 
membrane translocation and, thus, activation. The kinase domain of Akt shares high 
sequence similarity with other members from the same AGC [cAMP-dependent 
protein kinase (PKA)/protein kinase G/protein kinase C (PKC)] kinase family, such as 
PKA and PKC. The hydrophobic motif located at the carboxyl terminal is typical of 
the AGC kinases and is required for their full activation (Hanada et al., 2004).  
 
1.3.2 Activation process of Akt  
 
Full activation of Akt requires phosphorylation at two important sites, the 
threonine308 (Thr308) residue in the activation loop and the serine473 (Ser473) 
residue in the hydrophobic motif in Akt1. The corresponding phosphorylation sites 
are Thr309/Ser474 in Akt2 and Thr305/Ser472 in Akt3. Throughout this thesis, we 
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shall use Thr308 and Ser473 to generally represent these phosphorylation sites on Akt. 
Phosphorylation on Thr308 and Ser473 are mediated by PDK1 and the rictor/mTOR 
complex respectively (Liao and Hung, 2010).  
 
1.3.2.A   Step 1: Membrane translocation 
One of the earliest findings for Akt activation is that it is a phosphoinositide 3‑kinase 
(PI3K) dependent process. Increased Akt kinase activity, which was observed after 
stimulation with PDGF, EGF, insulin and bFGF, was abolished by the PI3K inhibitor 
wortmannin. Expression of mutated PDGF receptor or mutated p85 subunit of PI3K 
provided further evidence for the essential role of PI3K in Akt activation (Burgering 
and Coffer, 1995). Additionally, Akt constructs with mutations in the PH domain 
failed to respond to PDGF stimulation, indicating a critical role for the PH domain in 
PDGF-mediated Akt activation (Franke et al., 1995).  
 
The requirement for PI3K and the PH domain in Akt activation was later revealed to 
be related to the membrane translocation process of Akt. Membrane translocation of 
Akt is facilitated by the interaction of the PH domain with the D3-phosphorylated 
phosphoinositides, especially PIP3. Translocation of Akt to the membrane was 
observed within minutes after insulin-like growth factor-1 (IGF-1) stimulation 
(Andjelković et al., 1997). Similar membrane translocation was also observed after 
PDGF stimulation and was inhibited by wortmannin (Bellacosa et al., 1998). However, 
the PH domain mutant of Akt did not translocate to the membrane following PDGF 
stimulation. Moreover, mutations in the predicted phospholipid binding residues 
resulted in a decrease in the kinase activity of Akt (Bellacosa et al., 1998). Membrane 
localization of Akt was reported to be essential for the activation of the Akt kinase. 
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The membrane localized myristoylated/palmitylated-Akt exhibited high activity even 
in unstimulated cells (Andjelković et al., 1997). Furthermore, forced membrane 
localization of Akt by means of myristylation could lead to Akt activation even when 
the PH domain was defective (Bellacosa et al., 1998). A later report showed that 
membrane localized Akt had high transforming ability, which was not dependent on 
the intact PH domain (Aoki et al., 1998).  
 
1.3.2.B   Step 2: Phosphorylation 
The second important step in Akt activation following membrane translocation is the 
phosphorylation of the kinase. In 1996, it was reported that Akt activation by insulin 
or IGF-1 was accompanied by its phosphorylation on Thr308 and Ser473. More 
importantly, phosphorylations on both sites were needed to generate a high Akt 
activity (Alessi et al., 1996). Furthermore, membrane targeted 
myristoylated/palmitylated-Akt was heavily phosphorylated on both Thr308 and 
Ser473 and exhibited high activity, even in unstimulated cells (Andjelković et al., 
1997; Bellacosa et al., 1998). The fact that the T308D/S473D double mutant is 
constitutively active also suggests that phosphorylation on these two sites is a critical 
step for Akt activation (Bellacosa et al., 1998). 
 
Phosphorylation of Thr308 
The kinase that is responsible for phosphorylation on Thr308 was identified as 3-
phosphoinositide-dependent protein kinase-1 (PDK1). It was first purified from rabbit 
skeletal muscle extracts and was characterized to phosphorylate Akt on Thr308 in the 
presence of PIP3 or PIP2 (Alessi et al., 1997). Human PDK1 was then cloned and 
reported as the human homologue of the Drosophila DSTPK61 kinase (Alessi et al., 
Chapter 1: Introduction 22
1997). Phosphorylation of Akt by PDK1 is dependent on membrane translocation of 
PDK1. PDK1 was shown to translocate to the plasma membrane upon PDGF 
treatment in a PI3K-dependent manner, and this translocation was associated with the 
ability of PDK1 to induce Akt activation (Anderson et al., 1998). A PDK1 mutant that 
failed to translocate to the membrane also failed to induce Akt activity, while the 
membrane-directed myristoylated-PDK1 led to constitutive activation of Akt 
(Anderson et al., 1998).  
 
The D3-phosphorylated phosphoinositide PIP3 at the plasma membrane is, thus, a 
critical messenger for Akt activation, as it is involved in the regulation of both PDK1 
and Akt translocation. PIP3 was shown to cause membrane translocation of Akt itself 
and the upstream PDK1 (Stephens et al., 1998). The inhibitory effect of wortmannin 
on myristoylated-PDK1-mediated Akt activation suggested that localization of Akt at 
the membrane was not functionally redundant (Anderson et al., 1998). Similarly, the 
phosphorylation and activity of the myristoylated/palmitylated-Akt could still be 
decreased by the PI3K inhibitor wortmannin or LY294002, supporting a role of PIP3 
in PDK1 recruitment and activation (Andjelković et al., 1997; Bellacosa et al., 1998). 
Therefore, PIP3 functions to activate the upstream kinase PDK1 and to render Akt as 
a substrate for PDK1 at the plasma membrane.  
 
The importance of PIP3 in Akt activation suggests that PI3K is not the only key 
regulator, because the production of PIP3 can be reversed by phosphoinositide 
phosphatases. The most well-established regulator is the Phosphatase and Tensin 
Homolog Deleted on Chromosome 10 (PTEN), which was first identified as a tumour 
suppressor gene at chromosome 10q23.3 and is mutated in variety of human cancers 
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(Steck et al., 1997; Li et al., 1997). PTEN functions as a lipid phosphatase to 
dephosphorylate the D3 position of the lipid products such as PIP3 (Maehama and 
Dixon, 1998). Therefore, PTEN counteracts the effect of PI3K by decreasing the level 
of PIP3. Loss of PTEN results in elevated Akt phosphorylation and activation 
(Stambolic et al., 1998). Therefore, the balance between the forward PI3K-dependent 
signal and the reverse PTEN-dependent signal determines the plasma membrane level 
of PIP3 and, thus, regulates PIP3-dependent activation of Akt.  
 
Phosphorylation of Ser473 
The identity of the kinase responsible for Akt phosphorylation at Ser473 was under 
debate for a long period of time. Several kinases have been proposed to be the 
prospective kinase for Ser473 such as DNA-dependent protein kinase (DNA-PK), 
integrin-linked kinase (ILK), Akt itself and PDK1 (Feng et al., 2004; Persad et al., 
2001; Toker and Newton, 2000; Balendran et al., 1999). However, there are also 
controversial observations suggesting that these kinases are not responsible for Ser473 
phosphorylation  (Williams et al., 2000; Hill et al., 2002; Lynch et al., 1999; Hill et al., 
2001; Alessi et al., 1996). For example, Williams et al. showed that, in PDK1-/- mouse 
embryonic stem cells, IGF1-induced Akt phosphorylation was still observed on 
Ser473, suggesting that another kinase phosphorylates Akt on Ser473 in PDK1-/- cells 
(Williams et al., 2000). In addition, it was shown by Hill et al. that Akt itself was 
unlikely to be the kinase for Ser473. In cells treated with 1µM staurosporine, insulin-
stimulated Akt activation was abolished, while phosphorylation on Ser473 was not 
affected (Hill et al., 2001). 
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It is now widely accepted that the rictor/mTOR complex is responsible for 
phosphorylation of Akt on the Ser473 residue. The mammalian target of rapamycin 
(mTOR) is a serine/threonine kinase which forms two functionally important 
complexes in cells, rictor/mTOR (mTORC2) and raptor/mTOR (mTORC1). Each 
complex consists of several components. Among these, mLST8 and deptor are shared 
by the two complexes, while rictor, mSIN1 and protor are unique for the rictor/mTOR 
complex (Sparks and Guertin, 2010). A report in 2005 showed that knockdown of 
rictor or mTOR expression by shRNA led to a decrease in Akt phosphorylation on 
Ser473 (Sarbassov et al., 2005). An in vitro phosphorylation assay also showed that 
only mTOR bound to rictor, but not raptor, could phosphorylate Akt on Ser473 
(Sarbassov et al., 2005). Another group also reported, in 3T3-L1 adipocytes, that 
immunoprecipitated complexes containing mTOR and rictor could phosphorylate 
Ser473. Moreover, introduction of rictor siRNA led to suppression in insulin-induced 
Akt phosphorylation on Ser473 (Hresko and Mueckler, 2005). Further investigations 
suggested that SAPK interacting protein 1 (SIN1) is an essential component for the 
rictor/mTOR complex. Knockdown or genetic ablation of SIN1 resulted in disruptions 
in rictor-mTOR interaction and Ser473 phosphorylation (Jacinto et al., 2006; Yang et 
al., 2006). On the other hand, reconstitution of SIN1 in SIN-/- MEF cells could restore 
Akt phosphorylation on Ser473 (Jacinto et al., 2006). In contrast to the non-redundant 
role of SIN1 in the rictor/mTOR complex, the other rictor/mTOR-specific component, 
protor, is not required for the rictor/mTOR complex formation (Pearce et al., 2007).  
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1.3.3 A second level of regulation on Akt phosphorylation and activity: protein 
phosphatases 
 
A second level of regulation is dependent on the protein phosphatases. The main 
protein phosphatases involved in Akt regulation are protein phosphatase 2A (PP2A) 
for the Thr308 site and pleckstrin homology domain leucine-rich repeat protein 
phosphatase (PHLPP) for the Ser473 site (Liao and Hung, 2010). The balance 
between phosphorylation by kinases and dephosphorylation by phosphatases 
determines the phosphorylation level of the Akt kinase. The phosphorylated and, thus, 
activated Akt functions as a serine/threonine kinase and phosphorylates downstream 
substrates in various cellular compartments, including cytosol, mitochondria, and 
nucleus (Liao and Hung, 2010). 
  
1.3.3.A   PP2A 
The PP2A holoenzyme is a heterotrimer consisting of three subunits, the scaffold A 
subunit, the regulatory B subunit and the catalytic C subunit. The catalytic subunit (C 
subunit) and scaffold subunit (A subunit) form the core dimer, which further binds 
with a wide variety of regulatory subunits. The B subunit is responsible for substrate 
specificity and subcellular localization (Millward et al., 1999). Multiple isoforms have 
been identified for each subunit. A summary of the PP2A isoforms is shown in Table 
3 (Janssens and Goris, 2001).   
 
The effect of protein phosphatase on Akt was initially shown by the use of protein 
phosphatase inhibitors okadaic acid and vanadate, which led to an activation of Akt 
accompanied by a decrease in electrophoretic mobility (Andjelković et al., 1996). In 
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the same report, an in vitro assay showed that PP2A could dephosphorylate Akt and 
reduce Akt activity (Andjelković et al., 1996). Later, the involvement of PP2A in the 
regulation of Akt phosphorylation was confirmed in rat adipocytes (Resjö et al., 2002) 
and in the context of osmotic shock (Meier et al., 1998; Chen et al., 1999). In addition, 
Akt forms a complex with the PP2A catalytic (PP2A-C) subunit, and its activity was 
reduced by overexpression of the PP2A-C subunit (Ivaska et al., 2002).  
 











B' (B56 or  PR61) family  
á 
â 1,2 










B''' (PR93/PR110) family 
  
Table 3: Summary of PP2A isoforms for each subunit 
Summarized from (Janssens and Goris, 2001). 
 
The PP2A-dependent Akt dephosphorylation has been reported extensively over the 
years in different systems, mainly by the use of phosphatase inhibitors like okadaic 
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acid, or by downregulation of either the scaffold or the catalytic subunit. However, 
these approaches essentially affect a wide range of substrates that are sensitive to 
PP2A (Millward et al., 1999). Given the complexity in substrate recognition by the 
various regulatory subunits, it is, therefore, important to highlight the specific 
regulatory subunit(s) involved in the regulation of Akt phosphorylation. This will 
allow an understanding of the specific effect of PP2A in the Akt pathway. In 2005, it 
was reported that the B’ family was the responsible modulator for Akt by using an 
Aα-exchange system. In this system, the endogenous Aα subunit was silenced while 
an RNAi-resistant Aα mutant defective in binding to B’ family regulatory subunits 
was expressed. The selective removal of the PP2A/B’ heterotrimers resulted in 
attenuated Akt phosphorylation upon stimulation by EGF, FGF2 and nerve growth 
factor (NGF), suggesting that B’ family was involved in Akt modulation (Van 
Kanegan et al., 2005). The same B’ family containing PP2A homoenzymes was also 
shown to be responsible for the ability of IEX (immediate early response gene X-1) to 
delay Akt phosphorylation (Harnett and Harnett, 1993). On the other hand, the B55α 
subunit was identified by Kuo et al. as the particular regulatory subunit to target Akt 
phosphorylation (Kuo et al., 2008). Akt was coimmunoprecipitated with the B55α 
subunit. Moreover, overexpression of B55α could reduce phosphorylation on Thr308 
in FL5.12 cells after IL-3 stimulation as well as in NIH3T3 cells after serum 
stimulation, while knockdown of B55α resulted in an increase in phosphorylation on 
Thr308 in either un-stimulated FL5.12 cells or serum-stimulated NIH3T3 cells. An in 
vitro assay further confirmed that the PP2A-B55α holoenzyme effectively catalyzed 
Akt dephosphorylation on Thr308. Notably, in the overexpression, knockdown and 
the in vitro dephosphorylation assays, only Thr308 phosphorylation was significantly 
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affected while the phosphorylation on Ser473 was not regulated by the PP2A-B55α 
holoenzyme.  
 
1.3.3.B   PHLPP 
PHLPP was discovered by Gao et al. as the phosphatase responsible for the regulation 
of Ser473 phosphorylation (Gao et al., 2005). PHLPP was reported to interact with 
Akt and to selectively dephosphorylate Akt at Ser473 but not at Thr308 in 293T cells 
transfected with HA-PHLPP. Similarly, transfection of siRNA against PHLPP led to 
an increase in phosphorylation on Ser473 but not on Thr308. Further investigation 
discovered a second isoform, PHLPP2, with a similar function as the previously 
identified PHLPP1 to specifically dephosphorylate Ser473 but not Thr308 of the Akt 
kinase (Brognard et al., 2007). The difference of PHLPP1 and PHLPP2 in regulating 
Akt turned out to be the selectivity for different Akt isoforms. Knockdown of 
PHLPP1 affected Akt2 and Akt3, while knockdown of PHLPP2 increased 
phosphorylation of Akt1 and Akt3 (Brognard et al., 2007). Other studies later 
revealed the relationship between impaired Ser473 phosphorylation level and the 
higher level of PHLPP1 in skeletal muscle cells from type 2 diabetic patients 
(Cozzone et al., 2008). Moreover, elevated Ser473 phosphorylation level and reduced 
PHLPP level were reported in metastatic cells as compared to primary cells (Qiao et 
al., 2007). In addition, one group showed that FK506-binding protein 51 (FKBP51) 
could serve as a scaffolding protein for Akt and PHLPP and was, thus, a negative 
regulator of Akt phosphorylation (Pei et al., 2009). Interestingly, recent reports 
showed that PI3K/Akt could regulate PHLPP by suppressing PHLPP degradation (Li 
et al., 2009) or by taking part in insulin-induced decrease of PHLPP phosphatase 
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activity (Kanan et al., 2010). These observations suggest the existence of a feed back 
regulation loop between Akt and PHLPP.  
 
1.3.4 Other regulators: Akt interacting proteins 
 
In addition to the responses to upstream kinases and phosphatases, Akt 
phosphorylation and activity are also under the regulation of other Akt-interacting 
proteins. Carboxyl-terminal modulator protein (CTMP) was identified to bind 
specifically to the carboxyl-terminal of Akt at the plasma membrane (Maira et al., 
2001). Increased CTMP expression led to a decrease in Akt activity as well as Akt 
phosphorylation induced by pervanadate, insulin and IGF-1, but the mechanism 
involved is not yet understood. Keratin K10 is another Akt-interacting partner that 
negatively regulates Akt by cytoskeleton sequestration and prevention of intracellular 
translocation of Akt (Paramio et al. 2001). Trb3 negatively affects Akt 
phosphorylation and activity, possibly by binding directly to and masking the Thr308 
phosphorylation site (Du et al., 2003). Other proteins such as Akt phosphorylation 
enhancer (APE), Grb10 and Tcl10 were reported to activate Akt with unknown 
mechanisms (Jahn et al., 2002; Laine et al., 2000; Pekarsky et al., 2000; Anai et al., 
2005). Another important Akt-binding protein is heat shock protein 90 (Hsp90). 
Hsp90 and Akt were found to form a complex in vivo, the disruption of which led to 
dephosphorylation and inactivation of Akt (Sato et al., 2000). The dephosphorylation 
in this case was reported to be a PP2A-dependent process (Sato et al., 2000). A 
similar observation of the PP2A-Hsp90 mediated Akt dephosphorylation was recently 
reported by Cao et al. (Cao et al., 2009). In this paper, a ROS-mediated 
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conformational change in Akt led to a disruption of Akt-Hsp90 interaction, but an 
increase in Akt-PP2A interaction (Cao et al., 2009).  
 
1.4 Redox regulation of Akt  
 
ROS production has been documented as a mediator of signal transduction under 
different stimuli such as platelet-derived growth factor (PDGF), epidermal growth 
factor (EGF), insulin, endothelin-1  and angiotensin II (Sundaresan et al., 1995; Bae et 
al., 1997; Mahadev et al., 2001; Daou and Srivastava, 2004; Ushio-Fukai et al., 1999). 
The specific requirement for ROS in Akt activation is well documented. For example, 
Ang II-induced Akt activation was prevented by NAC and DPI, which were shown to 
abrogate ANG II-stimulated ROS production (Feliers et al., 2006). In OVCAR-3 cells, 
EGF-induced H2O2 production was necessary for Akt activation, as inhibition of H2O2 
by catalase blocked EGF-mediated Akt activation (Liu et al., 2006). Similarly, in 
insulin-stimulated 3T3-L1 adipocytes, DPI was able to abolish H2O2 generation as 
well as Akt activation induced by insulin (Mahadev et al., 2001). In terms of 
mechanism, ROS mediated redox regulation of Akt can be achieved either by 
indirectly affecting the upstream kinases and phosphatases or by directly modifying 
Akt itself, which will be discussed in this section.   
 
1.4.1 PI3K related redox regulation of Akt  
 
The most widely studied Akt regulator in response to redox changes is PI3K. PI3K 
signalling could be redox regulated either through the protein tyrosine phosphatases 
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that affect PI3K activation, or through the lipid phosphatase PTEN which catalyzes 
the dephosphorylation of PIP3 and, thus, counteracts the effect of PI3K.  
 
The major PI3K involved in Akt regulation is the Class I PI3Ks that produce PIP3 
from PIP2.  There are different routes of input signals for Class I PI3K activation 
including Ras and other small GTPases, G-protein coupled receptor (GPCR) and 
tyrosine kinases. The Src homology (SH2) domain of the p85 regulatory subunits of 
PI3Ks is engaged in the interaction with the specific phospho-tyrosine motif in 
tyrosine kinase receptors, resulting in the activation of corresponding PI3Ks 
(Vanhaesebroeck et al. 2010). In this case, PI3K activation is counteracted by protein 
tyrosine phosphatases (PTP), which function to remove the phospho-tyrosine signal 
needed for SH2 binding. The major tyrosine phosphatases reported to be relevant to 
the redox regulation of PI3K-Akt signalling include protein-tyrosine phosphatase 1B 
(PTP1B), the 45-kDa spliced variant of the T cell protein-tyrosine phosphatase 
(TC45), and the SH2 domain-containing PTP (SHP-2). Recombinant PTP1B was 
oxidized and inactivated by H2O2 in vitro, and the oxidative inactivation on PTP1B 
was also achieved by EGF-produced H2O2 in A431 human epidermoid carcinoma 
cells (Lee et al., 1998). Insulin-induced H2O2 production showed a similar oxidative 
inhibitory effect on PTP1B activity, and the observed inhibition was prevented by 
catalase (Mahadev et al., 2001). Furthermore, catalase reduced the insulin-induced 
tyrosine phosphorylation of insulin receptor β-subunit and IRS-1 proteins, suggesting 
that inhibition of protein tyrosine phosphatases by the redox signal might be required 
for the activation of tyrosine kinase receptor. In addition to PTP1B, TC45 was 
identified as another protein tyrosine phosphatase that was rapidly and transiently 
oxidized in response to insulin (Meng et al., 2004). TC45 recognizes the insulin 
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receptor β-subunit as the substrate and affects phosphorylation on the Tyr972 site. 
Dephosphorylation of Tyr972 by TC45 influences insulin-induced PI3K-Akt activity, 
as the Tyr972 site is important for PI3K activation. Moreover, SHP-2 was also 
reported to be a target for oxidation and inactivation by H2O2 treatment and PDGF 
stimulation in Rat-1 cells and by T-cell receptor generated ROS in T cells (Meng et al., 
2002).  
 
The lipid phosphatase PTEN is another important redox sensitive regulator of the 
PI3K-Akt signalling pathway. PTEN functions to directly remove the PIP3 signal by 
dephosphorylating PIP3 at the D3 position and, thus, serves as a negative regulator of 
the PI3K-Akt pathway. The oxidative regulation of PTEN was first reported as 
disulfide bond formation upon H2O2 treatment. The H2O2-mediated oxidation 
involved the Cys(124) residue in the active site of PTEN and, thus, led to an 
reversible inactivation of the protein (Lee et al., 2002). This oxidation was shown 
with the purified PTEN in vitro as well as in NIH3T3 or Hela cells exposed to H2O2 
(Lee et al., 2002). The oxidative inactivation of cellular PTEN by H2O2 resulted in an 
increase in PIP3 level and Akt activation, which was not observed in cells lacking 
PTEN (Leslie et al., 2003). The same paper also showed that, in RAW264.7 
macrophage, the endogenous oxidant production by lipopolysaccharide (LPS) and 
phorbol 12-myristate 13-acetate (PMA) caused PTEN oxidation, and this was 
correlated with activation of the downstream Akt kinase (Leslie et al., 2003). PTEN 
oxidation was also shown to be induced by various peptide growth factors such as 
PDGF, EGF and insulin (Kwon et al., 2004). Moreover, recombinant PTEN was 
shown to be reversibly oxidized by S-nitrosothiols including S-nitrosocysteine 
(CSNO), S-nitrosoglutathione (GSNO), and S-nitroso-N-acetylpenicillamine (SNAP). 
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In line with this, the cellular PTEN molecule was also oxidized in A431 cells 
incubated with CSNO, GSNO and SNAP (Yu et al., 2005). The thiol modification on 
PTEN led to a reversible inhibition of the phosphatase activity, but the CSNO-
induced oxidation was identified as a mixed disulfide, which was different from the 
disulfide formation found in H2O2-induced PTEN oxidation (Yu et al., 2005). In 2007, 
a paper from our lab showed that the induction in Akt phosphorylation by serum was 
dependent on O2.- -mediated PTEN oxidation, which was attributed to S-nitrosylation 
of the protein (Lim and Clément, 2007).  
 
The functional significance of oxidatively inactivated PTEN on downstream Akt 
activation was extensively reported in many cases, including mitochondria-derived 
H2O2 accumulation (Connor et al., 2005), respiratory deficiency induced NADH 
increase (Pelicano et al., 2006), peroxynitrite-mediated neuroprotection (Delgado-
Esteban et al., 2007), or arachidonic acid (AA) metabolism in pancreatic cancer cell 
lines (Covey et al., 2007). The important role of PTEN oxidation in Akt activation 
was demonstrated by Seo et al. in two human neuroblastoma cell lines. It was shown 
that insulin-stimulated PDK1 membrane translocation and Akt phosphorylation were 
only observed in SK-N-SH cells, in which PTEN oxidation was observed upon ROS 
production by insulin stimulation, but not in SK-N-BE (2) cells that did not display 
ROS-mediated PTEN oxidation in response to insulin stimulation (Seo et al., 2005). 
In spite of the different types of ROS/RNS involved or the different types of oxidative 
modifications reported, these investigations provide evidence that the oxidative 
inactivation of PTEN contributes to the activation of downstream Akt signalling 
pathway.  
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1.4.2 Akt as the direct target for redox regulation  
 
Direct redox-mediated modifications have been reported on the Akt protein itself. The 
AMS (4-Acetamido-4-maleimidylstilbene-2, 2-disulfonic acid) alkylation assay was 
used to detect the increased formation of oxidized Akt upon H2O2 treatment (Murata 
et al., 2003). Studies on the mutant constructs of Akt showed that Cys297 and Cys311 
were involved in disulfide bond formation in Akt oxidation. A transient 
dephosphorylation of Akt was associated with the enhanced interaction between 
PP2A and Akt upon H2O2-induced Akt oxidation. Overexpression of the antioxidant 
protein, glutaredoxin (GRX), protected Akt from oxidation by H2O2 and suppressed 
recruitment of PP2A to Akt (Murata et al., 2003). These results indicate that the redox 
status of Akt might affect the phosphorylation status of the protein via the interaction 
with PP2A. In line with the disulfide formation in H2O2-mediated Akt oxidation 
shown by Murata et al., another study on the crystal structure of the Akt2 kinase 
domain also showed intermolecular disulfide bond formation in the activation loop 
between Cys297 and Cys11 (Huang et al., 2003). A more recent paper demonstrated 
that the synthetic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR) could induce 
ROS generation and disulfide formation. In addition, the amount of oxidized Akt was 
increased by 4-HPR treatment, while phosphorylation of Akt on Ser473 was 
concurrently reduced by 4-HPR (Cao et al., 2009). All together, these reports suggest 
that cysteine oxidation (such as disulfide bond formation) in the activation loop could 
possibly lead to oxidative inactivation of the Akt kinase via the phosphatase-mediated 
dephosphorylation of Akt.   
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In addition to disulfide bond formation, S-nitrosylation is reported in the regulation of 
Akt oxidation. The nitric oxide (NO) donor SNAP was shown to prevent insulin-
induced Akt activation in mouse C2C12 myotubes or mouse 3T3-L1 adipocytes, as 
well as to prevent FBS-induced or PDGF-induced activation of Akt/PKB in C2C12 
myotubes (Yasukawa et al., 2005). S-nitrosylation of Akt was detected on cellular Akt 
immunoprecipitated from SNAP-treated C2C12 cells and was correlated with the 
inhibition of Akt activity. Studies on the mutant constructs of all the seven cysteine 
residues showed that SNAP failed to S-nitrosylate or to inactivate Akt1/PKB (C224S), 
indicating that S-nitrosylation of Akt mainly occurred on Cys224 (Yasukawa et al., 
2005). Similarly, enhanced Akt S-nitrosylation was observed upon GSNO treatment. 
Insulin-induced Akt activity was reduced by GSNO treatment in vitro as 
demonstrated by an in vitro kinase assay using immunoprecipitated Akt after insulin 
stimulation in vivo. This indicated that S-nitrosylation on Akt inhibited Akt activity 
(Carvalho-Filho et al., 2005). Most recently, Akt dysfunction in aged skeletal muscle 
was related to an increase in Akt S-nitrosylation (Wu et al., 2009). 
 
Taken together, although the mechanisms are not well defined, emerging evidence 
suggests that Akt is also a redox sensitive protein and is subjected to different redox 
modifications. The exact physiological relevance of these modifications remains to be 
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1.5 Rationale of the project 
 
Reactive oxygen species (ROS) are produced as products of normal cellular 
metabolism. Despite the historically implicated deleterious effects of ROS, it is now 
widely accepted that ROS are important secondary messengers for cellular signalling 
pathways (Valko et al., 2007). In that regard, our group has demonstrated that 
production of intracellular superoxide (O2.-) inhibits tumour cells’ sensitivity to a 
variety of apoptotic triggers, including anti-cancer drugs (Clément and Stamenkovic, 
1996; Pervaiz et al., 1999; Pervaiz et al., 2001; Clément et al., 1998). Interestingly, we 
recently demonstrated that, in serum-deprived mouse embryonic fibroblasts (MEFWT), 
an increase in intracellular level of O2.- through pharmacological inhibition of the 
Cu/ZnSOD protein or the downregulation of its expression mimics growth factor-
induced phosphorylation of Akt. The O2.- -induced Akt phosphorylation was achieved 
through oxidation of PTEN by S-nitrosylation (Lim and Clément, 2007). These results 
support the notion that O2.- is a physiologically relevant second messenger for Akt 
activation through S-nitrosylation of PTEN, and offer a mechanistic explanation for 
the mitogenic and pro-survival activities of O2.-. 
 
Interestingly, we noticed that, in mouse embryonic fibroblasts that do not express the 
tumour suppressor PTEN (MEFPTEN-/- cells), a decrease in the intracellular level of 
O2.- abrogated the hyperphosphorylation of Akt that was observed in these cells. The 
Akt dephosphorylation observed could not be attributed to the effect of O2.- on the 
PTEN molecule in these MEFPTEN-/- cells. Therefore, we hypothesize that O2.- may 
regulate the PI3K-Akt pathway not only through the inhibition of PTEN but also 
through a novel pathway that may be critical for the maintenance of the 
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hyperphosphorylated Akt observed in  MEFPTEN-/- compared to MEFWT cells. Hence, 
the present study is designed to unravel the pathways involved in the redox control of 
Akt phosphorylation in MEFPTEN-/- cells. 
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CHAPTER 2 MATERIALS AND METHODS 
 
2.1 Materials 
2.1.1 Chemicals and reagents  
Company Chemicals and reagents 
Hyclone (UT, USA) 
 
Dulbecco’s  Modified  Eagle’s  Medium  (DMEM),  
Fetal  Bovine  Serum  (FBS), Phosphate Buffered 
Saline (PBS), Trypsin, L-glutamine 
  
Calbiochem (Calbiochem, San 
Diego, CA)  
LY294002  
Promega (Promega, Madison, 
WI, USA) 
PP2A activity assay kit 
Merck (Germany)  Hydrogen peroxide (H2O2) 
Molecular Probes (Molecular 




Carboxyfluorescein  (AM-BCECF),   
5-(and-6)-chloromethyl-2´,7´-
dichlorodihydrofluorescein  diacetate  acetyl ester  
(CM-H2DCFDA) 
Pierce (Pierce, Thermo Fisher 
Scientific Inc, Rockford, IL, 
USA)  
Coomassie PlusTM Protein assay  reagent,  
RestoreTM Western  Blot  stripping  buffer,  
Supersignal  west  Pico  chemiluminescent substrate  
Lonza (Walkersville, MD, 
USA) 
Gentamicin sulfate 
Sigma-Aldrich (St. Louis, 
USA) 
 
Triton X-100, Aprotinin, Pepstatin A, 
Phenylmethanesulfonyl Fluoride (PMSF), Leupeptin, 
Sodium orthovanadate,  RNAase A, Propidium  
Iodide  (PI), Dithiothreitol  (DTT), Bovine Serum 
Albumin  (BSA), crystal violet,  
O – phthalaldehyde (OPT), reduced glutathione 
(GSH), Bis-N-methylacridinium (Lucigenin), 
Somatic ATP releasing reagent, 
Diethylthiocarbamate (DDC),  
Diphenyleneiodonium chloride (DPI) , 
Dimethylsulfoxide  (DMSO), Nigericin,  
N-acetylcysteine (NAC), Buthionine sulfoximine 
(BSO)  
Santa Cruz Biotechnology 
(Santa Cruz, CA, USA)  
Okadaic acid 
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Cell Signalling Technology 
Inc. (Beverly, MA, USA) 
Calyculin A,  in vitro Akt kinase assay kit 









Horseradish peroxidase (HRP)-conjugated goat anti-
rabbit secondary antibody 
Pierce (Pierce, Thermo 
Fisher Scientific Inc, 
Rockford, IL, USA) 
Horseradish peroxidase (HRP)-conjugated goat anti-
mouse secondary antibody 
Cell Signalling Technology 
Inc. (Beverly, MA, USA) 
Rabbit polyclonal Anti-PTEN 
Rabbit polyclonal Anti-phospho Akt Ser473 
Rabbit polyclonal Anti-phospho Akt Thr308 
Rabbit polyclonal Anti-Akt 
Rabbit polyclonal Anti-Akt1 
Rabbit polyclonal Anti-Akt2 
Rabbit polyclonal Anti-Akt3 
Mouse monoclonal Immobilized Akt antibody (bead 
conjugate) 
Immobilized Mouse IgG(bead conjugate) 
Rabbit polyclonal Anti-PDK1 
Rabbit polyclonal Anti-mTOR 
Rabbit polyclonal Anti-Rictor 
Rabbit polyclonal Anti-Raptor 
Rabbit polyclonal Anti-phospho GSK3α/β Ser21/9 
Rabbit polyclonal Anti-GSK3α 
Rabbit polyclonal Anti-GSK3β 
Rabbit polyclonal Anti-phospho p70S6K Thr389 
Rabbit polyclonal Anti-p70S6K  
Rabbit polyclonal Anti-phospho ERK(44/42) 
Thr202/Tyr204 
Rabbit polyclonal Anti-ERK(44/42) 
Rabbit polyclonal Anti-VDAC 
Mouse monoclonal Anti-HA 
Clontech (Clontech 
Laboratories, Inc., Palo 
Alto, CA, USA) 
Mouse monoclonal Anti-PARP 
Echelon (Salt Lake City, 
UT) 
Mouse monoclonal IgM Fluorescein (FITC) 
conjugated Anti-PIP3  
Chemicon (CA,USA) Mouse monoclonal Anti-NHE1 
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Sigma-Aldrich (St. Louis, 
USA) 
Mouse monoclonal Anti-β-actin 
Upstate biotechnology (Lake 
placid, NY,USA) 
Rabbit polyclonal Anti-Cu/ZnSOD 
Mouse monoclonal Anti-PP2A-C 
Abcam Inc (Cambridge, 
MA, USA). 
Mouse monoclonal Anti-Cadherin 
Mouse monoclonal Anti-phosphoserine 
Rabbit polyclonal Anti-phosphothreonine 
Rabbit polyclonal Anti-phosphotyrosine 
Santa Cruz Biotechnology 
(Santa Cruz, CA, USA) 
Mouse monoclonal Anti-PP2A-B55α 
Rabbit polyclonal Anti-Nox4 
 
2.1.3 Plasmids 
Plasmid Myr-Akt-HA encodes for Akt protein fused to a N-terminal myristylation 
signal and a C-terminal hemagglutinin (HA) epitope tag. The construct was cloned in 
the CMV6 expression vector. This plasmid was kindly provided by Dr. Tung O. Chan 
from Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA. 
 
Plasmid pCMV-HA-NHE1 encodes for NHE1 protein fused to a N-terminal 
hemagglutinin (HA) epitope. This plasmid was kindly provided by Dr. Jeffrey R. 
Schelling from MetroHealth Medical Centre, Cleveland, Ohio, USA. 
 
2.1.4 Cell lines and cell culture  
Wild type mouse embryonic fibroblasts (MEFWT) and PTEN knockout MEFs 
(MEFPTEN-/-) were obtained from Dr Tak W. Mak (University Health network, 
Toronto, Ontario, Canada).  The MEF cells were maintained in Dulbecco’s modified 
Eagle’s medium/high glucose (DMEM) supplemented with 2mM L-glutamine and 
1mM gentamicin. Cells were incubated in a 5% CO2 incubator at 37ºC. Cells were 
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normally grown in DMEM containing 10% fetal bovine serum (FBS). Under serum 
starved condition, cells were starved in DEMD containing 0.5% FBS.  
 
The human prostate cancer cell line LNCaP was purchased from American Type 
Culture Collection (ATCC). LNCaP cells were maintained in RPMI 1640 medium 
supplemented with 2 mM L-glutamine, 1 mM sodium pyruvate and 1 mM gentamicin. 
Cells were incubated in 5% CO2 incubator at 37ºC. Cells were normally grown in 




2.2.1 Plasmid amplification 
Plasmid DNA was amplified by transformation of competent E.coli DH5α cells, 
minipreparation using Wizard® Plus SV Minipreps DNA purification System 
(Promega, Madison, WI, USA), and maxi preparation using Macherey-Nagel 
Nucleobond PC500 (Promega, Madison, WI, USA). Transformation was done by 
adding about 10ng of the plasmid into the competent cells, followed by heat shock at 
37°C for 45 seconds and incubation overnight at 37°C for about 16 hours. After 
transformation, a single colony was picked and incubated in LB medium containing 
antibiotics for about 16 hours at 37°C.  
 
For minipreparation, the bacterial pellet was collected by centrifugation for 5 minutes 
at 10,000g from 1ml mini culture. Cell resuspension solution and cell lysis solution 
were added into the pellet to lyse the cells. Alkaline protease solution and 
neutralization solution were subsequently added before bacterial lysate was 
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centrifuged at 14,000rpm for 10 minutes. The cleared lysate was then allowed to pass 
through the Wizard® Plus SV Minipreps Spin Column. The plasmid DNA was eluted 
from the column and was checked by running a DNA gel.  
 
For maxi preparation, 1ml of mini culture was added into 200ml of LB containing 
antibiotics and incubated at 37°C with shaking for about 16 hours. After this, the 
bacterial culture was centrifuged at 2500rpm for 30 minutes. The pellet was then 
resuspended in resuspension buffer containing RNase and lysed in lysis buffer. After 
addition of neutralization buffer, the bacterial suspension was centrifuged at 
12,000rpm for 45 minutes. The supernatant was then passed through the Nucleobond 
cartridge and eluted, after which isopropanol was added. The DNA pellet was 
collected by centrifugation at 12,000rpm for 30 minutes, washed with 70% ethanol 
and dissolved in sterile water. The DNA pellet was further purified by adding 5M 
NaCl and 95% ethanol, storing in -80°C for at least 30 minutes, centrifugation at 
14,000rpm, washing in 70% ethanol and, lastly, dissolving in sterile water.  
 
2.2.2 Mammalian cell transfection 
Cells were transiently transfected with plasmid DNA using the calcium phosphate 
precipitation method. Transfection was performed using the CalPhos™ Mammalian 
Transfection Kit (Clontech Laboratories, Inc., Palo Alto, CA, USA). Cells were plated 
in a 100mm dish about 30 hours prior to transfection. The transfection mixture 
consisted of DNA plasmid, 2M CaCl2 solution and HEPES-buffered saline. The 
mixture was incubated at room temperature for 20 minutes to allow the formation of 
calcium phosphate precipitate. Thereafter, the transfection complex was added drop 
wise to the cells. The transfection medium was removed after 14 hours incubation. 
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The cells were washed once with 1xPBS and replaced with fresh medium. Cells were 
harvested for respective assays 48 hours post transfection.  
 
2.2.3 RNA Interference (RNAi) Assay 
Small interfering RNA (siRNA) inhibition of endogenous Nox4, PP2A-B55α, and 
NHE1 were performed using the following siRNAs. Nox4 and PP2A-B55α siRNAs 
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). NHE1 
siRNA sequence was 5’GAU AGG UUU CCA UGU GAU C (QIAGEN-Xeragon, 
Valencia,CA, USA). A control siRNA (non-homologous to any known gene sequence) 
(QIAGEN-Xeragon, Valencia, CA, USA) was used as a negative control.  
 
Cell transfection of siRNA was performed using lipofectamine RNAiMAX 
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s protocol. Briefly, 
cells were plated and grown for about 30 hours prior to transfection. Before 
transfection, cells were replaced with DMEM/10% FBS medium without antibiotics. 
The respective siRNA was mixed with lipofectamine RNAiMAX in the Opti-MEM®I 
medium supplied. The mixture was incubated for 20 minutes and then added into the 
cells. Cells were washed with 1xPBS and replaced with fresh DMEM/10%FBS 
medium after 15-16 hours incubation with the siRNA mixture. Cells were harvested 
for different assays either 24 hours or 48 hours post transfection.  
.  
2.2.4 RNA extraction and PCR 
Cells were transfected with control siRNA or Nox4 siRNA. Cells were harvested for 
RNA extraction and PCR analysis 24 hours or 48 hours post transfection to assess the 
efficiency of knockdown.  
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RNA was isolated using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA). RNA 
was collected in TRIzol reagent, followed by phase separation with the addition of 
chloroform. RNA precipitation was then performed by adding isopropyl alcohol and 
the pellet was washed with 75% ethanol. RNA was dissolved in RNase-free water. 
The concentration and quality of the RNA was determined with NanoDrop ND-1000 
spectrophotometer (Thermo scientific, Thermo Fisher Scientific Inc, Rockford, IL, 
USA).  
 
Reverse-transcription PCR was performed using the TaqMan® Reverse Transcription 
Reagent (Applied biosystems) according to the manufacturer’s description. PCR was 
performed using the Platinum® Taq DNA Polymerase (Invitrogen, Carlsbad, CA, 
USA) according to the manufacturer’s description. Nox4 and GAPDH were amplified 
by PCR with the following primers:  
Nox4 forward, 5’-GAA GCC CAT TTG AGG AGT CA-3’;  
Nox4 reverse, 5’-GGG TCC ACA GCA GAA AAC TC-3’; (Mahadev et al., 2004) 
GAPDH forward, 5'- ATC ATC CCT GCA TCC ACT GGT GCT G- 3’;  
GAPDH reverse, 5'- TGA TGG TAT TCA AGA GAG TAG GGA G-3’; (Orii et al., 
2006) 
The PCR products were separated on a 1.5% agarose gel and the predicted sizes for 
Nox4 and GAPDH PCR products are 409bp and 553bp respectively.   
 
2.2.5 Sodium Dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
and Western blot analysis 
SDS-PAGE and Western blot analysis were used to detect the phosphorylation level 
or total level of respective proteins. Cells were washed once with cold 1x PBS and 
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collected in PBS. The cell pellet was then lysed in the lysis buffer (50mM Tris-HCl 
pH7.4, 150mM NaCl, 1mM EGTA, 1mM EDTA, 0.5% (v/v) Triton X-100) 
containing 1mM PMSF, 5μg/ml leupeptin, 5μg/ml pepstatin A, 1μg/ml aprotinin and 
1mM of sodium orthovanadate. Before measurement of protein concentration, the 
lysate was centrifuged at 14,000rpm for 10 minutes to remove the debris. Protein 
quantification was performed using the Coomassie Plus™ Protein assay reagent 
(PIERCE, Thermo Fisher Scientific Inc, Rockford, IL, USA).  
 
SDS-PAGE was performed using the Bio-Rad Mini-PROTEAN® 3 Cell (CA, USA). 
The stacking gels used were 4% and the resolving gels used were 6.5%, 8% or 12% 
depending on the size of the target proteins. Protein samples were mixed with the 
5xloading dye (0.313M Tris HCl (pH 6.8), 10% SDS (w/v), 0.05% bromophenol blue, 
50% glycerol and 0.5M DTT) and heated at 95°C for 5 minutes before loading. For 
the AMS assay samples, DTT was omitted from the loading dye and no heating was 
performed. For detection of NHE1 protein, heating was performed at 37°C. Gel 
electrophoresis was conducted in the 1xSDS/Glycine buffer at 100V for 12% gel or at 
120V for 6.5% and 8% gel. The resolved proteins were transferred onto a 
nitrocellulose membrane by the wet transfer method using the Bio-Rad Mini Trans-
Blot® Cell (CA, USA). The transfer was conducted at 350mA for 1 hour at 4°C. The 
membrane was blocked in 5% (w/v) milk diluted in 1xTBST (20mM Tris – HCl (pH 
7.6), 137mM NaCl, and 0.1% Tween 20) for 1hour at room temperature. The 
membrane was washed with TBST to remove excess milk before blotted with 
respective primary antibodies (diluted in 5% (w/v) BSA) overnight at 4°C. After 
washing off the unbound primary antibody with TBST, the membrane was 
subsequently incubated with the respective horse radish peroxidase conjugated 
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secondary antibodies (diluted in 5% (w/v) milk) for 1 hour at room temperature. The 
detection was then performed with the Enhanced Chemiluminscence (ECL) using the 
Supersignal west Pico chemiluminescent substrate (PIERCE, Thermo Fisher 
Scientific Inc, Rockford,IL, USA). For re-probing the same membrane for different 
proteins, the membrane was stripped in the Restore Western Blot Stripping Buffer by 
5 minutes incubation at room temperature plus 10 minutes incubation at 37°C. The 
membrane was then blotted with primary antibodies and respective secondary 
antibodies. For densitometric analysis, the blots were scanned with EPSON Perfection 
1250 and analysed by FujiFilm Multigauge V3.0.  Protein size was indicated beside 
the gel photo when the Western blot of a particular protein was first shown in figures.  
 
2.2.6 Immunoprecipitation assay 
Cells were washed once with cold 1xPBS and collected in PBS. The cell pellet was 
then lysed in the lysis buffer (50mM Tris-HCl pH7.4, 150mM NaCl, 1mM EGTA, 
1mM EDTA, 0.5% (v/v) NP-40) containing 1mM phenylmethylsulfonyl fluoride 
(PMSF), 5μg/ml leupeptin, 5μg/ml pepstatin A, 1μg/ml aprotinin and 1mM of sodium 
orthovanadate. Cell lysate was collected by centrifugation at 14,000rpm for 10 
minutes. The lysate was incubated with respective primary antibodies (Akt, NHE1, 
HA) overnight at 4°C with gentle rocking. Protein A/G agarose beads were then 
added into the mixture and incubation was allowed for 3 hours before the beads were 
washed three times. The proteins pulled down were then released from the beads by 
resuspending in the loading dye and heating at 95°C for 5 minutes. SDS-PAGE and 
Western blot analysis were then performed to detect the respective target proteins. 
IgG control was included for coimmunoprecipitation experiments, where the IgG of 
the same species as the primary antibody was added into the lysate 
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2.2.7 In vitro Akt kinase assay 
The In vitro Akt kinase assay was performed according to the manufacturer’s protocol 
(Cell Signalling Technology, Inc. Beverly, MA). Cells were washed once with cold  
1x PBS and collected in PBS. The cell pellet was then lysed in the 1x lysis buffer 
(20mM Tris-HCl (pH7.5), 150mM NaCl, 1mM Na2EDTA, 1mM EGTA, 1% (v/v) 
Triton X-100, 2.5mM sodium pyrophosphate, 1mM β-glycerophosphate) 
supplemented with 1mM phenylmethylsulfonyl fluoride (PMSF), 1μg/ml leupeptin, 
1μg/ml pepstatin A, 1μg/ml aprotinin and 1mM sodium orthovanadate. 
Immunoprecipitation was performed with the immobilized Akt antibody overnight at 
4°C. The immunocomplexes were washed twice with the 1x lysis buffer followed by 
once with the 1xkinase buffer. The complexes were then mixed with 40µl of 1xkinase 
buffer supplemented with 1µg GSK3 fusion protein and 200µM ATP. The Akt kinase 
reaction was conducted at 30°C for 30 minutes. The reaction was then terminated by 
adding 20µl of loading dye and heating at 95°C for 5 minutes. The supernatant was 
loaded into the gel for SDS-PAGE and Western blot analysis. Detection of the 
phosphorylation level of the GSK3 fusion protein was achieved using the antibody 
against phospho-GSK3α/β(ser21/9). Unfortunately, the total protein level of the 
currently using GSK3 fusion protein could not be detected by the antibody against 
GSK3α or GSK3β (we have checked with the manufacturer, but no solution was 
suggested). The total Akt proteins being pulled down were also detected using the 
antibody against total Akt. The Akt kinase activity was thus expressed as (Phospho-
GSK3 fusion protein/ Total Akt).    
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2.2.8 Membrane fractionation 
Membrane fractionation was performed as described previously (Taylor et al., 2000). 
Cells were washed once and collected in ice-cold PBS. The cell pellet was 
resuspended in fractionation buffer (20mM HEPES (pH 7.4), 5mM NaCl, 10mM 
MgCl2, 1mM EDTA) supplemented with 1mM phenylmethylsulfonyl fluoride 
(PMSF), 1μg/ml leupeptin, 1μg/ml pepstatin A, 1μg/ml aprotinin and 1mM sodium 
orthovanadate. Cells were lysed by 20 strokes with a dounce homogenizer at 4°C. The 
debris was removed by centrifugation at 700g for 10 minutes at 4°C. The P100 and 
S100 fractions were further separated by high speed centrifugation (100,000g for 30 
minutes at 4°C). The P100 fraction was then lysed in fractionation buffer containing 
0.5% (v/v) Triton X-100. S100 and P100 fractions were then analyzed by SDS-PAGE 
and Western blot.  For membrane fractionation, cadherin and SOD1 were used as 
membrane and cytosolic markers respectively. Absence of each marker in the 
opposite fraction showed the purity of the fractionation process. Moreover, they 
served as loading controls for the corresponding fractions. 
 
2.2.9 Mitochondrial fractionation 
Cells were washed once with cold 1xPBS and collected in PBS. The cell pellet was 
then lysed in buffer A (250mM sucrose, 20mM HEPES (pH 7.5), 10mM KCl, 1.5mM 
MgCl2, 1mM EDTA, 1mM EGTA) supplemented with 1mM phenylmethylsulfonyl 
fluoride (PMSF), 1μg/ml leupeptin, 1μg/ml pepstatin A, 1μg/ml aprotinin and 1mM 
sodium orthovanadate. After 20 minutes incubation on ice, cells were lysed by 35 
strokes with a dounce homogenizer at 4°C. The debris was removed by centrifugation 
at 700g for 10 minutes at 4°C. The supernatant was collected and further centrifuged 
at 10,000g for 30 minutes at 4°C. The mitochondria pellet was collected and lysed in 
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buffer A containing 0.5% (v/v) Triton X-100. The cytosolic supernatant was collected 
and supplemented with 0.5% (v/v) Triton X-100. The mitochondrial and cytosolic 
fractions were then analyzed by SDS-PAGE and Western blot.  For mitochondrial 
fractionation, VDAC and SOD1 were used as mitochondrial and cytosolic markers 
respectively.  
 
2.2.10 Nuclear fractionation 
Nuclear fractionation was achieved according to the manufacturer’s instructions 
(PIERCE, Thermo Fisher Scientific Inc, Rockford,IL, USA). The cell pellet was 
collected in PBS and excess PBS was removed to leave the pellet as dry as possible. 
The cell pellet was fully resuspended in 200µl of ice-cold CER I buffer by vortexing 
vigorously for 15 seconds. After adding 11µl CER II buffer, the tube was vortexed for 
5 seconds and left on ice for 1 minute. The tube was vortexed for 5 seconds again 
before centrifugation at 16,000xg for 5 minutes at 4°C. The supernatant was then 
collected as the cytosolic fraction. The nuclear pellet was lysed in 100µl of ice-cold 
NER buffer. Full lysis was achieved by vortexing for 15 seconds every 10 minutes for 
a total of 40 minutes. The sample was kept on ice during the interval between the 
vortexes. The debris was then removed by centrifugation at 16,000g for 10 minutes at 
4°C. The supernatant was collected as the nuclear extract. The nuclear and cytosolic 
fractions were analyzed by SDS-PAGE and Western blot. For nuclear fractionation, 
PARP and SOD1 were used as nuclear and cytosolic markers respectively. 
 
2.2.11 Determination of Akt oxidation by AMS assay  
The redox states of Akt protein were assessed by modifying free thiol with AMS (4-
Acetamido-4-maleimidylstilbene-2,2-disulfonic acid) as previously described (Murata 
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et al., 2003). Cells were washed once and collected in ice-cold PBS. The cell pellet 
was resuspended in lysis buffer (50mM Tris-HCl (pH 7.4), 0.5% (v/v) Triton X-100) 
supplemented with 1 mM phenylmethylsulfonyl fluoride (PMSF), 1μg/ml leupeptin, 
1μg/ml pepstatin A, 1μg/ml aprotinin and 1 mM sodium orthovanadate. DTT (2mM) 
was included in the AMS buffer when indicated. After 20 minutes incubation, cell 
lysates were collected by centrifugation at 14,000rpm for 10 minutes. Cell lysates 
were treated with 7.5% trichloroacetic acid for 20 minutes to precipitate the protein. 
The precipitated proteins were collected by centrifugation at 5,000g for 2 minutes at 
4°C. The pellet was then washed three times with cold acetone and dissolved in a 
buffer containing 50 mM Tris-HCl (pH 7.4), 1% SDS, and 15mM AMS. Proteins 
were then analyzed by SDS-PAGE and Western blot without using the reducing agent 
DTT in the loading dye.  
 
2.2.12 Cell viability estimation by crystal violet assay    
Crystal violet staining was used to assess viable and adherent cells, and was used as 
an estimation of cell proliferation. Cells were seeded in 12-well plate and subjected to 
various treatments. At the respective time points, cells were washed once with 1xPBS 
and stained with crystal violet solution (0.75% (w/v) crystal violet, 50% (v/v) ethanol, 
1.75% (v/v) formaldehyde, 0.25% (w/v) NaCl) for 10 minutes. The excess dye was 
then washed off gently with water. The cells were allowed to dry before 1%SDS/PBS 
solution was added to extract and solubilize the dye retained in the adherent cells. The 
absorbance was measured at 595nm using SpectrafluorPlus spectrofluorometer 
(TECAN, GmbH, Grödig, Austria) for quantification. Cell density at each time point 
(with or without treatments) was expressed as the percentage relative to the density of 
control cells at time zero.   
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2.2.13 Cell cycle analysis 
Cell cycle analysis was done by flow cytometry using propidium iodide staining. 
Cells subjected to respective treatments were harvested and collected in 1xPBS. Cell 
pellets were washed and then resuspended in PBS/1%FBS before fixation by adding 
75% ethanol drop wise. The sample was left at 4°C for at least 30 minutes and the 
pellet was washed again in PBS/1%FBS. After this, the cell pellet was stained in 
PBS/1%FBS containing propidium iodide and RNase for 30 minutes at 37°C. The 
sample was then ready for flow cytometry analysis using the excitation wavelength of 
488nm and emission wavelength of 610nm on the flow cytometer (BD FACSCanto II, 
BD Biosciences, CA, USA). 
 
2.2.14 Intracellular superoxide measurement by Lucigenin chemiluminescence 
assay  
Bis-N-methylacridinium (Lucigenin) was used as the chemiluminescence detector for 
intracellular O2.- detection. Lucigenin is first reduced by one electron to generate the 
lucigenin cation radical, which would then react with O2.- to yield an unstable 
intermediate dioxetane. This intermediate further decomposes to produce two parts of 
N-methylacridone, one in an excited state and the other in the ground state. The one in 
the excited state would emit a proton upon relaxation to the ground state. Detection of 
O2.-  was thus achieved by the measurement of the proton emission (Li et al., 1998).  
 
Cells were seeded and serum-deprived in 0.5%FBS/DMEM or maintained in 
10%FBS/DMEM before various drug treatments. At different time points, cells were 
washed once with 1xPBS, trypsinized and harvested. Cell pellet was collected after 
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centrifugation at 2000rpm at room temperature for 1 minute. The pellet was then 
resuspended and permeabilized in 430μl 1x somatic cell ATP-releasing reagent, 400μl 
of which was used for measurement. Proton emission was recorded for 30 seconds 
with the Sirius luminometer (Berthold Technologies, Germany) after 100μl of 850μM 
lucigenin solution was injected automatically before reading. A blank control 
containing only 400μl 1x somatic cell ATP-releasing reagent was used to monitor the 
signal from auto oxidation of lucigenin if there was any. The intracellular O2.- level 
was expressed as the luminescence unit after being normalized with the protein 
concentration (determined with the 30ul suspension left from the assay). The changes 
in O2.- level under different treatments were reported as the percentage relative to the 
respective control cells.   
 
2.2.15 PP2A activity assay  
Phosphatase activity was determined by the non-radioactive Serine/Threonine 
phosphatase assay system (Promega, Madison, WI, USA). The cells were subjected to 
different treatments before harvesting. The cells were washed once with cold 1xPBS 
and collected in PBS. The cell pellet was resuspended in 250μl lysis buffer containing 
no phosphatase inhibitors (50mM Tris-HCl PH7.4, 150mM NaCl, 1mM EGTA, 1mM 
EDTA, 0.5% Triton X-100, 1 mM phenylmethylsulfonyl fluoride (PMSF), 1μg/ml 
leupeptin, 1μg/ml pepstatin A, and 1μg/ml aprotinin). The cells were lysed on ice for 
30 minutes before the debris was removed by centrifugation at 14,000rpm for 10 
minutes. The lysate was then cleared of endogenous free phosphate by passing 
through the Sephadex-25 spin column provided. Three ug of total cell lysate was 
incubated with 100μM phosphopeptide substrate (RRA(pT)VA) in the PPase-2A 
reaction buffer ( 50mM imidazole pH7.2, 0.2mM EGTA, 0.03% β-mercaptoethanol, 
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0.1mg/ml BSA) in the presence or absence of 15nM okadaic acid. The enzyme-
substrate reaction was performed in a 96-Well plate with the total reaction volume of 
50μl per well and for 30 minutes at 30ºC. After 30 minutes incubation, the reaction 
was stopped by adding 50µl of molybdate dye/additive mixture. The full development 
of the color was allowed by an additional 30 minutes of incubation. Free phosphate 
generated from the phosphatase reaction was quantified by measuring the absorbance 
of the molybdate-malachite green-phosphate complex at 630nm. The amount of the 
free phosphate released was further determined from the standard curve (linear over 
the range of 0pmol to 4000pmol). The phosphopeptide used here was a compatible 
substrate for PP2A, PP2B and PP2C, but was a poor substrate for PP1. To specifically 
determine the PP2A activity over PP2B or PP2C, the assay was performed in the 
absence or presence of okadaic acid, which is a specific inhibitor towards PP2A but 
not PP2B or PP2C. Therefore, the PP2A activity from the total lysate was defined as 
the phosphopeptide phosphatase activity that is inhibitable by OA, which was 
calculated as the difference between the values from reactions with and without OA. 
Controls included reactions without cell lysate and reactions without the 
phosphopeptide substrate for each sample.  
 
2.2.16 Intracellular reduced glutathione (GSH) measurement 
Intracellular GSH measurement method was modified from that described by Hisson 
and Hiff (Hissin and Hilf, 1976). The method made use of ο-phthalaldehyde (OPT) as 
the fluorescent reagent. GSH specifically reacted with OPT at pH8.0 and generated a 
highly fluorescent product, with excitation at 350 nm and emission at 420 nm. 
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Cells were seeded in a 6-well plate and serum-deprived in 0.5%FBS/DMEM or 
maintained in 10%FBS/DMEM before various drug treatments. Upon the time of 
harvesting, cells were washed twice with cold 1xPBS and lysed in 360μl 6.5% cold 
trichloroacetic acid (TCA) for 10 minutes. The TCA solution was then collected for 
GSH measurement. Cells left on the plate were then lysed by 100μl 1M NaOH and 
used to measure protein concentration. To determine the fluorescence of the GSH-
OPT complex, the sample (in TCA solution) was mixed with the reaction buffer 
containing 1mg/ml OPT, 10mM KH2PO4, 5 mM EDTA and 11 mM NaOH, incubated 
for 25 minutes in dark conditions and measured at excitation wavelength of 350 nm 
and emission wavelength of 420 nm. The amount of GSH in the sample was 
extrapolated from the standard curve based on the GSH-OPT fluorescence obtained 
from a series of known amount of GSH. The intracellular GSH level was expressed as 
nmol/mg protein.  
 
2.2.17 Intracellular pH (pHi) Measurement and NHE activity Assay  
Intracellular pH was determined by measuring the fluorescent intensity of 2´,7´-bis-
(2-carboxyethyl)-5-(and-6)-Carboxyfluorescein  (AM-BCECF). Cells were seeded in 
12-well plates. After drug treatment for various time points, cells were washed once 
with 1xPBS. Cells were washed once with HEPES buffer (135 mM NaCl, 5 mM KCl, 
1.8 mM CaCl2, 1 mM MgSO4,5.5 mM glucose and 10 mM HEPES, pH 7.4) and were 
then incubated in dark conditions with 5µM BCECF-AM in HEPES buffer for 25 
minutes at 37ºC. Cells were washed once with HEPES buffer to remove excess dye 
and loaded with fresh HEPES buffer for fluorescence measurement with a dual 
excitation (430nm and 485nm) and a single emission (535nm). The 430nm 
wavelength was used as normalization for cell density across different wells.  
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To determine intracellular pH, a standard curve was set up as follows. After 
incubation with 5uM BCECF-AM, cells were incubated in potassium buffer with a 
known pH (pH 6.4, 6.8. 7.2, 7.6 and 8.0) for 3 minutes before fluorescent 
measurement was taken. Ten µM nigericin was included in the potassium buffer to 
ensure the equilibration of intracellular pH with the standard buffer pH. A standard 
curve was plotted with the standard pH value and the ratio of fluorescence after 
normalization (the emission from 485nm excitation/emission from 430nm excitation). 
The intracellular pH for cells was thus extrapolated from the standard curve. 
 
To determine the the activity of NHE proteins, acid loading and recovery was 
performed after the initial pH was recorded. Briefly, 30mM NH4Cl buffer was added 
and BCECF fluorescence was recorded for 8 cycles with 2 minutes interval. The cells 
were then loaded with Na+-free HEPES buffer (135 mM N-methyl glucamine, 5 mM 
KCl, 1.8 mM CaCl2, 1 mM MgSO4,5.5 mM glucose and 10 mM HEPES, pH 7.4) for 
30 seconds. Then the cells were replaced with HEPES buffer and recovery 
measurement was performed immediately for 15 cycles with 2 minutes interval. The 
recovery rate was calculated as ∆pH/∆t for the first 2 cycles of the recovery stage.  
 
2.2.18 Measurement of PIP3 by Immunofluorescence and Confocal Microscopy  
Cells grown on cover slips were washed once with 1x PBS and fixed in 4% 
paraformaldehyde for 20minutes. After quenching with 100 mM NH4Cl and washing 
with PBS, the cells were permeabilized with 0.25% saponin for 10 minutes at room 
termperature. The cells were blocked in 2% BSA, 5 % FBS in 1 x PBS and incubated 
with FITC conjugated anti – PIP3 antibody (Echelon, Salt Lake City, UT) at a dilution 
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of 1:50 for 1 hour at room temperature. The cells were washed three times before the 
cover slip was mounted for confocal analysis using a Carl Zeiss Lsm510 META 
microscope with identical acquisition parameters for the same image session.  
 
2.2.19 Statistical analysis 
Statistical analysis was performed using Student’s t-Test, with P<0.05 considered 
significant.  
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CHAPTER 3 RESULTS 
 
 
3.1 A decrease in intracellular O2.- level induces dephosphorylation of 
the survival kinase Akt in MEFPTEN-/- cells 
 
3.1.1 Characterization of MEFPTEN-/- cells 
 
Absence of PTEN in MEFPTEN-/- cells was confirmed by Western blot analysis. PTEN 
was resolved as a protein band at 55kDa in cell lysates from MEFWT cells, but not in 
the lysates from MEFPTEN-/- cells (Figure 1A). Identification of Akt isoforms present 
in MEF cells was performed by using the antibodies against Akt1, Akt2 and Akt3 
respectively. All three isoforms were detectable in both MEFWT and MEFPTEN-/- cells 
(Figure 1B). As the efficiency of each antibody to detect the respective isoform could 
be different, it is not appropriate to use the data obtained from these antibodies to 
compare the relative abundance of the three isoforms in MEF cells. Throughout the 
rest of the project, the Akt antibodies used to detect phospho-Akt or total Akt 
recognize all three isoforms.  
















Figure 1: Western blot analysis of MEFWT and MEFPTEN-/- cells. 
 
MEFPTEN-/- cells (KO) or MEFWT cells (WT) were grown in DMEM/10%FBS before 
Western blot analysis was performed for respective proteins. (A) Expression of PTEN 
was shown for MEFWT cells and MEFPTEN-/- cells. (B) Three Akt isoforms (Akt1, Akt 
2, and Akt3) are expressed in MEF cells.  
 
 
3.1.2 Hyperphosphorylation of Akt is detected in MEFPTEN-/- cells 
 
It is necessary to characterize the basal level of Akt phosphorylation in MEFPTEN-/- 
cells before we investigate the effect of O2.- on Akt phosphorylation. Akt 
phosphorylation in MEFPTEN-/- cells was assessed with reference to that in MEFWT 
cells. Samples from MEFPTEN-/- and MEFWT cells were loaded on the same gel to 
detect the phosphorylation on Threonine308 (Thr308) and Serine473 (Ser473). Akt 
phosphorylation level was detected in both serum deprived (0.5%FBS) and 10%FBS 
conditions. Hyperphosphorylation of Akt on both Thr308 and Ser473 was found in 
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MEFPTEN-/- cells. On the contrary, Akt phosphorylation, especially on Thr308, was 
minimal in MEFWT cells. Upon serum deprivation, Akt phosphorylation in MEFWT 
cells was reduced dramatically to a barely detectable level, while MEFPTEN-/- cells still 
exhibited a significant level of Akt phosphorylation (Figure 2A).  
 
Phosphorylation on these two sites is critical for Akt activation (Alessi et al., 1996) 
and is, therefore, widely accepted as an indication of Akt activity. To further 
investigate the in vivo kinase activity of Akt, the phosphorylation levels of glycogen 
synthase kinase-3α/β (GSK3α/β) and p70 S6 kinase (p70S6K), two downstream 
targets of the Akt pathway, were also examined. GSK3 was initially identified as a 
serine/threonine kinase that phosphorylates and inactivates glycogen synthase (Forde 
and Dale, 2007). The activity of GSK3 can be inhibited by Akt-mediated 
phosphorylation at Ser21 of GSK3α and Ser9 of GSK3β (Cross et al., 1995). p70S6K, 
on the other hand, is not a direct substrate of the Akt kinase, but lies further 
downstream in the Akt signalling pathway. Akt positively regulates mTOR, and the 
mTOR-raptor complex phosphorylates p70S6K at the site Thr389, the 
phosphorylation status of which is closely associated with p70S6K activity (Mamane 
et al., 2006; Sarbassov et al., 2005). GSK3α/β and p70S6K thus represent the 
downstream components of Akt pathway at two different levels. The phosphorylation 
levels of GSK3α/β and p70S6K at the critical phosphorylation sites provide additional 
information on the physiological effects of the changes in Akt phosphorylation. 
Consistent with the hyperphosphorylated Akt in MEFPTEN-/- versus MEFWT cells, 
phosphorylation levels on GSK3α/β and p70S6K were higher in MEFPTEN-/- compared 
to MEFWT cells (Figure 2B).  









































Figure 2: Hyperphosphorylation of Akt is detected in MEFPTEN-/- cells. 
 
MEFPTEN-/- cells (KO) or MEFWT cells (WT) were serum starved in DMEM/0.5%FBS 
for 24 hours or grown in DMEM/10%FBS before Western blot analysis was 
performed. (A) Akt phosphorylation on Thr308 and Ser473 was detected. (B) 
Phosphorylation levels of GSK3α/β and p70S6K were detected. A representative blot 
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3.1.3 Intracellular O2.- level is higher in MEFPTEN-/- cells compared to MEFWT 
cells 
 
In addition to Akt phosphorylation level, we have also compared the basal 
intracellular O2.- level in MEFPTEN-/- cells and MEFWT cells. MEFPTEN-/- cells exhibited 
a higher level of intracellular O2.- than MEFWT cells when cultured in both 0.5%FBS- 
and 10%FBS-containing medium (Figure 3). Although the increase in O2.- was only 
about 10% to 20%, this moderate but significant increase could be physiologically 
relevant. As redox homeostasis is kept under tight control, a mild change in 
intracellular ROS level could have a disproportionately greater impact on 
physiological events, especially in the case of cell signalling (Pervaiz et al., 1999; 




































Figure 3: Basal level of intracellular O2.-  is higher in MEFPTEN-/- cells compared 
to  MEFWT cells.  
 
MEFPTEN-/- cells (KO) or MEFWT cells (WT) were serum starved in DMEM/0.5%FBS 
for 24 hours or grown in DMEM/10%FBS before intracellular O2.- level was assessed 
by lucigenin luminescence. The level of intracellular O2.- was expressed as percent of 
MEFWT
 
control cells grown in respective serum conditions. The value represents the 
mean+S.D. of four independent experiments.   * p < 0.05  
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3.1.4 Akt is dephosphorylated upon the decrease in intracellular O2.- level by DPI  
 
3.1.4.A  DPI treatment decreases the level of intracellular O2.- 
In order to investigate the possible role of O2.- in regulating Akt phosphorylation in 
MEFPTEN-/- cells, diphenyleneiodonium (DPI), a commonly used inhibitor of cellular 
O2.- production, was used to lower the intracellular O2.- level in MEFPTEN-/- cells. DPI 
is an inhibitor of flavoenzymes, such as NADPH oxidase, NADH reductase, and nitric 
oxide synthase. Despite its non-specific effect, DPI is widely used as an inhibitor of 
the O2.--producing  NADPH oxidase (Li et al., 2003; Chen et al., 2005; Hancock and 
Jones, 1987; Menon et al., 2003; Li and Trush, 1998). To establish the efficiency of 
DPI in our system, MEFPTEN-/- cells were treated with different concentrations 
(ranging from 0.5µM to 10µM) of DPI for 2 hours before O2.- level was measured. A 
significant decrease in O2.- level was observed from 1µM DPI treatment onwards 
(Figure 4). However, in order to achieve a moderate and stable reduction in 
intracellular O2.- level, 6µM of DPI was used for the rest of the study.  








































Figure 4: DPI causes a dose-dependent reduction in the level of intracellular O2.-. 
 
MEFPTEN-/- cells grown in DMEM/10%FBS were treated with different doses of DPI 
for 2 hours before intracellular O2.- level was measured by lucigenin luminescence. 
The level of intracellular O2.- for cells under each treatment was expressed as percent 
of the DMSO control cells. The data represent the mean+S.D. of four independent 
experiments for 1µM, 2µM and 6µM; and represent the mean+S.D. of three 
independent experiments for 0.5µM and 10µM. * p < 0.05  
 
 
The level of intracellular O2.- was then measured at different time points after cells 
were treated with 6µM DPI in order to monitor the time kinetic response to DPI. 
MEFPTEN-/- cells grown in 10%FBS-containing medium were treated with 6µM DPI 
(or with DMSO as vehicle control) for 1 hour to 6 hours. At each time point, 
intracellular O2.- level was measured in control cells (DMSO) and treated (DPI) cells. 
A significant reduction in the level of intracellular O2.- was detected from 2 hours 
onwards after DPI treatment (Figure 5A). To demonstrate that DPI could also reduce 
intracellular O2.- level in 0.5% serum condition, MEFPTEN-/- cells were serum deprived 
(0.5%FBS) for 24 hours before being exposed to DPI treatment. Similarly, a 
significant reduction in the level of intracellular O2.- was achieved after 2 hours 
(Figure 5B).     
 









































































Figure 5: DPI causes a time-dependent reduction in the level of intracellular O2.-. 
 
(A) MEFPTEN-/- cells (KO) grown in DMEM/10%FBS or (B) serum starved in 
DMEM/0.5%FBS were treated with 6µM DPI (or DMSO as control) for different 
time points before intracellular O2.- level was measured by lucigenin luminescence. 
The level of intracellular O2.- was expressed as percent of DMSO control cells for 
each time point. The value represents the mean+S.D. of three independent 
experiments.   * p < 0.05  
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3.1.4.B  The level of Akt phosphorylation is reduced  upon the decrease in 
intracellular O2.- level by DPI   
To understand the effect of O2.- on Akt phosphorylation, the phospho-Akt level was 
measured under the conditions in which intracellular O2.- level was reduced. Time 
kinetic analysis (Figure 6A and 6B) from 1 hour to 6 hours shows that the Akt 
phosphorylation level was only slightly reduced after 1 hour treatment with DPI, 
corresponding to the insignificant decrease in intracellular O2.- level at 1 hour time 
point (Figure 5A). From 2 hours onwards, there was a significant reduction in the 
level of Akt phosphorylation. This is consistent with the reduced level of intracellular 
O2.- after DPI treatment for 2 to 6 hours. Similarly, Akt dephosphorylation was 
observed in serum starved cells treated with DPI (Figure 6C and 6D).  
 
On the contrary, the phosphorylation level of ERK1/2 was not reduced by DPI 
treatment in both serum conditions (Figure 6A and 6C). Similar to Akt, ERK1/2 are 
important kinases involved in cell survival and cell proliferation. However, ERK1/2 
proteins reside in a different signalling cascade, the mitogen-activated protein kinases 
(MAPKs) network (Lu and Xu, 2006; Roux and Blenis, 2004). The ERK1/2 proteins 
are therefore used as a control for the specificity of any treatment that alters Akt 
phosphorylation level. Our data suggest that the effect of O2.- in decreasing the 
phosphorylation level of Akt is specific for this kinase, as no effect could be seen on 
the phosphorylation level of ERK1/2. 
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Figure 6: A time-dependent decrease in Akt phosphorylation correlates with the 




(A) MEFPTEN-/- cells grown in DMEM/10%FBS (KO 10%) were treated with 6µM 
DPI (or DMSO as control) for different time points before cells were harvested for 
Western blot analysis. (B) Densitometric analysis of Akt phosphorylation level on 
Thr308 and Ser473 for cells as described in (A).  
(C) MEFPTEN-/- cells serum starved in DMEM/0.5%FBS (KO 0.5%) were treated with 
6µM DPI (or DMSO as control) for different time points when cells were harvested 
for Western blot analysis. (D) Densitometric analysis of Akt phosphorylation level on 
Thr308 and Ser473 for cells as described in (C).  
For densitometric analyses shown in (B) and (D), the phosphorylation level for each 
phosphorylation site was calculated as phosphorylation level relative to total protein 
level. The change in phosphorylation level was shown as a fold difference relative to 
DMSO control cells at respective time points. n=3 for 1hr and 2hr; n=2 for 4hr and  
6hr; n=1 for 3hr and 5hr.
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Furthermore, dephosphorylation of Akt was correlated with a reduced kinase activity 
as revealed by two lines of evidence. Firstly, Western blot analysis of the cell lysates 
from DPI-treated cells showed a decreased level of phosphorylation on the Akt 
substrate GSK3α/β (Figure 7A). Secondly, an in vitro Akt kinase assay was conducted 
using the GSK3 fusion protein as the substrate. Akt protein was immunoprecipitated 
by an anti-Akt antibody and the ability of Akt to phosphorylate the GSK3 fusion 
protein reflected its in vitro activity. Akt kinase activity was calculated as the level of 
phosphorylated GSK3 relative to the amount of total Akt that was pulled down. As the 
antibody to detect total GSK3 fusion protein was unavailable, the assumption made 
was that the loading was equal for the total amount of GSK3 fusion protein for each 
sample. The data show that Akt activity was reduced after 2 hours of incubation with 
DPI (Figure 7B). As a control for the assay, MEFPTEN-/- cells were incubated with the 
PI3-kinase inhibitor LY294002, which had been shown to inhibit Akt phosphorylation 
and activity (Taylor et al., 2000; Haas-Kogan et al., 1998; Vlahos et al., 1994). 
Reduction in Akt activity by LY294002 was observed in the current experimental set 
up as well (Figure 7B). These results suggest that the dephosphorylation of Akt by 
DPI corresponds to a reduced activity of the kinase and, thus, leads to the 




























































Figure7: Akt activity is reduced upon the dephosphorylation of Akt by DPI.  
 
(A) MEFPTEN-/- cells grown in DMEM/10%FBS were treated with 6µM DPI (or 
DMSO as control) for different time points before cells were harvested for Western 
blot analysis. Phosphorylation level of endogenous GSK3α/β was detected. A 
representative blot from two independent experiments is shown. (B) MEFPTEN-/- cells 
were grown in DMEM/10%FBS and treated with 6uM DPI or 25uM LY294002(LY) 
for 2 hours. In vitro Akt kinase assay was performed as described in the Materials and 
Methods (section 2.2.7). The Akt kinase activity was calculated as phosphorylation 
level of GSK3 fusion protein normalized to the total amount of Akt pulled down. The 
change in Akt activity after each treatment was expressed as a fold difference relative 
to DMSO control cells. The value represents the mean+S.D. of three independent 
experiments.  
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3.1.4.C  DPI does not change the overall phosphorylation status 
To further clarify whether DPI caused nonspecific dephosphorylation in the cell, we 
used antibodies against phospho-Serine (P-Ser), phospho-Threonine (P-Thr) and 
phospho-Tyrosine (P-Tyr) to detect global changes (if any) in phosphorylation level. 
However, there was no detectable changes in the overall phosphorylation profile after 
MEFPTEN-/- cells were treated with DPI for 2 hours, for all the three antibodies used 

































Figure 8: Treatment of MEFPTEN-/- cells with DPI does not lead to a global 
dephosphorylation.  
 
MEFPTEN-/- cells grown in DMEM/10%FBS were treated with 6µM DPI (or DMSO as 
control) for 2 hours before cells were harvested for Western blot analysis. The 
antibody against (A) phospho-Serine, (B) phospho-Threonine and (C) phospho-
Tyrosine were used. A representative blot from three independent experiments is 
shown. 
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3.1.4.D  Restoration of intracellular O2.- level by DDC in DPI-treated cells is 
associated with the recovery of Akt phosphorylation level   
Results shown so far suggest that DPI-mediated reduction in the level of intracellular 
O2.- is correlated with a specific decrease in Akt phosphorylation, but not in the level 
of ERK1/2 phosphorylation or the global phosphorylation. To further confirm that the 
main effective ROS that regulates Akt phosphorylation in this system is O2.-, we used 
the drug diethyldithiocarbamate (DDC) to reconstitute the intracellular O2.- level in 
DPI-treated cells. DDC is an inhibitor of the cytosolic Cu/Zn superoxide dismutase 
(Cu/ZnSOD). DDC functions by binding to copper and, thus, removing it from the 
active site of the enzyme (Halliwell and Gutteridge, 2007; Misra, 1979). DDC 
therefore effectively increases intracellular O2.- level in many cell systems (Clément 
and Stamenkovic, 1996; Yin et al., 2007; Didion et al., 2001; Lijnen et al., 2008). In 
our system, 1mM DDC alone could significantly increase the level of intracellular O2.- 
(compare “DMSO+DDC” and “DMSO” in Figure 9A). In DPI-treated MEFPTEN-/- 
cells, intracellular O2.- level was reconstituted by co-incubation with DDC (compare 
“DPI+DDC” and “DPI” in Figure 9A). In serum deprived cells (0.5%FBS), DDC was 
just as effective in restoring the level of intracellular O2.- for DPI-treated cells (Figure 
9B). Consistent with the recovery in O2.- level, the decrease in Akt phosphorylation by 
DPI was also prevented by DDC in both 10%FBS and 0.5%FBS conditions (compare 
“DPI+DDC” and “DPI” in Figure 10). In addition, the phosphorylation levels of 
GSK3α/β or p70S6K exhibited similar changes as Akt phosphorylation.  
 







































































Figure 9: Presence of DDC can reconstitute the level of intracellular O2.-  in DPI-
treated cells.  
 
(A) MEFPTEN-/- cells  grown in DMEM/10%FBS or (B) serum starved in 
DMEM/0.5%FBS  were treated with 6µM DPI in the presence or absence of 1mM 
DDC for 2 hours. Intracellular O2.- level was assessed by lucigenin luminescence. The 
level of intracellular O2.- in treated cells was expressed as percent of  the DMSO 
control cells. The value represents the mean+S.D. of three independent experiments. * 
p < 0.05 































































































































































































Figure 10: Presence of DDC can rescue Akt dephosphorylation in DPI-treated 
cells. 
 
(A) MEFPTEN-/- cells grown in DMEM/10%FBS or (C) serum starved in 
DMEM/0.5%FBS were treated with 6µM DPI in the presence or absence of 1mM 
DDC for 2 hours. Western blot analysis was performed. A representative blot from 
three independent experiments is shown. (B) Densitometric analysis of Akt 
phosphorylation level on Thr308 and Ser473 was shown for cells described in (A). (D) 
Densitometric analysis of Akt phosphorylation level on Thr308 and Ser473 was 
shown for cells described in (C). For densitometric analyses shown in (B) and (D), the 
phosphorylation level for each phosphorylation site was calculated as phosphorylation 
level relative to total protein level. The change in phosphorylation level was shown as 
a fold difference relative to DMSO control cells. The value represents the mean+S.D. 
of at least three independent experiments. * p < 0.05  
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It was noticed that, in the presence DDC, DPI could not reduce the level of 
intracellular O2.- as effectively (compare “DMSO+DDC” and DPI+DDC in Figure 9). 
Concurrently, Akt phosphorylation was not different in these two conditions (Figure 
10). The reason for this could be that, in the current experimental set-up, the 
concentration of DPI used to inhibit O2.- production was not potent enough to 
counteract the DDC-mediated accumulation of O2.-. Therefore, the observed 
intracellular O2.- level and Akt phosphorylation level reflected the integrative effect of 
the two drugs. 
 
Additionally, the increase in Akt phosphorylation in MEFPTEN-/- cells following the 
DDC-induced increase in intracellular O2.- level was not as dramatic as what was 
shown previously in MEFWT cells. In MEFWT cells starved in 0.5%FBS condition, 
incubation with DDC for 2 hours resulted in a 4-fold increase in Akt phosphorylation 
(Lim and Clément, 2007). For MEFPTEN-/- cells starved in 0.5%FBS condition, there 
was almost no increase in Akt phosphorylation after DDC treatment alone for 2 hours 
(Figure 10B). For MEFPTEN-/- cells in 10%FBS condition, there was only a slight 
increase in Akt phosphorylation. The difference between the two cell lines was most 
probably due to the lack of PTEN-dependent regulation of Akt phosphorylation in 
MEFPTEN-/- cells. However, for 10%FBS condition, there might be other unknown 
factors causing the slight increase in Akt phosphorylation in MEFPTEN-/- cells. 
 
We have shown so far that downregulation of the hyperphosphorylated Akt in 
MEFPTEN-/- cells is associated with the reduction in intracellular O2.- level by DPI. This 
regulation is applicable to cells grown in 10%FBS-containing medium as well as to 
cells starved in 0.5%FBS-containing medium. To understand more about this 
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regulation pathway, the rest of the experiments are mainly performed in 10%FBS 
condition, as Akt in this condition is most highly phosphorylated.     
 
3.1.4.E  Prolonged reduction in intracellular O2.- level disrupts cell proliferation 
Activation of Akt is important in various cellular processes including cell proliferation 
and cell survival. Indeed, the Akt pathway is identified as the major survival pathway 
and plays important roles in many tumour cells (Testa and Tsichlis, 2005). In this 
regard, we investigated the long term effect of Akt dephosphorylation after lowering 
the intracellular O2.- level. MEFPTEN-/- cells were incubated with DPI for 2 hours 
before the drug was washed off and the cells were grown for another 24 or 48 hours. 
Although the drug was not incubated with the cells for the prolonged period of 24 or 
48 hours, a sustained reduction in the level of intracellular O2.- was achieved (Figure 
11A). The sustained effect of DPI could be due to the irreversible mode of action of 
the drug, which was previously reported in other systems as well (Scaife, 2005; 
O'Donnell et al., 1993). 
 
Correspondingly, the Akt phosphorylation level remained lower in treated cells 
compared to vehicle (DMSO) control cells at 24 and 48 hours (Figure 11B and 11C). 
On the other hand, ERK1/2 phosphorylation was not affected (Figure 11B and 11D), 
which reinforced the specificity of the effect of DPI on Akt but not ERK1/2. In 
addition, the phosphorylation level of p70S6K, which is downstream of Akt, was 
reduced at 24 hours and 48 hours as well (Figure 11E).  
 












































































Figure 11: The levels of intracellular O2.- and Akt phosphorylation are reduced 
by DPI over the long period of time. 
 
MEFPTEN-/- cells were incubated with 6µm DPI (or DMSO as control) for 2hrs before 
the cells were washed with 1x PBS and replaced with fresh medium. (A) Intracellular 
O2.- level was measured by lucigenin luminescence at respective time points. The level 
of intracellular O2.-  in treated cells was reported as percent of DMSO control cells for 
respective time points. The value represents the mean+S.D. of three independent 
experiments. * p < 0.05  (B) Cells were harvested for Western blot analysis at 2hr, 
24hr and 48hr. The blot represents three independent experiments. (C) Densitometric 
analysis of Akt phosphorylation level for cells described in (B). (D) Densitometric 
analysis of ERK1/2 phosphorylation level for cells described in (B). For densitometric 
analyses, the phosphorylation level for each protein was calculated as phosphorylation 
level relative to total protein level. The change in phosphorylation level was shown as 
a fold difference relative to DMSO control cells at respective time points. The value 
represents the mean+S.D. of at least four independent experiments. * p < 0.05 (E) 
Western blot analysis of p70S6K. A representative blot from two independent 
experiments is shown.   
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With the reduction in intracellular O2.- level and Akt phosphorylation level, cell 
proliferation was significantly retarded (Figure 12).  Figure 12A shows photographs 
of treated (DPI) and untreated control (DMSO) cells after 24 and 48 hours. Less 
healthily attached cells were observed after DPI treatment. For a more quantitative 
representation of the data, crystal violet assay was performed to estimate the number 
of attached cells (Figure 12B). The number of attached cells was significantly lower 
in DPI-treated cells than in control cells at both time points. The control cells 
exhibited an exponential growth curve. For DPI-treated cells, cell number barely 
changed in the first 24 hours, while the cell number increased slightly between 24 to 
48 hours. This suggests that cell proliferation was retarded after DPI treatment.  
 
Furthermore, cell cycle analysis by propidium iodide (PI) staining revealed that there 
was no apparent increase in the percentage of subG1 population of DPI treated cells at 
both 24 and 48 hours (Figure 12C and 12D). In addition, there was no obvious cell 
cycle arrest at any phases (Figure 12C). These results indicate that the reduced 
proliferation rate is not due to apoptotic cell death or cell cycle arrest. It possibly 
reflects a slowing down of the overall cell proliferation process. Further investigations 
are needed to identify the downstream molecules involved in slowing down cell 
proliferation.  























































































Figure 12: Retardation of cell proliferation after prolonged reduction in 
intracellular O2.- level by DPI.  
 
MEFPTEN-/- cells grown in DMEM/10% FBS were incubated with 6µm DPI (or 
DMSO as control) for 2hrs before the cells were washed with 1xPBS and replaced 
with fresh medium. The cells were grown for another 24 or 48 hours.  (A) Cell 
photographs were taken at each time point. (B) Cell density was assessed by crystal 
violet assay at indicated time points and expressed as OD at 595nm. Each value 
represents the mean+S.D. of three samples from one representative experiment. The 
same experiment was repeated three times. * p < 0.05.  (C) Cell cycle analysis was 
performed by PI staining and flow cytometry analysis. A representative graph of the 
cell cycle profile was shown. (D) Cell percentage of subG1 population was reported. 
Each value represents the mean+S.D. of four samples from two independent 
experiments done in duplicates. 
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3.1.5 Akt is dephosphorylated upon the reduction in intracellular O2.- level by 
Nox4 silencing 
 
We have used the pharmaceutical drug DPI to decrease intracellular O2.- level in the 
previous experiments. We further confirm our findings with a molecular approach, 
namely by knocking down the O2.- producing NADPH oxidase (Nox). As different 
Nox isoforms are found in different cell types (Table 2), it is important to identify the 
specific isoforms expressed in the MEF cells. As shown in Table 2, the presence of 
Nox2 and Nox4 was previously reported in fibroblasts. Many reports have suggested 
that Nox4 is the most abundant isoform in fibroblasts (Bedard and Krause, 2007; 
Chamseddine and Miller, 2003). Moreover, studies in NIH3T3 mouse fibroblasts or in 
RelA-/- MEF cells showed that Nox4 but not Nox2 was detectable in these cell lines 
(Friis et al., 2008; Anrather et al., 2006). These two cell lines are similar mouse 
fibroblast cells to the MEF cells used in this project. Therefore, we checked the 
presence of Nox4 in MEFPTEN-/- cells.  
 
Firstly, detection of Nox4 mRNA was achieved by PCR. When 500ng and 250ng of 
input RNA were used for PCR, PCR products at the predicted size (409bp) were 
generated. However, no difference in the band intensity was observed in spite of the 
different amount of starting RNA (Figure 13A). This indicates that the signal is 
saturated for the amount of RNA used. In addition, a “NO RT” reagent control, where 
only RNA but not the reagent for reverse-transcription was included in the reverse-
transcription step, did not produce any band.  This suggested that the band detected in 
the sample was not from genomic DNA contamination. Next, less amounts of RNA 
(ranging from 100ng to 12.5ng) were used for the initial step of reverse-transcription 
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to ensure that the amount of RNA and the PCR conditions used were suitable to detect 
any decreases in the mRNA level of the target gene. Figure 13B shows that a 
decreasing amount of PCR product was detected in accordance with the decreasing 
amount of input RNA. In the subsequent PCR reactions, 100ng of RNA and the 
current PCR conditions were used to evaluate Nox4 mRNA levels. To further confirm 
that the PCR product detected indeed represented Nox4, cells were transfected with 
siRNA against Nox4 and were harvested 48 hours post transfection for PCR analysis. 
This experiment also allows us to check the efficiency of the siRNA to knockdown 
Nox4. The results show that there was a decrease in the amount of the 409bp PCR 
product in the siNox4 samples, and that the two concentrations of siRNA tested 
(10nM and 20nM) could both effectively downregulate Nox4 mRNA levels (Figure 
13C). The subsequent experiments were performed with 10nM siRNA to knockdown 
Nox4.  
 
Secondly, Western blot analysis was used to detect the Nox4 protein. However, 
multiple bands were detected by the antibody used (Figure 13D). One band was close 
to the predicted molecular size of 70kDa. However, when siNox4 samples were 
examined on Western blot, the intensity of the band at 70kDa did not change (Figure 
13E). These results indicate that the band at 70kDa is possibly a non-specific band. 
We also tried another Nox4 antibody from a different company which also showed 
multiple, likely non-specific bands (data not shown).  
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Figure 13: Detection of Nox4 in MEF cells. 
  
(A) MEFPTEN-/- cells grown in DMEM/10%FBS were harvested for RNA extraction, 
followed by PCR analysis with the primers for Nox4. Different amount of RNA was 
used for PCR. “NO RT” was the reagent control. (B) Different amount of RNA was 
used to optimize the PCR condition. (C) MEFPTEN-/- cells grown in DMEM/10%FBS 
were transfected with siRNA for Nox4 (siNox4), control siRNA (sico) or mock 
control (mock). Cells were harvested for RNA extraction 48 hours post transfection. 
PCR analysis with the primers for Nox4 or GAPDH was then performed. (D) 
MEFPTEN-/- cells or MEFWT cells grown in DMEM/10%FBS were harvested for 
Western blot analysis. (E) MEFPTEN-/- cells grown in DMEM/10%FBS were 
transfected with siRNA for Nox4 (siNox4) or control (sico). Un-transfected control 
(UT) and mock control (mock) were also included. Cells were harvested for Western 
blot analysis 48 hours post transfection. The antibody against Nox4 was used for (D) 
and (E).  
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Due to the lack of a good Nox4 antibody to detect Nox4 protein expression, we could 
only use the Nox4 mRNA level as a guideline for the efficiency of Nox4 knockdown. 
As there is a delay in the change of protein level following the change in mRNA level, 
Nox4 mRNA level was assessed at an earlier time point at 24 hours post transfection. 
As shown in Figure 14A, Nox4 mRNA level was already downregulated by siRNA at 
24 hours post transfection. The reduction was sustained at 48 hours post transfection. 
The downregulation of mRNA achieved at an earlier time point allows us to speculate 
that the Nox4 protein level should also be downregulated at 48 hours post transfection. 
Moreover, consistent with the downregulation in Nox4 mRNA, the intracellular O2.- 
level was reduced by siNox4 at both 24 and 48 hours post transfection (Figure 14B). 
As the protein is the major functional molecule involved in regulating the intracellular 
O2.- level, the observed reduction in O2.- level indirectly suggests that the Nox4 
protein level has most likely been downregulated by siNox4. The rest of the siNox4 
experiments are therefore performed 48 hours post transfection.  
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Figure 14: Intracellular level of O2.- is reduced by siNox4. 
 
MEFPTEN-/-cells grown in DMEM/10%FBS were transfected with siRNA for Nox4 
(siNox4) or control siRNA (sico). (A) Cells were harvested for RNA extraction 24 
hours or 48 hours post transfection. PCR analysis with the primers for Nox4 or 
GAPDH was then performed. (B) Intracellular O2.- level was measured by lucigenin 
luminescence 24 hours or 48 hours post transfection. The level of intracellular O2.- 
was expressed as percent of sico cells. The value represents the mean+S.D. of two 
independent experiments.  
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The intracellular O2.- level was reduced by siNox4 to about 80% of the control cells 
48 hours post transfection (Figure 15A). This reduction in the level of intracellular 
O2.- level was accompanied by a significant decrease in Akt phosphorylation level 
(Figure 15B and 15C). On the contrary, phosphorylation on ERK1/2 was not affected. 
Similar to Akt, GSK3á/â and p70S6K were dephosphorylated as well (Figure 15D).  
 
Cell cycle phase analysis was then performed to verify the effect of siNox4 on cell 
proliferation. There were no obvious changes in the percentage of cells in each phase 
(Figure 16A). Statistical analysis suggests that there was no significant increase in the 
percentage of subG1 population (Figure 16B). It was previously shown that Nox4 
siRNA could induce G2-M cell cycle arrest in two melanoma cell lines, MM-BP and 
928mel (Yamaura et al., 2009). A contrasting result was reported for HUVECs 
(human umbilical vein endothelial cells), in which siNox4 induced cell proliferation 
(Lener et al., 2009). In our system, however, siNox4 did not cause either G2-M arrest 
or cell proliferation. The discrepancies of the results observed can be due to the 
differences in the cell lines used. Firstly, there are different Nox isoforms present in 
different cell types. Therefore, knockdown of one particular isoform might have a 
different impact on ROS homeostasis in different systems. Secondly, in response to 
the ROS changes, different cells might respond differently depending on the intrinsic 
cellular background such as the antioxidant capacity.   
 









































































































Figure 15: Reduction of intracellular O2.- level by siNox4 results in Akt 
dephosphorylation.  
 
MEFPTEN-/- cells grown in DMEM/10%FBS were transfected with siRNA for Nox4 
(siNox4) or control (sico). (A) Intracellular O2.- level was measured by lucigenin 
luminescence 48 hours post transfection. The level of intracellular O2.- was expressed 
as percent of sico cells. The value represents the mean+S.D. of three independent 
experiments. * p < 0.05 (B) Cells were harvested for Western blot 48 hours post 
transfection. A representative blot from four independent experiments is shown. (C) 
Densitometric analysis of Akt phosphorylation level for cells described in (B). The 
phosphorylation level of Akt was calculated as phosphorylation level relative to total 
Akt level. The change in phosphorylation level was shown as a fold difference 
relative to sico cells. The value represents the mean+S.D. of four independent 
experiments. * p < 0.05 (D) Western blot analysis of GSK3α/β and p70S6K. A 
representative blot from three independent experiments is shown. 




























Figure 16: Cell cycle analysis after silencing of Nox4. 
 
MEFPTEN-/- cells grown in DMEM/10%FBS were transfected with siRNA for Nox4 
(siNox4) or control siRNA (sico). Cell cycle analysis was performed by PI staining 
and flow cytometry analysis 48 hours post transfection. (A) A representative graph of 
the cell cycle profile is shown. (B) Cell percentage of subG1 population was reported. 
Each value represents the mean+S.D. of six samples from two independent 
experiments done in triplicates.  
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3.2 Decrease in the intracellular level of O2.- induces the 
dephosphorylation of cytosolic Akt 
 
We have shown so far that the reduction in intracellular level of O2.- results in a 
decrease in Akt phosphorylation level in MEFPTEN-/- cells. We then investigated how 
the O2.-dependent regulation of Akt phosphorylation is achieved.  
 
3.2.1 The kinase-mediated process is not involved in the reduction of Akt 
phosphorylation 
 
As illustrated in Figure 17, Akt phosphorylation level is dependent on the fine balance 
between “on” and “off” signals. The “on” signal refers to the addition of a phosphate 
group on Akt by protein kinases, while the “off” signal refers to the removal of a 
phosphate group by protein phosphatases. Therefore, Akt dephosphorylation upon the 
reduction in intracellular O2.- level could be achieved via two ways. One is to reduce 
the “on” signal by decelerating the kinase-mediated process. The other is to increase 










Figure 17: Simplified diagram illustrating the two direction regulation of Akt 
phosphorylation.  
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We first investigated whether the kinase-mediated phosphorylation step was involved 
in the O2.--mediated Akt dephosphorylation. For Akt protein to be phosphorylated by 
kinases, the first important step involves translocation of Akt to the plasma membrane 
via the interaction of its PH domain with membrane phosphoinositides, in particular 
PIP3 (Andjelković et al., 1997; Burgering and Coffer, 1995). The PIP3 level is the 
primary determinant in Akt translocation and the level of PIP3 is tightly regulated by 
PI3K and lipid phosphatases. After translocation, the second step is the 
phosphorylation by upstream kinases. The kinases responsible for the two important 
sites Thr308 and Ser473 are PDK1 and rictor/mTOR complex respectively (Aoki et 
al., 1998; Alessi et al., 1997; Sarbassov et al., 2005). Translocation of PDK1 to the 
membrane, which is crucial to facilitate Akt phosphorylation, is also dependent on 
PIP3 (Anderson et al., 1998; Bellacosa et al., 1998; Stephens et al., 1998). In contrast, 
details of the rictor/mTOR-mediated process are not well understood yet. In this 
project, two parameters, the PIP3 level and the membrane translocation of Akt and 
PDK1, are used to assess if there are any changes in the kinase-mediated process after 
the reduction in intracellular O2.- level by DPI or siNox4. 
 
The PIP3 level was measured by immunofluorescence. The cells were stained with an 
anti-PIP3 antibody followed by confocal microscopic analysis. Validation of the 
method was performed by comparing the PIP3 staining in MEFWT cells and  
MEFPTEN-/- cells. As expected, MEFPTEN-/- cells exhibited a higher level of PIP3 
staining compared to MEFWT cells (Figure 18A), which corresponded to the absence 
of PTEN in MEFPTEN-/- cells. Moreover, membrane fractionation results show that 
more Akt and PDK1 were detected in the membrane fraction (P100) for MEFPTEN-/- 
cells as compared to MEFWT cells, while there was no difference in Akt or PDK1 
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protein level in the total cell lysate (TCL) between the two cell lines (Figure 19A). 
These results suggest that, in line with the accumulation of PIP3 in MEFPTEN-/- cells, 
Akt and PDK1 are more efficiently recruited to the membrane in MEFPTEN-/- cells 
compared to MEFWT cells. The results obtained in MEFWT and MEFPTEN-/- cells 
suggest that the methods used are appropriate for measuring the two parameters, PIP3 
level and Akt/PDK1 translocation.    
 
Measurement of PIP3 level in MEFPTEN-/- cells subjected to DPI treatment or siNox4 
showed that PIP3 staining was not reduced in both conditions (Figure 18B and 18C). 
In addition, the reduction in intracellular O2.- level by DPI or siNox4 did not disrupt 
membrane translocation of Akt or PDK1 either (Figure 19B and 19C). Taken together, 
PIP3 measurement and membrane localization data suggest that the kinase-mediated 
phosphorylating process at the plasma membrane is likely not disrupted and could not 
explain the dephosphorylation of Akt upon the reduction in the level of intracellular 
O2.-  in MEFPTEN-/- cells.  
 
On the other hand, in the case of serum deprivation, MEFPTEN-/- cells starved in 
0.5%FBS-containing medium exhibited lower levels of PIP3 as compared to cells 
grown in 10%FBS-containing medium (Figure 18D). In accordance with the reduced 
PIP3 level, membrane translocation of Akt and PDK1 was reduced in serum-deprived 
cells, while there was no difference in Akt or PDK1 protein levels for total cell lysate 
(Figure 19D). The reduced level of PIP3 and Akt/PDK1 translocation indicate that the 
kinase-mediated process is likely decreased in the case of serum deprivation. 
Therefore, Akt dephosphorylation (Figure 19D) upon serum withdrawal is at least 
partially due to the disruption of upstream kinase-mediated process, which is likely a 
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different mechanism from the Akt dephosphorylation mediated by the reduction in 
intracellular O2.- level.   
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Figure 18: Confocal analysis of cellular PIP3 level. 
 
(A) MEFPTEN-/- cells (KO) or MEFWT cells (WT) were grown in DMEM/10%FBS. (B) 
MEFPTEN-/- cells were grown in DMEM/10%FBS and treated with 6uM DPI (or 
DMSO as control) for 2 hours. (C) MEFPTEN-/- cells grown in DMEM/10%FBS were 
transfected with siRNA for Nox4 (siNox4) or control siRNA (sico). Measurement of 
PIP3 level was performed 48 hours post transfection. (D) MEFPTEN-/- cells were serum 
starved in DMEM/0.5%FBS for 24 hours (KO 0.5%) or grown in DMEM/10%FBS 
(KO 10%).  
The cells described in (A) to (D) were then processed for immunofluorescence with 
the primary antibody against PIP3. The negative control was included where no 
primary antibody (no 1’Ab) was used. Scale bar = 20μm.  

























































































































Figure 19: Membrane translocation of Akt or PDK1 is not affected by DPI or 
siNox4. 
 
(A) MEFPTEN-/- cells (KO) or MEFWT cells (WT) were grown in DMEM/10%FBS. (B) 
MEFPTEN-/- cells were grown in DMEM/10%FBS and treated with 6uM DPI (or 
DMSO as control) for 2 hours. (C) MEFPTEN-/- cells grown in DMEM/10%FBS were 
transfected with siRNA for Nox4 (siNox4) or control siRNA (sico). The assay was 
performed 48 hours post transfection. (D) MEFPTEN-/- cells were serum starved in 
DMEM/0.5%FBS for 24 hours or grown in DMEM/10%FBS. Cells described in (A) 
to (D) were subjected to membrane fractionation before the samples from cytosolic 
(S100) and membrane (P100) fractions were analysed on Western blot. Protein level 
of SOD1 and cadherin were detected on Western blot as the fractionation markers for 
S100 and P100 respectively. Total cell lysate was collected and analysed as well. 
Cadherin and SOD1 were probed as membrane and cytosolic markers respectively. 
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3.2.2 The dephosphorylation mainly occurs on cytosolic Akt than membrane Akt 
 
Having established that the kinase-mediated process at the membrane was not 
involved in Akt dephosphorylation by the reduction in O2.- level, the next possible 
mechanism is the accelerated phosphatase-mediated process. We first examined 
whether the phosphorylation level of membrane associated Akt is similarly affected as 
that of Akt from the cytosolic pool. Identifying the target pool of Akt for 
dephosphorylation will help us to identify the prospective regulators.    
 
Using the membrane fractionation method, we show that Akt from the cytosolic 
fraction (S100) was readily dephosphorylated after DPI treatment, while Akt from the 
membrane fraction (P100) was only slightly dephosphorylated (Fig. 20A). For Thr308, 
the phosphorylation level of cytosolic Akt reduced to 44% of untreated controls, while 
the phosphorylation level of membrane Akt was still 79% of untreated controls. For 
Ser473, the cytosolic Akt phosphorylation level reduced to 54% of untreated controls 
and the membrane Akt phosphorylation level was 92% of untreated controls (Figure 
20B). Similarly, membrane fractionation was performed on cells subjected to siNox4. 
The results also show that the dephosphorylation was more pronounced on cytosolic 
Akt than on the membrane Akt (Figure 20C and 20D).   
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Figure 20: Cytosolic Akt is more sensitive to DPI- and siNox4-mediated 
dephosphorylation than membrane Akt. 
 
(A) MEFPTEN-/- cells grown in DMEM/10%FBS were treated with 6µM DPI (or 
DMSO as control) for 2hrs before cytosolic (S100) and membrane (P100) fractions 
were separated and Akt phosphorylation on Thr308 and Ser473 in each fraction was 
analysed on Western blot. For Thr308, Akt from the cytosolic fraction was pulled 
down by immunoprecipitation before the phosphorylation was detected. The blot 
represents at least three independent experiments. (B) Densitometric analysis of Akt 
phosphorylation level in different fractions as described in (A). (C) MEFPTEN-/- cells 
grown in DMEM/10%FBS were transfected with siRNA for Nox4 (siNox4) or control 
siRNA (sico). Membrane fractionation was performed 48 hours post transfection. The 
blot represents three independent experiments. (D) Densitometric analysis of Akt 
phosphorylation level in different fractions as described in (C). For densitometric 
analyses shown in (B) and (D), the phosphorylation level of Akt was calculated as 
phosphorylation level relative to total Akt level. The change in phosphorylation level 
was shown as a fold difference relative to DMSO control cells for respective fraction. 
The value represents the mean+S.D. of at least three independent experiments. * p < 
0.05 
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To further demonstrate that the membrane associated Akt was less sensitive to 
dephosphorylation by the reduction in O2.- level, MEFPTEN-/- cells were transfected 
with a Myr-tagged Akt construct (Myr-Akt-HA) in which the N-terminal 
myristoylation allows the Akt protein expressed to associate with the plasma 
membrane (Kohn et al., 1996; Bellacosa et al., 1998; Ahmed et al., 1997). After 
transfection, MEFPTEN-/- cells were treated with DPI for 2 hours. The phosphorylation 
status of the over-expressed Myr-Akt was then determined after Myr-Akt was 
immunoprecipitated using an anti-HA antibody. Western blot analysis shows that 
Myr-Akt was not dephosphorylated by DPI (Figure 21A and 21B). As a control, to 
make sure that the absence of dephosphorylation was not due to any intrinsic defect of 
the Myr-Akt construct, MEFPTEN-/- cells were subjected to the same process but 
treated with LY294002, a PI3K inhibitor. The phosphorylation on Myr-Akt was 
completely abolished by LY294002 (Figure 21A), which showed that the Myr-Akt-
HA is indeed susceptible to dephosphorylation. Therefore, the resistance to 
dephosphorylation is specific to DPI treatment. 
 
Together with the previous data from membrane fractionation experiments, these 
results suggest that the decrease in Akt phosphorylation level does not occur equally 
on membrane and cytosolic pools of Akt. The membrane Akt is more resistant to the 
dephosphorylation caused by DPI- and siNox4-mediated reduction in intracellular O2.- 
level.  
 
































































Figure 21: Membrane-bound Myr-Akt is not sensitive to DPI-mediated 
dephosphorylation. 
 
(A) MEFPTEN-/- cells were transfected with HA tagged Myr-Akt-HA construct and 
treated with 6µM DPI (or DMSO as control) or 25µM LY294002 for 2 hours. Myr-
Akt was immunoprecipitated with anti-HA antibody before the phosphorylation level 
of Myr-Akt was detected on Western blot. (B) Densitometric analysis of the 
phosphorylation level of the membrane-bound Myr-Akt. The phosphorylation level of 
Akt was calculated as phosphorylation level relative to total Akt level. The change in 
phosphorylation level was shown as a fold difference relative to DMSO control cells. 
The value represents the mean+S.D. of three independent experiments.  
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3.2.3 The dephosphorylation of Akt is similarly observed in mitochondria and 
nucleus as in cytosol 
 
After showing that the cytosolic Akt was more sensitive to dephosphorylation than 
membrane Akt upon the decrease in intracellular O2.- level by DPI or siNox4, we also 
examined the status of Akt phosphorylation in the mitochondria and the nucleus. 
Translocation of Akt into the mitochondria or nucleus enables it to phosphorylate the 
downstream substrates in these compartments, which represents an important aspect 
of the biological functions of Akt (Miyamoto et al., 2009). Mitochondrial 
fractionation and nuclear fractionation were performed, and the lysates from different 
fractions were analyzed by Western blot. The mitochondrial and nuclear Akt showed a 
similar decrease in phosphorylation level as cytosolic Akt after DPI treatment (Figure 
22A and 22B) or siNox4 (Figure 22C and 22D). This could be important for the 
dephosphorylated Akt to downregulate the downstream physiological processes by 
regulating the substrates in these compartments.  
 



















































































Figure 22: DPI- and siNox4-mediated Akt dephosphorylation is similarly 
observed in mitochondria and nuclear fractions. 
 
MEFPTEN-/- cells were treated with 6µM DPI (or DMSO as control) for 2 hours. (A) 
Mitochondria (Mito) or (B) nuclear (Nuc) fractionations were performed to reveal 
phosphorylation level and total amount of Akt in these compartments as compared to 
that in cytosolic fraction (Cyt).  
MEFPTEN-/- cells grown in DMEM/10%FBS were transfected with siRNA for Nox4 
(siNox4) or control (sico). (C) Mitochondria (Mito) or (D) nuclear (Nuc) 
fractionations were performed 48 hours post transfection.  
VDAC, PARP and SOD1 were probed as mitochondrial, nuclear and cytosolic 
markers respectively. A representative blot from two independent experiments is 
shown. 
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3.3 The cytosolic dephosphorylation of Akt is dependent on PP2A 
 
We have shown so far that the dephosphorylation of Akt was not due to a deficiency 
in the kinase-mediated phosphorylating process, and we have also identified cytosolic 
Akt as the main target of the dephosphorylation induced by a decrease in the 
intracellular level of O2.-. Next we tried to elucidate the involvement of the 
phosphatase-mediated process, focusing on cytosolic Akt.  
 
3.3.1 Thr308 is the more sensitive site for dephosphorylation 
 
The reduction in Akt phosphorylation level was observed at both of the two important 
sites Thr308 and Ser473. A semi-quantitative kinetics analysis (Figure 23) revealed 
that the dephosphorylation occurred faster on Thr308 (as early as 1hr DPI treatment), 
and also to a greater extent on Thr308 (as indicated by the slope of the 
dephosphorylation curve for the first 2 hours). Therefore, Thr308 seems to be the 
more sensitive phosphorylation site on Akt that is affected by the reduction in the 
level of intracellular O2.-. 
 











Figure 23: Akt dephosphorylation is faster and more intense on Thr308 than on 
Ser473. 
 
Densitometric analysis of Akt phosphorylation for (A) MEFPTEN-/- cells grown in 
DMEM/10%FBS or (B) MEFPTEN-/- cells serum starved in DMEM/0.5%FBS after 
treated with 6µM DPI for different time points.  
Note: figure 23 is the densitometric analysis taken from figure 6. It is included for 
easy reference.  
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3.3.2 Ser129 is not involved in the current system 
 
It was previously shown in HEK 293T cells that the dephosphorylation on Thr308 
could be related to the phosphorylation status of another Akt phosphorylation site, 
Ser129. CK2 was shown to phosphorylate Ser129, which could facilitate the 
association of Akt with Hsp90 and prevent dephosphorylation of Thr308 (Di Maira et 
al., 2009). Considering this observation, we examined whether the phosphorylation 
level of Ser129 was affected upon the decrease in the level of intracellular O2.-. Figure 
24A shows that there was no change in Ser129 phosphorylation level after treatment 
with DPI at different doses that was previously shown to cause the dephosphorylation 
on Thr308. Considering that the change on Ser129 might be an earlier event preceding 
the dephosphorylation of Thr308, a time kinetic study starting from 0.5 hour was 
performed. At all time points tested, phosphorylation of Ser129 was not affected by 
DPI (Figure 24B). Therefore, the O2.--dependent dephosphorylation on Thr308 of Akt 
is not related to the phosphorylation status of Ser129.   
 

































Figure 24: Akt phosphorylation on Ser129 is not affected by DPI. 
 
(A) MEFPTEN-/- cells grown in DMEM/10%FBS were treated with different doses of 
DPI for 2 hours before Akt phosphorylation on Ser129 was measured by Western blot. 
(B) MEFPTEN-/- cells grown in DMEM/10%FBS were treated with 6µM DPI for 
different time points before Akt phosphorylation on Ser129 was measured by Western 
blot.  
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3.3.3 Akt dephosphorylation is dependent on PP2A 
 
Having identified cytosolic Akt and the Thr308 site as the sensitive target of 
dephosphorylation upon the reduction in intracellular O2.-, we next investigated the 
involvement of protein phosphatase 2A (PP2A), which is a major phosphatase to 
regulate Akt phosphorylation on Thr308 in the cytosol (Liao and Hung, 2010).  
 
In order to assess if PP2A is responsible for Akt dephosphorylation in the current 
system, the phosphatase inhibitors okadaic acid (OA) and calyculin A (CA) were used 
to inhibit PP2A activity. The effective concentration of the inhibitors varied a lot in 
published papers. This is mainly due to two reasons. Firstly, we need to distinguish 
between the experiments done in vitro and in vivo. The IC50 values reported in vitro 
using cell lysates or purified enzymes might not be applicable to in vivo experiments 
in which cultured cells are treated with the inhibitors. Secondly, the effective 
concentration to inhibit PP2A phosphatase activity varies in different cell types. This 
is dependent on the different cellular uptake rate of the inhibitors and the cellular 
concentration of the target phosphatase (Schönthal, 1998; Janssens and Goris, 2001). 
The reported concentration to achieve selective inhibition for PP2A against PP1 is 
also different in different systems (Yin et al., 2006; Guichard et al., 2006). This could 
be attributed to the differences in cellular uptake rate of the drug and endogenous 
level of the phosphatases as well.  
 
Therefore, we first tested the effective concentration of OA and CA to use in our 
system in order to inhibit PP2A activity. PP2A activity assay was used to monitor the 
overall PP2A activity in the cells treated with the inhibitors. A dose-dependent 
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inhibition was observed for OA and CA (Figure 25A).In order to achieve a moderate 
level of inhibition without affecting cell viability, 150nM OA and 0.8nM CA were 
used in the rest of the experiments. At the concentrations chosen, both OA (150nM) 
and CA (0.8nM) could effectively inhibit PP2A activity (Figure 25B).  
 
To investigate the role of PP2A in Akt dephosphorylation by the reduction in 
intracellular O2.- level, MEFPTEN-/- cells were co-incubated with DPI and the 
phosphatase inhibitors. The results show that the reduction in intracellular O2.- level 
by DPI was achieved to a similar extent with or without the inhibitors (Figure 26). 
This indicates that presence of OA/CA does not interfere with the efficiency of DPI to 
reduce O2.- level. However, when PP2A activity was inhibited by OA/CA, Akt 
dephosphorylation was at least partially attenuated (Figure 27A and Figure 27C). The 
densitometric analysis of the Western blot is presented for OA (Figure 27B) and CA 
(Figure 27D) respectively for a clearer illustration. In the absence of the inhibitors, 
Akt phosphorylation level on Thr308 in DPI-treated cells is about 40% to 50% of 
control cells. In the presence of OA/CA, Thr308 phosphorylation level in DPI-treated 
cells was rescued to about 80% to 85% of control cells. For Ser473, a similar 
prevention of dephosphorylation was observed in cells incubated with OA/CA. 
Notably, almost a 100% rescue was observed for Ser473 by CA. Another point to 
notice was that OA/CA alone caused an increase in Akt phosphorylation on Thr308 
but not on Ser473 (compare “OA+DMSO” and “DMSO+DMSO” or “CA+DMSO” 
and “DMSO+DMSO”). This result suggests that the two inhibitors used did not affect 
the activity of the Ser473-specific phosphatase PHLPP. This is consistent with what is 
reported previously (Gao et al., 2005).  






















































































Figure 25: PP2A activity is efficiently reduced by the inhibitors. 
 
(A) MEFPTEN-/- cells grown in DMEM/10%FBS were treated with different doses of 
phosphatase inhibitor okadaic acid (OA) or calyculin A (CA) for 2 hours before the 
cells were harvested for PP2A activity assay as described in Materials and Methods 
(section 2.2.15). (B) MEFPTEN-/- cells grown in DMEM/10%FBS were treated with 
selected concentration of OA (100nM) and CA (0.8nM) for 2 hours. The PP2A 
activity measured in (A) and (B) was expressed as fold difference relative to DMSO 
control cells. The value in (B) represents the mean+S.D. of four independent 
experiments. * p < 0.05  
 




































































Figure 26: Presence of the phosphatase inhibitors OA and CA does not interfere 
with DPI-mediated reduction in the intracellular level of O2.-. 
 
MEFPTEN-/- cells grown in DMEM/10%FBS were treated with 6µM DPI (or DMSO as 
control) for 2 hours in the presence or absence of (A) OA or (B) CA. Intracellular O2.- 
level was assessed by lucigenin luminescence. The level of intracellular O2.- was 
expressed as percent of DMSO control cells. The value represents the mean+S.D. of 
three independent experiments. * p < 0.05  





















































































































































































Figure 27: DPI-mediated Akt dephosphorylation is partially inhibited by 
phosphatase inhibitors OA and CA. 
 
MEFPTEN-/- cells grown in DMEM/10%FBS were treated with 6µM DPI (or DMSO as 
control) for 2 hours in the presence or absence of (A) OA or (C) CA before the cells 
were harvested for Western blot analysis. A representative blot from three independent 
experiments is shown. (B) Densitometric analysis of Akt phosphorylation level for 
cells described in (A). (D) Densitometric analysis of Akt phosphorylation level for 
cells described in (C). For densitometric analysis, the phosphorylation level of Akt 
was calculated as phosphorylation level relative to total Akt level. The change in 
phosphorylation level was shown as a fold difference as relative to DMSO control 
cells. The value represents the mean+S.D. of three independent experiments. * p < 
0.05.  
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3.3.4 The PP2A-B55α subunit is involved in Akt dephosphorylation 
 
Since the phosphatase inhibitors used may have non-specific inhibition on other 
protein phosphatases such as PP1, we then used a more specific molecular approach 
to knockdown PP2A expression in order to ensure the specificity of inhibition.  
 
The functional PP2A phosphatase consists of 3 subunits. The catalytic subunit (C 
subunit) and the scaffold subunit (A subunit) form the core dimer, which further binds 
with a wide variety of regulatory subunits (B subunit). The regulatory subunit is 
mainly responsible for substrate recognition and cellular localization (Millward et al., 
1999). To date, four different families of B subunits have been identified with various 
isoforms within each family (Janssens and Goris, 2001). It has been shown that the 
PP2A-B55α isoform is involved in the regulation of Akt phosphorylation (Kuo et al., 
2008).  
 
In our project, in order to understand the specific PP2A-dependent regulation on Akt 
phosphorylation, siRNA against PP2A-B55α was used to knockdown this isoform. 
MEFPTEN-/- cells were transiently transfected with siB55α. The cells were treated with 
DPI for 2 hours before harvested for Western blot analysis to examine Akt 
phosphorylation level on Thr308 and Ser473. DPI-mediated dephosphorylation was 
effectively prevented by B55α siRNA (Figure 28A and 28B). It was noticed that the 
dephosphorylation on Ser473 was only marginal in control siRNA (sico) cells upon 
DPI treatment for 2 hours. However, rescue of Akt phosphorylation level by siB55α 
on Ser473 was still noted. Similarly, in siNox4 cells, co-transfection of the siRNA for 
PP2A-B55α was performed. For Thr308, siNox4 caused a 50% reduction in Akt 
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phosphorylation in cells that were not co-transfected with siB55α, while Akt 
phosphorylation level was rescued to about 80% of control cells in siB55α cells 
(Figure 28C and 28D). However, prevention of dephosphorylation was only observed 
for Thr308 but not for Ser473. In fact, siB55α itself did not cause any increase in the 
phosphorylation level of Ser473 (compare “sico+siB55α” and “sico+sico”) while it 
did affect Thr308. This is consistent with the previous observation that the PP2A-
B55α holoenzyme catalyses dephosphorylation on Thr308, and has little effect on 
Ser473 (Kuo et al., 2008). The fact that PP2A is the functional phosphatase only for 
Thr308 but not for Ser473 may explain why dephosphorylation on Ser473 by siNox4 
is not rescued by siB55α.  
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Figure 28: DPI- and siNox4-mediated Akt dephosphorylation is dependent on the 
PP2A-B55α subunit. 
 
(A) MEFPTEN-/- cells were transfected with siRNA of PP2A-B55α (siB55α) or control 
siRNA (sico). Transfected cells were treated with 6um DPI (or DMSO as control) for 
2hrs before harvested for Western blot analysis. A representative blot from three 
independent experiments is shown. (B) Densitometric analysis of Akt phosphorylation 
level for cells described in (A). (C) MEFPTEN-/- cells were co-transfected with siRNA 
of PP2A-B55α and Nox4 (siB55α + siNox4), sicontrol (sico + sico) or transfected 
with each siRNA alone (siB55α + sico or sico+ siNox4). Cells were harvested for 
Western blot analysis 48 hours post transfection. A representative blot from three 
independent experiments is shown. (D) Densitometric analysis of Akt phosphorylation 
level for cells described in (C). For densitometric analyses shown in (B) and (D), the 
phosphorylation level of Akt was calculated as phosphorylation level relative to total 
Akt level. The change in phosphorylation level was shown as a fold difference 
relative to DMSO control cells. The value represents the mean+S.D. of three 
independent experiments. * p < 0.05  
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3.3.5 PP2A-C and PP2A-B55α subunits are mainly present in cytosol 
 
Data from the previous section suggest that a PP2A-dependent dephosphorylation 
process is responsible for the decrease in Akt phosphorylation level under the current 
context of DPI- or siNox4-mediated reduction in intracellular O2.- level. In particular, 
PP2A-mediated Akt dephosphorylation is enhanced in this case. In agreement with the 
observation that the cytosolic Akt is the main target for dephosphorylation, the PP2A 
catalytic subunit (PP2A-C) as well as the PP2A-B55α subunit were predominantly 
detected in the cytosolic fraction instead of the membrane fraction (Figure 29). This 
















Figure 29: PP2A-C and PP2A-B55α are predominantly detected in the cytosol. 
 
MEFPTEN-/- cells grown in DMEM/10%FBS were treated with 6µM DPI (or DMSO as 
control) for 2hrs before cytosolic (S100) and membrane (P100) fractions were 
separated and the respective protein level in each fraction was analysed on Western 
blot. Cadherin and SOD1 were probed as membrane and cytosolic markers 
respectively. A representative blot from two independent experiments is shown. 
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3.3.6 Changes in PP2A-Akt interaction might be related to the enhanced Akt 
dephosphorylation 
 
To further clarify how PP2A regulates Akt phosphorylation in the case of DPI 
treatment, we first investigate the changes in PP2A protein expression level and PP2A 
activity. The enhanced dephosphorylation of Akt by PP2A can be achieved via an 
increase in either expression or activity of the phosphatase. However, our data show 
that DPI treatment did not affect protein level of PP2A-C subunit or PP2A-B55α 
subunit (Figure 30A). Moreover, PP2A activity in MEFPTEN-/- cells was not changed 
by addition of DPI (Figure 30B). Therefore, Akt dephosphorylation was not enhanced 
via changes in PP2A protein expression or activity. 
 
The next possible factor affecting the way PP2A regulates Akt is the interaction 
between the two proteins. It is logical that when the interaction is enhanced between 
the phosphatase and the substrate, dephosphorylation is accelerated. To examine this 
possibility, co-immunoprecipitation was performed in DPI-treated cells or DMSO 
control cells using an anti-Akt antibody. As shown in Figure 31, more PP2A-C 
subunit was detected in the sample from DPI-treated cells provided that a similar 
amount of Akt was pulled down from both treated and control cells. This result 
suggests that the PP2A-Akt interaction is enhanced in MEFPTEN-/- cells after the 
decrease in intracellular O2.- level by DPI. Therefore, the accelerated 
dephosphorylation of cytosolic Akt might be attributed to an enhanced interaction 
between Akt and the phosphatase PP2A.  
 



















































Figure 30: There is no change in PP2A protein expression level or PP2A activity 
upon DPI treatment. 
  
(A) MEFPTEN-/- cells grown in DMEM/10%FBS were treated with 6µM DPI (or 
DMSO as control) for indicated time points before cells were harvested for Western 
blot analysis. A representative blot from two independent experiments is shown. (B) 
MEFPTEN-/- cells grown in DMEM/10%FBS were treated with 6µM DPI (or DMSO as 
control) for 2 hours before cells were harvested for PP2A activity assay. The PP2A 
activity was expressed as a fold difference relative to DMSO control cells. The value 
represents the mean+S.D. of five independent experiments.  
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Figure 31: PP2A-Akt complex formation is enhanced upon the reduction in 
intracellular O2.- level by DPI.  
 
MEFPTEN-/- cells grown in DMEM/10%FBS were treated with 6µM DPI (or DMSO as 
control) for 2 hours before cells were harvested for coimmunoprecipitation assay as 
described in Materials and Methods (section 2.2.6). Akt was immunoprecipitated and 
Western blot analysis was performed to detect the level of Akt and PP2A-C subunit. A 
representative blot from three independent experiments is shown. 
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3.4 Regulation of Akt phosphorylation by the redox sensitive 
oxidation status of Akt 
 
It was previously reported that the redox status of Akt might affect Akt 
phosphorylation level via the changes in the interaction of Akt with PP2A (Murata et 
al., 2003). Akt oxidation was detected after cells were exposed to H2O2. This increase 
in Akt oxidation was associated with the enhanced interaction between Akt and PP2A, 
and therefore the transient dephosphorylation on Akt after exposure to H2O2 (Murata 
et al., 2003). Although the model is proposed in the context of exogenously added 
H2O2, redox changes caused by other ROS like O2.- could possibly lead to alterations 
in the redox status of Akt as well. In this section, we investigate the changes in Akt 
redox status upon changes in O2.- level, and thereafter the relation between Akt redox 
status and Akt phosphorylation level.  
 
3.4.1 Detection of Akt oxidation by AMS assay 
 
Detection of Akt oxidation was performed using the AMS assay modified from a 
previously described protocol (Murata et al., 2003). The basic principle of the assay is 
illustrated in Figure 32. Briefly, AMS (4-Acetamido-4-maleimidylstilbene-2,2-
disulfonic acid) functions to modify free thiol groups. Alkylation of the free thiols by 
AMS causes either a change in protein conformation or in molecular weight, which 
allows separation of the AMS-modified protein and the un-modified protein by SDS-
PAGE under non-reducing conditions. The more oxidized proteins with less free thiol 
groups exhibit less AMS modification and are detected as a lower band with higher 
mobility, while the proteins with lower mobility represent the reduced form. The 
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higher mobility of the oxidized protein can be attributed to its lower molecular weight 























Figure 32: Simplified graphic illustration of the AMS assay.  
 
The reduced and oxidized form of Akt is separated by SDS-PAGE after the AMS 
modification of free thiol groups.  
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As shown in Figure 33A, after AMS modification, detection of Akt protein on the 
Western blot showed two distinct bands (Lane 1), both of which were relatively 
higher than the Akt band detected from the total cell lysate prepared without AMS 
modification (Lane 3). In order to confirm that the lower band indeed represented the 
oxidized form of Akt, cell lysate was incubated with the reducing agent DTT before 
the AMS modification was performed. Incubation with DTT essentially abolished the 
lower band (Lane 2). As a further validation of the method, Akt oxidation status was 
measured in serum-deprived MEFWT cells treated with H2O2 (Figure 33B). As the 
purpose of this experiment was to evoke oxidation, a relatively high concentration of 
H2O2 (2mM) was used. After 1 hour exposure to 2mM H2O2, the oxidized form of Akt 
became more dominant, corresponding to the known oxidizing power of H2O2 in 
MEFWT cells to increase protein oxidation (Lim and Clément, 2007).  
 
On Western blot, the upper band represents the reduced form of Akt (reduced-Akt), 
while the lower band represents the oxidized form of Akt (oxidized-Akt). For 
comparison across different lanes on Western blot in subsequent analyses, the 
parameter used is Oxi-Akt/Total Akt, which is the percentage of oxidized-Akt over 
total Akt (the total amount of oxidized-Akt plus reduced-Akt), instead of the absolute 
amount of oxidized-Akt in each sample. This helps to avoid the confusion caused by 
loading differences, if any. Hsp90 was used in these experiments as a loading control.       
 


























Figure 33: Detection of Akt oxidation status by AMS assay. 
 
(A) MEFPTEN-/- cells (KO) were grown in DMEM/10%FBS before harvested for AMS 
assay. Lysate from MEFPTEN-/- cells were incubated with or without DTT before the 
AMS modification was performed. The total cell lysate (TCL) was collected   
following the preparation protocol of normal Western blot. (B) MEFWT cells (WT) 
were serum starved in DMEM/0.5%FBS for 24 hours before treated with nothing or 
2mM H2O2 for 1 hour. The cells were then harvested for AMS assay.  
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3.4.2 Changes of Akt oxidation status in response to changes in O2.- level 
 
Having validated the AMS modification assay, we next examine the oxidation status 
of Akt in response to changes in intracellular O2.- level in MEFPTEN-/- cells. Firstly, 
there was an increase in the percentage of oxidized-Akt upon reduction in intracellular 
O2.- level by DPI treatment, which was significantly reversed by addition of DDC. 
DDC alone also caused a significant reduction in the percentage of oxidized-Akt, 
which was inversely correlated to the increase in intracellular O2.- level in DDC-
treated cells (Figure 34A and 34B). Our data suggest that the changes in the 
percentage of oxidized-Akt (Figure 34B) closely reflects the changes in the level of 
intracellular O2.-  in MEFPTEN-/- cells (Figure 9A). Similarly, in serum-deprived 
MEFPTEN-/- cells (0.5%FBS), the level of Akt oxidation was (Figure 34C) also 
negatively correlated with the intracellular O2.- level (Figure 9B). However, in 
0.5%FBS condition, the change in oxidized-Akt caused by DPI or DDC is not as 
striking as that in 10%FBS condition. This corresponded to the less dramatic change 
in the level of intracellular O2.- in 0.5%FBS condition (Figure 9B) as compared to 
10%FBS condition (Figure 9A).  
 
Secondly, Akt oxidation status was determined in cells subjected to siNox4. The AMS 
assay shows that the ratio of oxidized-Akt increased in the siNox4 sample as 
compared to the control siRNA sample (Figure 35). This observation reinforces the 
point that Akt oxidation status is sensitive to intracellular O2.- level. 
 






















































































Figure 34: Changes in Akt oxidation status is in accordance with the changes in 
intracellular O2.- level. 
 
(A) MEFPTEN-/- cells (KO) grown in DMEM/10%FBS  were treated with 6µM DPI in 
the presence or absence of 1mM DDC for 2 hours before cells were harvested for 
AMS assay. A representative blot from three independent experiments is shown. (B) 
Densitometric analysis of Akt oxidation for cells described in (A). The percentage of 
the oxidized-Akt was calculated as amount of oxidized-Akt relative to amount of total 
Akt. The change in Akt oxidation level was shown as a fold difference relative to 
DMSO control cells. The value represents the mean+S.D. of three independent 
experiments. * p < 0.05 (C) MEFPTEN-/- cells (KO) serum starved  in 
DMEM/0.5%FBS were treated with 6µM DPI in the presence or absence of 1mM 
DDC for 2 hours before cells were harvested for AMS assay. A representative blot 
from two independent experiments is shown.  

































Figure 35: Change of Akt oxidation status in response to the reduction in 
intracellular O2.- level by siNox4.  
 
MEFPTEN-/- cells grown in DMEM/10%FBS were transfected with siRNA for Nox4 
(siNox4) or control siRNA (sico). Cells were harvested 48 hours post transfection for 
AMS assay. A representative blot from three independent experiments is shown.  
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3.4.3 Akt phosphorylation level is associated with the changes in Akt oxidation 
status in MEFPTEN-/- cells 
 
Furthermore, changes in the oxidation status of Akt in cases of DPI and siNox4 
indeed correlate with changes in Akt phosphorylation level, where dephosphorylation 
is enhanced when Akt oxidation is increased. When the AMS Western blot membrane 
was blotted with the antibody against phospho-Akt (Thr308 and Ser473), it was noted 
that the phosphorylation level of oxidized-Akt was consistently lower than that of 
reduced-Akt (Figure 34A, 34C and 35). Take Figure 34A for example, in the control 
sample (DMSO lane), the band intensity for oxidized-Akt (lower band) and reduced-
Akt (upper band) was almost the same when the membrane was blotted with total Akt 
antibody. However, the band intensity for oxidized-Akt (lower band) was obviously 
lower than reduced-Akt (upper band) when the antibodies against phospho-Thr308 or 
phospho-Ser473 were used. This observation is in line with the idea that Akt 
phosphorylation level is related with Akt oxidation status. Next, when O2.- level was 
lowered by DPI or siNox4, there was a shift from the reduced form to the oxidized 
form of Akt. The phosphorylation level of reduced-Akt was decreased corresponding 
to the decreased amount of total reduced-Akt. However, the phosphorylation level of 
oxidized-Akt was not proportionally increased with the increase in the total amount of 
oxidized-Akt. A possible explanation is that the change from the reduced form to the 
oxidized form renders the protein more susceptible to dephosphorylation. Therefore,  
as a reflection of the changes in phosphorylation on oxidized-Akt and reduced-Akt, a 
decrease in total Akt phosphorylation is observed after the reduction in intracellular 
O2.- level by DPI or siNox4. 
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Taken together, these results demonstrate that Akt oxidation is enhanced by DPI- and 
siNox4-mediated decrease in intracellular O2.- level in MEFPTEN-/- cells. Moreover, a 
decrease in Akt phosphorylation is observed together with the increase in Akt 
oxidation level as well as Akt-PP2A interaction. These results are consistent with the 
previously proposed model on how Akt redox status affects Akt phosphorylation level 
via the interaction with PP2A (Murata et al., 2003). However, further investigations 
are needed to understand whether there is really a causal relationship between Akt 
redox status and Akt phosphorylation level, as well as whether Akt-PP2A interaction 
is affected by Akt oxidation.    
 
3.4.4 Akt phosphorylation level is associated with the changes in Akt oxidation 
status in MEFWT and LNCaP cells 
 
Having established the connections between intracellular O2.- level, Akt oxidation 
level and Akt phosphorylation level in MEFPTEN-/- cells, we then briefly investigated 
whether similar connections are observed in other cell lines. Interestingly, in MEFWT 
cells, incubation with DPI did not cause any increase in oxidized-Akt (Figure 36A) 
although intracellular O2.- level was similarly reduced (Figure 36B). In accordance 
with the absence of a shift in Akt oxidation status, Akt phosphorylation at both 
Thr308 and Ser473 was not changed for either reduced-Akt or oxidized-Akt (Figure 
36A). The DDC treatment only slightly decreased oxidized-Akt level, while Akt 
phosphorylation was greatly enhanced. The induction of Akt phosphorylation by DDC 
in MEFWT cells was previously reported to be due to the increase in PTEN oxidation 
(Lim and Clément, 2007). Whether the reduction in Akt oxidation also contributes to 
the increase in Akt phosphorylation is not clear at the moment. The fact that the 
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decrease in the level of intracellular O2.- does not change Akt oxidation status in 
MEFWT cells indicates that the changes in intracellular O2.- level might not be 
sufficient to trigger the changes in Akt oxidation status. The overall changes in the 
cellular redox environment might determine how the Akt molecule would respond.  
 
Alternatively, we have tested the model in another PTEN defective cell line, the 
androgen-sensitive human prostate cancer cell LNCaP. Absence of PTEN in LNCaP 
cells was shown in Figure 37. DPI treatment for 2 hours in LNCaP cells resulted in an 
decrease in intracellular O2.- level (Figure 38A), as well as an increase in Akt 
oxidation (Figure 38B). In addition, Akt phosphorylation on both Thr308 and Ser473 
was reduced (Figure 38B). Therefore, LNCaP cells, with a similar background in 
terms of PTEN knockout, respond similarly to DPI as MEFPTEN-/- cells. 
 



























































Figure 36: Akt oxidation and phosphorylation is not affected upon reduction in 






cells grown in DMEM/10%FBS were treated with 6µM DPI in the 
presence or absence of 1mM DDC for 2 hours before cells were harvested for AMS 
assay. A representative blot from two independent experiments is shown.  
(B) MEFWT
 
cells grown in DMEM/10%FBS were treated with 6µM DPI in the 
absence of presence of 1mM DDC for 2 hours before cells were harvested for 
measurement for intracellular O2.- level. The level of intracellular O2.- was expressed 
as percent of DMSO control cells. The value represents the mean+S.D. of at least two 
independent experiments. n=4 for DPI; n=2 for other treatments. * p < 0.05  















and LNCaP cells were harvested for Western blot analysis for the detection of 
PTEN.  
 


















































Figure 38: The reduction in O2.- level is associated with the changes in Akt 
oxidation and phosphorylation in PTEN deficient LNCaP cells. 
 
(A) LNCaP cells grown in RMPI/10%FBS were treated with 6µM DPI (or DMSO as 
control) for 2 hours before intracellular O2.- level was assessed by lucigenin 
luminescence. The level of intracellular O2.- was expressed as percent of cells grown 
in 10%FBS. The value represents the mean+S.D. of three independent experiments. 
(B) LNCaP cells grown in RMPI/10%FBS were treated with 6µM DPI (or DMSO as 
control) for 2 hours and the cells were harvested for AMS assay. A representative blot 
from three independent experiments is shown. 
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3.4.5   Serum deprivation induces Akt oxidation in both MEFPTEN-/- and MEFWT 
cells 
 
Next, the oxidation status of Akt was examined after serum deprivation (0.5%FBS). 
The reason why we checked this was that serum deprivation (0.5%FBS) in both 
MEFPTEN-/- and MEFWT cells resulted in a decrease in O2.- level as compared to cells 
maintained in 10%FBS (Figure 39A). We would like to investigate whether the 
connection between intracellular O2.- level and Akt oxidation status also applies in this 
case. The results show that an increase in oxidized-Akt level was detected in 
0.5%FBS condition for both cell lines (Figure 39B). Therefore, the decrease in 
intracellular O2.- level still correlates with the level of Akt oxidation in MEFPTEN-/- 
cells. However, as Akt oxidation in MEFWT cells is not responsive to DPI-mediated 
reduction in intracellular O2.- level, other factors may be involved in inducing Akt 
oxidation in the case of serum deprivation in MEFWT cells. Moreover, in MEFWT cells, 
a decrease in PTEN oxidation upon serum deprivation was reported (Lim and 
Clément, 2007) and this was also detected here (Figure 39B). This is opposite of what 
is observed for Akt oxidation. Therefore, even under the same redox environment, the 
responses of different proteins could be different, like the oxidation status of Akt and 
PTEN. This difference could be due to the difference in the types of modifications 
(for example, disulfide bond formation or S-nitrosylation) involved, which needs 
further investigation.     
 





























































Figure 39: Intracellular O2.- level  and Akt oxidation level are changed in 
response to serum deprivation.  
 
MEFPTEN-/- cells (KO) or MEFWT cells (WT) were serum starved in DMEM/0.5%FBS 
for 24 hours or grown in DMEM/10%FBS. (A) Intracellular O2.- level was assessed 
by lucigenin luminescence. The level of intracellular O2.- was expressed as percent of 
cells grown in 10%FBS. The value represents the mean+S.D. of four independent 
experiments.   * p < 0.05 (B) The cells were harvested for AMS assay. A 
representative blot from three independent experiments is shown. 
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3.4.6 Changes in the cellular redox environment after DPI- or siNox4-mediated 
changes in intracellular O2.- level 
 
In the previous section 3.4.2, we have shown that the DPI- and siNox4-mediated 
reduction in intracellular O2.-  level is correlated with a shift in Akt oxidation status in 
MEFPTEN-/- cells. This observation suggests that there exists a reducing/oxidizing 
machinery responsible for O2.--dependent regulation of Akt oxidation. 
 
Reduced glutathione (GSH) is an important low-molecular-weight thiol, which 
functions not only as a reducing agent but also a mediator in many cellular signalling 
processes (Franco et al., 2007). GSH is classically known to maintain the reducing 
cellular environment and the reducing states of proteins. It is also known to scavenge 
several reactive oxygen species including O2.- and hydroxyl radical, as well as to form 
S-nitrosoglutathione (GSNO) with nitric oxide (NO). Of equal importance, together 
with its oxidized form GSSG, GSH actively participates in the formation of protein S-
glutathionylation and S-nitrosylation (Franco et al., 2007). Therefore, alterations in 
GSH homeostasis, in particular GSH depletion, are associated with pathological 
conditions such as apoptosis, cancer, and diabetes (Franco et al., 2007; Estrela et al., 
2006). In view of the importance of GSH in maintaining the reducing environment, 
we were interested to find out whether the changes in Akt oxidation in our system 
were related to the disturbance in intracellular GSH level. 
 
It was previously reported that DPI could trigger efflux of reduced glutathione (GSH) 
from T24 bladder carcinoma cells and, thus, cause a rapid loss of intracellular GSH 
(Pullar and Hampton, 2002). The DPI-induced reduction in GSH was inhibited by 
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bromosulfophthalein (BSP) and dibromosulfophthalein (DBSP), which are inhibitors 
of the GSH transporters.  
 
To assess possible changes in cellular GSH level in our system, we adopted a 
fluorometric measurement method as described in Materials and Methods (section 
2.2.16). Upon DPI treatment, intracellular GSH level was significantly reduced 
(Figure 40). The decrease in GSH level was at least partially rescued by addition of 
DDC (Figure 40). These changes in GSH level correlated with the changes in the 
level of oxidized-Akt and Akt phosphorylation in DPI-treated cells. To investigate 
whether GSH is a necessary mediator in the DPI-mediated change of Akt oxidation, 
we used the same inhibitor BSP, which was shown to prevent DPI-induced GSH 
efflux (Pullar and Hampton, 2002). First of all, the presence of BSP did affect the 
reduction of intracellular O2.- level by DPI (Figure 41A). Secondly, DPI alone caused 
a reduction in GSH level (compare “DMSO” and “DPI” in Figure 41B). On the 
contrary, in the presence of 0.5mM or 1mM BSP, DPI could not induce further loss of 
GSH level (compare “BSP+DMSO” and “BSP+DPI” in Figure 41B). However, BSP 
could not prevent the dephosphorylation of Akt (Figure 41C), nor the increase in Akt 
oxidation (Figure 41D) by DPI. It was noted that BSP itself caused a decrease in GSH 
level (compare “BSP+DMSO” vs “DMSO” in Figure 41B). This effect of BSP was 
suggested to be due to the fact that, in addition to be an inhibitor of the canalicular 
GSH transporters, BSP is a substrate for the glutathione S-transferases (Pullar and 
Hampton, 2002). Therefore, although the presence of BSP prevented a further drop in 
GSH level after DPI treatment, the GSH level was not rescued to a level close to 
untreated (DMSO) cells by BSP. This might be the reason why BSP could not prevent 
the changes in Akt phosphorylation or oxidation. To understand whether GSH is 
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playing a role in connecting O2.- and Akt oxidation or phosphorylation, other 
approaches would be needed  to prevent the drop in GSH level upon DPI treatment.      
 
On the other hand, in cells subjected to siNox4, there was no significant change in 
intracellular GSH level (Figure 42). This indicates that the GSH level is not the cause 
of the changes in oxidized-Akt level and Akt phosphorylation level in the case of 
siNox4.  
 
Taken together, we have investigated the involvement of intracellular GSH level in 
the connections between O2.- and Akt oxidation or phosphorylation level. In siNox4-
mediated O2.- reduction, intracellular GSH is not involved. In the case of DPI, more 
investigations are needed.   
 































Figure 40: DPI reduces the cellular GSH level, while DDC prevents the decrease. 
 
MEFPTEN-/- cells grown in DMEM/10%FBS were treated with 6µM DPI (or DMSO as 
control) in the presence or absence of 1mM DDC for 2 hours before GSH level was 
measured as described in Materials and Methods (section 2.2.16). The value 
represents the mean+S.D. of six samples from three independent experiments done in 
duplicates. * p < 0.05 









































































































Figure 41: BSP does not prevent Akt dephosphorylation or Akt oxidation. 
 
MEFPTEN-/- cells grown in DMEM/10%FBS were treated with 6µM DPI (or DMSO as 
control) in the presence or absence of 0.5mM or 1mM BSP for 2 hours. (A) 
Intracellular O2.- level was assessed by lucigenin luminescence. The value represents 
the mean+S.D. of duplicates. (B) GSH level was measured. The value represents the 
mean+S.D. of duplicates. (C) Akt phosphorylation was assessed by Western blot 
analysis. (D) Cells were harvested for AMS assay.  


























Figure 42: There is no change in GSH level in response to siNox4. 
  
MEFPTEN-/- cells (KO) grown in DMEM/10%FBS were transfected with siRNA for 
Nox4 (siNox4) or control siRNA (sico). Cells were harvested 48 hours post 
transfection for GSH measurement. The value represents the mean+S.D. of nine 
samples from three independent experiments done in triplicates.  
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3.5 Regulation of Akt phosphorylation by NHE1 
 
In the previous sections, we have investigated the cytosolic regulation of Akt 
phosphorylation by O2.-. Next, we are going to focus on one aspect of membrane-
related regulation of Akt phosphorylation.   
 
3.5.1 NHE1 positively regulates Akt phosphorylation 
 
NHE1 is the most widely expressed isoform of the Na+/H+ exchanger (NHE) protein 
family. Besides its role as a sodium-proton exchanger and pH regulator, NHE1 has 
been reported as a regulator of physiological processes such as cell proliferation, cell 
differentiation and cell migration (Slepkov et al., 2007; Putney et al., 2002; Malo and 
Fliegel, 2006). NHE1 is ubiquitously expressed on the plasma membrane of 
mammalian cells, which makes it a functionally important scaffolding platform to 
facilitate assembly of signalling complexes (Baumgartner et al., 2004).  
 
Regulation of Akt phosphorylation by NHE1 was first observed when NHE1 was 
knocked down in MEFPTEN-/- cells. In cells under both 0.5%FBS and 10%FBS 
conditions, siNHE1 resulted in a decrease in Akt phosphorylation level (Figure 43). 
The effect was specific to Akt, as no reduction in ERK1/2 phosphorylation was 
observed. It was noticed that the reduction in Akt phosphorylation after siNHE1 was 
more obvious in a serum-deprived condition. Therefore, the following experiments 
were performed mainly in serum-deprived cells.    
 























Figure 43: Decrease in NHE1 protein by siRNA leads to Akt dephosphorylation. 
  
MEFPTEN-/- cells (KO) were transfected with siRNA for NHE1 (siNHE1) or control 
(sico). Twenty four hours post transfection, cells were serum-deprived in 
DMEM/0.5%FBS (KO 0.5%) for another 24 hrs or grown in DMEM/10%FBS (KO 
10%). Cells were harvested for Western blot analysis 48 hours post transfection. A 




To investigate whether NHE1 ion exchange activity is necessary for the NHE1-
mediated regulation on Akt phosphorylation, two classical NHE activity inhibitors, 
namely ethylisopropylamiloride (EIPA) and cariporide, were used to treat the cells 
(Putney et al., 2002; Masereel et al., 2003). Detection of the general NHE activity was 
achieved by the “NHE activity assay” as described in Materials and Methods. NHE 
activity was indicated by the slope of the curve at the initial cycles of the recovery 
stage (cycle 10 to cycle 11). At lower concentrations (1uM of EIPA or cariporide) 
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where NHE activity was sufficiently inhibited (Figure 44A), Akt phosphorylation was 
not affected (Figure 44B). This result suggests that the ion exchange activity might 
not be involved in this regulation. Surprisingly, incubation with higher concentration 
of the drugs (10uM for EIPA and 30uM for cariporide) resulted in a decrease in the 
protein level of the 110kDa form of NHE1. At the same time, there was a concurrent 
decrease in Akt phosphorylation (Figure 44B). The 110kDa form of NHE1 (upper 
band) represents the mature form of the polypeptide which is the glycosylated form. 
This form of NHE1 is present at the cell surface (Counillon et al., 1994). Although the 
reason why the inhibitors reduce the level of the mature form of NHE1 is not 
understood at the moment, the data suggest that there might be a connection between 
the mature form of NHE1 and Akt phosphorylation. 
 
As Akt phosphorylation is known to be induced by various growth factors including 
serum, we then examined whether NHE1 could affect the way Akt responds to FBS 
stimulation. MEFPTEN-/- cells were serum-starved for 24 hours before 10% FBS was 
added to stimulate Akt activation. Akt phosphorylation in response to FBS after 
different time points was detected in both control siRNA cells and siNHE1 cells. As 
shown in Figure 45, FBS increased the phosphorylation level of Akt (which peaked at 
30min) while down-regulation of NHE1 attenuated the effect of FBS on Akt 
phosphorylation. Taken together, these results indicate that NHE1 positively regulates 
Akt phosphorylation, at both basal level and during FBS-induced activation.  































Figure 44: NHE1 expression but not activity is involved in regulation of Akt 
phosphorylation. 
  
(A) MEFPTEN-/- cells were treated with different doses of EIPA or cariporide in 
DMEM/0.5%FBS for 24 hrs before NHE activity was measured as describe in 
Materials and Methods. (B) MEFPTEN-/- cells were treated with different doses of EIPA 
or cariporide (Cari) in DMEM/0.5%FBS for 24 hrs before harvested for Western blot 
analysis. A representative blot from two independent experiments is shown. 
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Figure 45: siNHE1 attenuates the effect of FBS stimulation on Akt 
phosphorylation. 
  
MEFPTEN-/- cells were transfected with siRNA for NHE1 (siNHE1) or control (sico). 
Twenty four hours post transfection, cells were serum-deprived in DMEM/0.5%FBS 
(0.5%) for another 24 hrs before 10%FBS was added in. Cells were harvested for 
Western blot analysis at indicated time after FBS stimulation. A representative blot 
from three independent experiments is shown. 
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3.5.2 Akt-NHE1 interaction is detected 
 
The involvement of NHE1 in regulating Akt was previously reported by Wu et al. 
(Wu et al., 2004). It was reported that NHE1 activation by NH4Cl or sucrose led to an 
increase in Akt phosphorylation, which was dependent on the interaction between 
NHE1 and the ERM (ezrin/radixin/moesin) proteins. However, the exact mechanism 
is not understood. In this project, we would like to investigate whether Akt could 
directly interact with NHE1. As membrane translocation of Akt readily occurs during 
Akt activation, it is possible for Akt protein to form a complex with NHE1 at the 
plasma membrane. Detection of complex formation was achieved by co-
immunoprecipitation. Immunoprecipitation was first performed with a primary 
antibody against Akt. A co-precipitated NHE1 protein band was detected on the 
Western blot (Figure 46A), while no band was observed in the negative control lanes 
where no primary antibody or the IgG control antibody was used. Furthermore, a 
similar experiment was performed after cells were transfected with siNHE1 to ensure 
the band detected was indeed NHE1. The band corresponding to NHE1 was detected 
in un-transfected (UT) and control siRNA (sico) samples (Figure 46B), but not in the 
IgG control sample. Moreover, the band intensity decreased a lot in the siNHE1 
sample corresponding to the efficient knockdown of total NHE1 protein as shown in 
total cell lysate (Input). The reciprocal immunoprecipitation was also performed using 
the primary antibody against NHE1. Akt was detected on the Western blot, while there 
was no clear band detected in the IgG control sample (Figure 46C). Therefore, these 
results support the idea that Akt and NHE1 form a complex in MEFPTEN-/- cells.         
 



































Figure 46: NHE1-Akt interaction in MEFPTEN-/- cells.  
 
(A) MEFPTEN-/- cells were harvested and immunoprecipitation was performed with 
antibody for Akt or control IgG. NHE1 and Akt were detected on Western blot. (B) 
MEFPTEN-/- cells were transfected with siRNA for NHE1 (siNHE1) or control (sico). 
Un-transfected cells (UT) were also included as control. Cells were harvested 48 
hours post transfection and immunoprecipitation was performed with antibody for Akt 
or control IgG. NHE1 and Akt were detected on Western blot. (C) MEFPTEN-/- cells 
were harvested and immunoprecipitation was performed with antibody for NHE1 or 
control IgG. NHE1 and Akt were detected on Western blot. A representative blot from 
at least two independent experiments is shown. 
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3.5.3 Akt dephosphorylation induced by LY294002 is delayed by the 
overexpression of NHE1 
 
Having identified the Akt-NHE1 complex formation, we then asked whether the 
interaction between the two proteins is important in the NHE1-dependent regulation 
of Akt phosphorylation. As membrane localization is very important in the process of 
Akt activation, we hypothesize that NHE1 might help to enhance Akt anchorage at the 
membrane. PIP3 is known as the classical binding site for Akt at the membrane and 
inhibition of PIP3 production by PI3K inhibitors leads to rapid dephosphorylation of 
Akt. Therefore, we investigated whether NHE1 could delay the process of Akt 
dephosphorylation by a PI3K inhibitor LY294002. Figure 47 shows that, in cells 
transfected with the control vector, Akt phosphorylation rapidly decreased within 
15mins exposure to LY294002 and there was no observable phospho-Akt by 30mins. 
On the contrary, cells overexpressing wild-type HA-NHE1 were more resistant to 
LY294002-mediated dephosphorylation, where more Akt phosphorylation was 
maintained at 15mins and 30mins after exposure to LY294002. In control cells, 
reduced PIP3 level would disrupt the membrane binding of Akt. In NHE1 transfected 
cells, this process was delayed. This indicates that, with the help of NHE1, Akt could 
still be maintained at the membrane for some time after the PIP3 level is reduced. 
Therefore, NHE1 possibly functions as an additional anchoring point to facilitate 
membrane localization of Akt and, thus, positively involved in regulating Akt 
phosphorylation. This is consistent with the observation in Figure 43B where the 
mature form of NHE1, which is located at cell surface, is functionally important in 
regulating Akt phosphorylation.     
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Figure 47: Akt dephosphorylation by LY294002 is delayed in MEFPTEN-/- cells 
overexpressing NHE1.  
 
MEFPTEN-/- cells grown in DMEM/10%FBS were transfected with HA-NHE1 or 
vector control. Forty eight hours post transfection, cells were treated with 25uM 
LY294002 (LY) for indicated time points and then harvested for Western blot analysis. 
A representative blot from two independent experiments is shown. 
 
Chapter 3: Results 161
3.5.4 Redox regulation of the Akt-NHE1 signalling 
 
As down regulation of NHE1 and the intracellular O2.- level led to the same effect of 
Akt dephosphorylation, we would like to find out whether these two pathways act 
independently on Akt, or whether there is merging point of the two pathways. Firstly, 
intracellular O2.- level was measured after NHE1 knockdown. There was no obvious 
change in the level of intracellular O2.- in the siNHE1 cells as compared to control 
cells (Figure 48).  
 
Next, NHE1 protein expression and activity were measured after the reduction in 
intracellular O2.- level by DPI. DPI treatment for 2 hours did not alter the protein level 
of NHE1 (Figure 49A). Detection of the general NHE activity was achieved by the 
“NHE activity assay” as described in Materials and Methods. A representative profile 
of the results is shown in Figure 49B. NHE activity was indicated by the slope of the 
curve at the initial cycles of the recovery stage (cycle 10 to cycle 11). Figure 49C 
shows the statistical analysis of the NHE activity, which was reduced by DPI 
treatment. When the intracellular level of O2.- was reconstituted by DDC, NHE 
activity was recovered. Moreover, DDC alone led to a significant increase in NHE 
activity. These results suggest that NHE activity is sensitive to the changes in 
intracellular O2.- level.    
 
































Figure 48:  siNHE1 does not affect intracellular level of O2.-. 
 
MEFPTEN-/- cells were transfected with siRNA of NHE1 (siNHE1) or si-control (sico). 
Twenty four hours post transfection, cells were serum-starved in DMEM/0.5%FBS 
for another 24 hrs. Cells were then harvested for the measurement of intracellular O2.- 
level by lucigenin luminescence. The value represents the mean+S.D. of duplicates 
from a representative experiment. The same experiment was repeated twice. 




































Figure 49: DPI does not affect NHE1 protein expression but reduces NHE 
activity. 
 
(A) MEFPTEN-/- cells were treated with 6µM DPI (or DMSO as control) for 2 hours 
before cells were harvested for Western blot analysis. (B) MEFPTEN-/- cells were 
treated with 6µM DPI in the presence or absence of 1mM DDC for 2 hours. NHE 
activity was then assessed. A representative graph of three independent experiments is 
shown. (C) The statistical summary of NHE activity, which is expressed as a fold 
difference relative to DMSO control cells. The value represents the mean+S.D. of 
three independent experiments. * p < 0.05  
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We next investigated whether O2.- could affect Akt phosphorylation through its effect 
on NHE1. Having shown that the interaction between NHE1 and Akt is important to 
maintain Akt phosphorylation, we examined whether the change in O2.-  level could 
affect this interaction. Co-immunoprecipitation with the primary antibody against Akt 
was performed after cells were treated with DPI for 2 hours. As shown in Figure 50, 
there was a reduction in the band intensity for NHE1 after DPI treatment, while a 
similar level of Akt was pulled down. This result indicates that the reduction in the 
level of intracellular O2.- by DPI is accompanied with the decrease in the interaction 
between Akt and NHE1. Therefore, DPI could affect Akt phosphorylation at the 
membrane by interfering with the interaction between NHE1 and Akt. In fact, this is 
in accordance with the observation that there is still a significant reduction in Thr308 
phosphorylation on the membrane Akt (Figure 20A and 20B), although the membrane 
fraction of Akt is more resistant to dephosphorylation as compared to cytosolic Akt. 
 
We have described the cytosolic regulation of Akt phosphorylation by O2.- in the 
previous section, and here we have identified NHE1 as a regulator for Akt 
phosphorylation at the membrane. In addition, the NHE1 mediated regulation at the 
membrane is sensitive to intracellular O2.- level. Next, we are interested to find out the 
consequence of putting the two together. The MEFPTEN-/- cells were subjected to 
siNHE1 for about 46 hours before treated with DPI for 2 hours. The Western blot 
analysis revealed that siNHE1 or DPI alone caused a reduction in Akt phosphorylation. 
When cells were under the treatment of siNHE1 plus DPI, a further decrease in Akt 
phosphorylation was detected (Figure 51). The dephosphorylation was also observed 
on the two substrates GSK3á/â and p70S6K. The additive effect can be explained by 
the model that NHE1 and O2.-  are responsible for distinct pools of Akt. NHE1-
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dependent regulation of Akt phosphorylation targets the membrane pool of Akt. On 
the other hand, O2.- primarily regulates the cytosolic Akt, while it could still exert its 
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Figure 50: Effect of DPI on Akt-NHE1 interaction. 
 
MEFPTEN-/- cells were treated with 6uM DPI (or DMSO as control) for 2 hrs. 
Coimmunoprecipitation was performed with the anti-Akt antibody or with the IgG 
control antibody. A representative blot from three independent experiments is shown. 
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Figure 51: siNHE1 and DPI treatment result in an additive reduction in Akt 
phosphorylation.  
 
MEFPTEN-/- cells were transfected with siRNA of NHE1 (siNHE1) or si-control (sico). 
Twenty four hours post transfection, cells were serum-deprived in DMEM/0.5%FBS 
for another 24hrs before treated with 6µm DPI (or DMSO as control) for 2 hours. 
Cells were harvested for Western blot analysis. A representative blot from three 
independent experiments is shown. 
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CHAPTER 4 DISCUSSION 
 
Over the years, studies have demonstrated the emerging roles of O2.- as an essential 
signalling molecule (Buetler et al., 2004). Findings from our group have provided 
evidence that a mild increase in intracellular O2.- level endows tumour cells with a 
survival advantage against a variety of apoptotic triggers (Pervaiz and Clément, 2002; 
Pervaiz and Clement, 2007; Pervaiz et al., 1999; Clément and Stamenkovic, 1996; 
Pervaiz et al., 2001). In line with the pro-survival role of O2.-, our group recently 
demonstrated the role of O2.- in regulating the survival kinase Akt (Lim and Clément, 
2007). In this model, the inhibition of the tumour suppressor PTEN through S-
nitrosylation was shown to be responsible for the induction of Akt phosphorylation by 
O2.-.  
 
In the current project, we investigated the pathway involved in the regulation of Akt 
phosphorylation by O2.- in MEF cells that do not express PTEN (MEFPTEN-/- cells). 
Many reports have shown that the redox regulation of the PI3K/Akt pathway mainly 
involves the tyrosine phosphatase upstream of PI3-kinase and the lipid phosphatase 
PTEN (Leslie, 2006). However, in this study, we demonstrate that there is no 
alteration in the level of PIP3. This observation eliminates the involvement of the 
components upstream of PIP3. Furthermore, cytosolic Akt is identified as the major 
pool of the kinase that is affected. We provide evidence that the cytosolic regulation 
of Akt is dependent on a PP2A-mediated dephosphorylation of the kinase. Moreover, 
our data support the model that Akt oxidation status is correlated with the 
susceptibility of Akt to PP2A-dependent dephosphorylation. With these, we have 
demonstrated that O2.- is an additional factor contributing to the hyperphosphorylated 
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Akt in MEFPTEN-/- cells. Last but not least, NHE1 is identified as another regulator of 
Akt via its function as an Akt-binding scaffold protein at the membrane.  
 
4.1 The hyperphosphorylation of Akt in MEFPTEN-/- cells is 
downregulated upon a decrease in the intracellular level of O2.-  
 
PTEN was first identified as a tumour suppressor gene in human cancer (Li et al., 
1997). Dysfunctional PTEN in various forms such as deletion, mutation or 
downregulation is characterized in many tumour cells (Simpson and Parsons, 2001). 
Loss of PTEN function results in hyperphosphorylation of Akt (Stambolic et al., 
1998), which plays a role in the PTEN-mediated tumourigenesis (Tokunaga et al., 
2008; Carnero et al., 2008). In this report, we show that the hyperphosphorylated Akt 
in MEFPTEN-/- cells can be downregulated by a decrease in the intracellular level of 
O2.- . Understanding the mechanisms behind this will provide new strategies to 
modulate the activity of the Akt kinase in PTEN defective tumour cells.   
 
4.1.1 Reduction of intracellular O2.- level is achieved by DPI or siNox4 
 
In order to decrease the intracellular level of O2.- , inhibition of the NADPH oxidases 
(Nox) was achieved by two approaches. The drug DPI was used as the pharmaceutical 
inhibitor and siRNA for Nox4 was used as the molecular approach.  
 
DPI 
Diphenyleneiodonium (DPI) is the most commonly used Nox inhibitor. Electron 
transport from the flavin group or the heme group causes a reduction of DPI to a 
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radical form, which results in inhibition of the Nox enzymes via a direct phenylation 
of the protein (O'Donnell et al., 1993; Doussiere et al., 1999). The inhibitory effect of 
DPI is also reported on other flavoproteins like nitric oxide synthase (Stuehr et al., 
1991), xanthine oxidase (Sanders et al., 1997), P-450 NADPH reductase (Tew, 1993), 
and mitochondrial respiratory chain complex I (Luetjens et al., 2000). The effect of 
DPI on ROS production is complicated, depending on the concentration of the drug, 
the cell type used, as well as the incubation time. Induction of O2.-  production was 
detected in the human promyelocytic leukemia cell line HL-60 after exposure to 1-
200µM DPI for 10 min (Balcerczyk et al., 2005). In the human retinal pigment 
epithelial cell line ARPE-19, exposure to 10µM DPI resulted in the generation of 
DCFDA fluorescence at 24 hours, but not at early time points from 0.5 hours to 4 
hours (Park et al., 2007). On the contrary, incubation with 10µM DPI for 2 hours 
reduced the DCFDA fluorescence in the human pancreatic adenocarcinoma cell line 
PANC-1 (Mochizuki et al., 2006). Moreover, DPI was shown to inhibit mitochondria 
O2.-  production by 60% at 0.1µM in monocytes/macrophages (Li and Trush, 1998). In 
the present study, we showed that DPI effectively reduced intracellular O2.-  level at 
the dose used (6µM). The biological effect of lowering intracellular O2.- level was 
mostly examined at 2 hours, which was long enough to stably lower the O2.- level but 
not too long to stress the cells. However, the non-specific effect of the drug is always 
a concern for any pharmaceutical approaches. Thereafter, a molecular approach, 
which is to directly knock down the O2.- producing NADPH oxidase, was adopted as a 
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Nox4 
In this project, detection of Nox4 was achieved by PCR at the mRNA level. To detect 
Nox4 protein, we tried two different antibodies for Nox4, both of which detected 
multiple non-specific bands. As a matter of fact, detection of Nox4 by antibodies, 
especially by commercially available antibodies, is not well established. Detection of 
multiple bands was always observed, and the identity of these bands remained 
unknown (Gupte et al., 2005; Hilenski et al., 2004; Lener et al., 2009; Sturrock et al., 
2007; Shiose et al., 2001). Due to the non-specificity of the Nox4 antibody purchased, 
detection of Nox4 protein was not achieved by Western blot in this project. Therefore, 
measurement of Nox4 in this project was only based on the analysis of mRNA level 
by PCR.  
 
The efficiency of siNox4 to lower intracellular O2.- level was confirmed after 
transfection was performed for 24 hours and 48 hours. However, there was only about 
20% reduction in O2.- level 48 hours post transfection, while the knockdown of Nox4 
mRNA level was more than 50% at the same time point. There are several possible 
explanations for the different extent of reduction in mRNA level and intracellular O2.- 
level. Firstly, knockdown of Nox4 was only assessed at the mRNA level. The 
reduction in Nox4 protein might not reach the similar level as the mRNA, which 
could explain the less intensive reduction in the intracellular level of O2.- . Secondly, 
in response to the chronic decrease in O2.-  production after siNox4 transfection, the 
cells might react to restore O2.- level to the physiological range. The observation that 
reduction in the level of intracellular O2.- after 48 hours transfection was less than that 
after 24 hours could actually support this idea. Thirdly, it is proposed that O2.- released 
from Nox4 is almost undetectable as it is quickly converted to H2O2 (Serrander et al., 
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2007). In accordance with this, a previous report showed that, in rat VSMCs, 
reduction in basal O2.- level could not be achieved by siNox4 (Dikalov et al., 2008). In 
contrast, siNox4 significantly reduced intracellular O2.- level (by  25%) in human 
microvascular endothelial cells (HMECs) (Peshavariya et al., 2009). Moreover, a 
decrease in basal O2.-  level was correlated with the reduced Nox4 mRNA level in 
human PASMC (Mittal et al., 2007). Therefore, the efficiency of siNox4 to reduce 
intracellular O2.-  level might be dependent on the cell system used. In different cells, 
Nox4 may have different redundancy in O2.- production. Some cells depend more on 
Nox4 while others may rely on other Nox isoforms. In MEFPTEN-/- cells, the 
intracellular level of O2.- is at least significantly if not maximally reduced by siNox4.  
 
Although both DPI and siNox4 serve as effective tools to decrease the intracellular 
level of O2.-  in MEFPTEN-/- cells, some distinct features of the two approaches are to be 
noted.  The DPI experiments were mostly done after 2 hours treatment of DPI. This 
allows us to investigate the biological changes at the initial stage after lowering O2.-  
level. On the other hand, siNox4 experiments were done 48 hours post transfection. 
Although we are not certain of the exact time when intracellular O2.-  level starts to 
decrease, the level of O2.-  24 hours post transfection is already lowered. Therefore, the 
biological changes detected 48 hours post transfection reflect the chronic effect of 
lowering O2.-  level. To this effect, DPI and siNox4 experiments provide 
complementary information to each other.  
 
 
Chapter 4: Discussion 172
4.1.2 Akt is dephosphorylated upon the decrease in O2.- level by DPI and siNox4 
 
Downregulation of Akt phosphorylation on Thr308 and Ser473 is induced upon the 
decrease in O2.- level by both DPI and siNox4 . However, distinct features are noticed 
on the two phosphorylation sites.  
 
DPI was previously shown to prevent Akt phosphorylation induced by various 
stimulations including PDGF, Angiotensin II, insulin, lysophosphatidic acid (LPA) 
and hypoxia-reoxygenation (H/R) (Ishizawa et al., 2009; Wagner et al., 2007; Feliers 
et al., 2006; Ushio-Fukai et al., 1999; Schreiner et al., 2010; Seo et al., 2005; 
Mahadev et al., 2001; Saunders et al., 2010; Chen et al., 2007). A summary of these 
studies is shown in Table 4. However, the basal level of Akt phosphorylation was not 
affected by DPI in some experiments. This might be due to the short incubation time 
(35-45min), as well as the phosphorylation site (Ser473) detected in these experiments. 
In the present study, time kinetic analysis after DPI treatment allowed us to examine 
the changes of Akt phosphorylation level in more details. It showed that the 
dephosphorylation was minor at 1 hour time point and started to stabilize after 2 hours. 
It also suggested that the dephosphorylation occurred faster and more potently on 
Thr308 than on Ser473 in the first few hours. Therefore, in order to detect the effect 
of DPI on basal Akt phosphorylation level, 35-45 min might not be long enough and 
Ser473 might not be the sensitive site for early time points. As a matter of fact, at 
longer time points (at least 24 hours), the basal level of Akt phosphorylation was 
reduced by DPI on Thr308 as well as on Ser473 (Mochizuki et al., 2006; Block et al., 
2010). 
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Cell lines used Reduction of Akt Phosphorylation level by DPI Reference 
VSMCs from rat 
thoracic aortas 
Angiotensin II-induced phosphorylation 
(Ser473) is reduced; 
Basal phosphorylation level (Ser473) is not 
reduced by DPI treatment (10uM, 35min)  
Ushio-Fukai 
et al., 1999 
3T3-L1 
preadipocytes 
Insulin-induce phosphorylation (Ser473) is 
reduced;  
Basal phosphorylation level is not detected in 
control and DPI-treated  samples  
Mahadev  




Insulin-induce phosphorylation (Ser473) is 
reduced; 
DPI treatment alone not shown 




cells (MCT cells) 
Angiotensin II-induced phosphorylation 
(Ser473) is reduced; 
Basal phosphorylation level (Ser473) is not 
reduced by DPI treatment (10uM, 45min)  





PDGF-induced phosphorylation (Ser473) is 
reduced; 
DPI treatment alone not shown 
Wagner et al., 
2007 
Endothelial cells Hypoxia-reoxygenation (H/R)-induced 
phosphorylation (Ser473) is reduced; 
Basal phosphorylation level (Ser473) is not 
reduced by DPI treatment (10uM, 3hr)  





PDGF-induced phosphorylation (Ser473) is 
reduced; 
Basal phosphorylation level (Ser473) is not 
reduced by DPI treatment (10uM, 40min)  
Ishizawa  




LPA-induced phosphorylation (Thr308) is 
reduced; 
DPI treatment alone not shown 
Saunders  
et al., 2010 
VSMCs from rat 
thoracic aortas 
Angiotensin II –induced phosphorylation 
(Ser473) is reduced;  
DPI treatment alone not shown 
Schreiner  
et al., 2010 
Pancreatic cancer 
PANC-1 cells 
Basal phosphorylation level (Thr308) is 
reduced (10uM, 24 hr) 
Mochizuki  
et al., 2006 
Human VHL-
deficient renal 
carcinoma cell line 
RCC 
786-O 
Basal phosphorylation level (Ser473) is 
reduced (5uM, incubation time not specified)  
Block et al., 
2010 
Table 4: A summary of studies showing the effect of DPI on Akt phosphorylation 
Abbreviations: PDGF, Platelet-derived growth factor; LPA, Lysophosphatidic acid; 
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DPI data at longer time points are actually consistent with the siNox4 data obtained 
from our project, which reflects the long term effect. In the current system, Ser473 
was equally dephosphorylated as Thr308 after siNox4. This was different from what 
was observed for DPI treatment. The reason could be that Ser473 is allowed to be 
fully dephosphorylated over the prolonged period of time with lower intracellular O2.- 
level  after siNox4. SiNox4-induced reduction in Akt phosphorylation has also been 
reported in a few studies. The dephosphorylation on Thr308 was shown in pancreatic 
cancer PANC-1 cells (Mochizuki et al., 2006) and that on Ser473 was reported in 
metanephric mesenchymal cells (Wagner et al., 2007). For another two studies, the 
dephosphorylation was shown without specifying the exact phosphorylation site 
(Peshavariya et al., 2009; Block et al., 2007). A summary of these Nox4 studies is 
shown in Table 5.  
 
Cell lines used Reduction of Akt Phosphorylation 




Basal phosphorylation level (Thr308) 
is reduced (48hr post transfection)  




PDGF-induced and basal 
phosphorylation level (Ser473) is 
reduced (48hr post transfection) 
Wagner et al., 
2007 
VHL-deficient cells 
RCC 786-O cells 
Basal phosphorylation level is 
reduced (48hr post transfection); 
Phosphorylation site not specified 





Basal phosphorylation level is 
reduced (72hr post transfection); 
Phosphorylation site not specified 
Peshavariya et al., 
2009 
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4.1.3 Akt is dephosphorylated on both Thr308 and Ser473: interdependency of 
the two phosphorylation sites? 
 
Although Thr308 and Ser473 reach a similar level of dephosphorylation after a 
prolonged period of time with lower O2.- level, as shown in siNox4 experiments, it is 
interesting that Thr308 and Ser473 respond differently in the initial stage as indicated 
by the time kinetic analysis after DPI treatment. There are two possibilities to explain 
the early dephosphorylation on Thr308. Firstly, dephosphorylation on Ser473 is a 
secondary effect following the dephosphorylation on Thr308. Secondly, the regulation 
of phosphorylation on these two sites are independent events, and the regulators for 
the Thr308 site are more sensitively affected than those for Ser473.  
 
The relationship between these two critical phosphorylation sites in Akt activation is 
still under debate. The mutant constructs T308A and S473A are used in many studies 
to investigate the interdependency between the two sites. In these constructs, the 
Thr308 or Ser473 residue is mutated to alanine. Scheid et al. previously showed that 
phosphorylation of Thr308 and Ser473 were dependent on each other. In 293 cells 
transfected with these two mutants, absence of Thr308 phosphorylation on the S473A 
mutant and absence of Ser473 phosphorylation on the T308A mutant were observed 
(Scheid et al., 2002). However, when the S473A and the T308A constructs were 
transfected into keratinocytes, Ser473 phosphorylation was detected on the T308A 
mutant, while the T308A mutant failed to display phosphorylation on Ser473 (Goren 
et al., 2008). This observation suggests that phosphorylation on Ser473 is required for 
Thr308 phosphorylation but not vice versa. In agreement with the observed 
dependency of Thr308 on Ser473, in the study that identified the rictor-mTOR 
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complex as the kinase for Ser473, the author also demonstrated with an in vitro assay 
that the prior phosphorylation on Ser473 by rictor-mTOR could enhance the 
phosphorylation on Thr308 by PDK1 (Sarbassov et al., 2005). In contrast to the 
interdependency proposed from the above studies, Alessi et al. demonstrated that 
phosphorylation of Thr308 was not dependent on phosphorylation of Ser473 or vice 
versa in IGF-1 stimulated 293 cells, using the mutant constructs as well (Alessi et al., 
1996). Therefore, regulation mechanisms of phosphorylation on these two sites can be 
different in different cell systems. Even in the same 293 cells, different observations 
were made for un-stimulated cells (Scheid et al., 2002) or IGF-1 stimulated cells 
(Alessi et al., 1996). It is possible that IGF-1 stimulation activates other regulators for 
Akt phosphorylation and, thus bypasses the interdependency that is required in un-
stimulated cells. As many regulators are discovered for Thr308 and Ser473 
phosphorylation, the phosphorylation level on each site is a reflection of the 
integrative effect from all regulating factors. The interdependency of the two sites is 
complicated, as it could be overwhelmed by the input from other regulators.    
 
Under physiological conditions, regulation of phosphorylation on Thr308 and Ser473 
are reported as independent events in many cases. In one situation, alteration in 
phosphorylation is observed for Ser473 but not for Thr308. In another model, 
alteration on Thr308 was more obvious than that on Ser473. In the third situation, 
opposite effects are reported for Thr308 and Ser473.  A summary of selected studies 
and the respective references is shown in Table 6. For easy reference, a brief summary 
of the studies using the mutant constructs is also included in Table 6. 
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Dependent on each other (Scheid et al., 2002) 
 
Thr308 is dependent on Ser473 
NOT vice versa (Goren et al., 2008) 
 





Not dependent on each other (Alessi et al., 1996) 
 
Decrease phosphorylation on Ser473: 
- Age-related impairment of Akt activity 
(Shay and Hagen, 2009) 
- TPA treatment (Zhang and Xia, 2009) 
- siRNA for ILK (Fukuda et al., 2003)   
Regulation on 
Ser473 but NOT on 
Thr308 
 
Increase phosphorylation on Ser473: 
- In the outer layer of cortex after 
hypoglycemic coma (Ouyang et al., 
2000) 
- in neurons exposed to glutamate 
(Kitagawa et al., 2002) 
- Incubation with TNFα (O'toole et al., 
2001) 
- Incubation with Lithium (Kumari et al., 
2001) 
- Incubation with IL-6 (Weigert et al., 
2005) 
Regulation on 
Thr308 is more 
intense than on 
Ser473  
 
- Suppression by selenium is more potent 
on Thr308 (Wu et al., 2006) 
- Onset of induction is more rapid on 
Thr308 after stimulation by formyl-Met-




Opposite effects on 
Thr308 and Ser473 
- Increase on Ser473 in cerebrum and 
cerebellum, but decrease on Thr308 in 
cerebellum by high phosphate diet (Jin et 
al., 2006) 
- Increase on Ser473 but decrease on 
Thr308 after chronic ethanol intake (He 
et al., 2006)   
Table 6: Selected studies addressing the interdependency of Thr308 and Ser473 
phosphorylation 
Abbreviations: TPA, 12-O-tetradecanoylphorbol-1, 3-acetate; ILK, integrin-linked 
kinase; TNFα, tumour necrosis factor alpha; IL-6, Interleukin-6 
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All these observations indicate that phosphorylation on Thr308 and Ser473 are not 
always connected but are differentially regulated. As Thr308 and Ser473 are directly 
regulated by distinct kinases and phosphatases, these regulators may respond similarly 
or differently upon stimulations.  Hence, the details of how these two sites are 
regulated must be investigated in a case by case manner. 
 
In our project, clues on the interdependency of Thr308 and Ser473 are generated from 
the experiments in which the involvement of PP2A is demonstrated. However, 
different results were obtained from the DPI experiments and the siNox4 experiments. 
 
In the DPI study, incubation of the cells with the inhibitor OA alone resulted in an 
obvious increase in Thr308 phosphorylation, corresponding to its inhibitory effect 
against the Thr308 phosphatase PP2A. On the other hand, the phosphorylation level 
of Ser473 was not increased by OA due to the fact that OA does not affect the activity 
of the Ser473-specific phosphatase PHLPP (Gao et al., 2005). Interestingly, the 
dephosphorylation of Ser473 by DPI was prevented by OA as well. As Ser473 or 
PHLPP is insensitive to OA, the prevention of Ser473 dephosphorylation by OA 
might be related to the primary changes on Thr308, the dephosphorylation of which 
was prevented by OA. In this regard, the change on phospho-Ser473 upon DPI 
treatment could be a secondary effect of that on phospho-Thr308. Similarly, when 
siB55α was used instead of OA, the basal phosphorylation level on Ser473 was not 
regulated by siB55α, while DPI-mediated dephosphorylation was rescued by siB55α.  
 
However, in the case of siNox4, both the basal phosphorylation level and siNox4-
mediated dephosphorylation on Ser473 were not affected by siB55α. Therefore, 
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Ser473 might be independently and differentially regulated as Thr308 by siNox4. In 
the present study, understanding of the mechanisms is mainly initiated from the aspect 
of Thr308 regulation. More investigations are needed to identify the regulators 
responsible for the siNox4-mediated dephosphorylation on Ser473. For Ser473, 
although the rictor-mTOR complex has been identified as the functional kinase, the 
exact details in how the phosphorylation is facilitated are not as well studied as the 
PDK1-Thr308 pair. As phosphorylation on Ser473 is also dependent on membrane 
localization (Scheid et al., 2002), we speculated that the corresponding kinase rictor-
mTOR should be associated with the membrane as well. Indeed, membrane 
fractionation experiments showed that both rictor and mTOR were detected in the 
membrane fraction (Appendix A). When the same amount of proteins from membrane 
and cytosol were analyzed on the same gel, rictor and mTOR showed significant 
bands in the membrane fraction, while only a minor band was observed for the 
cytosolic fraction. In contrast, raptor, which forms another functionally distinct 
complex with mTOR, was detected in the cytosolic fraction. The difference in 
localization makes it reasonable to hypothesize that the localization of the rictor-
mTOR complex at the membrane can facilitate the phosphorylation on Ser473. 
Further experiments are needed to investigate this hypothesis. Preliminarily, siNox4 
did not change the membrane localization of rictor or mTOR (Appendix A). As a 
matter of fact, for Ser473, cytosolic Akt is more sensitive to siNox4-mediated 
dephosphorylation as well. Therefore, involvement of the phosphatase PHLPP would 
be further investigated. 
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4.2 Cytosolic regulation of Akt: an important aspect in maintaining 
Akt phosphorylation  
 
The downregulation of Akt phosphorylation by DPI was previously used to 
demonstrate the involvement of ROS or Nox in the activation of Akt in response to 
various stimulations such as TGFβ, PDGF, and Angiotensin II (Murillo et al., 2007; 
Chen et al., 2007; Ushio-Fukai et al., 1999; Feliers et al., 2006; Saunders et al., 2010; 
Ishizawa et al., 2009). Similarly, suppression of PDGF-induced Akt phosphorylation 
by siNox4 was used as an indication for the involvement of Nox4-generated ROS 
(Wagner et al., 2007). In other cases, dephosphorylation of Akt by siNox4 was 
implicated in studies showing the involvement of Akt in Nox dependent regulation in 
HIF-2 protein accumulation (Block et al., 2007), in proliferation of human endothelial 
cells (Peshavariya et al., 2009) or in cell survival signalling of PANC-1 cells 
(Mochizuki et al., 2006). However, none of these shows the mechanisms of how Akt 
phosphorylation is downregulated by the changes in ROS level. In this report, we 
show for the first time the mechanisms for Akt dephosphorylation upon DPI treatment 
or knockdown of Nox4. One of the key findings is that cytosolic Akt is the main 
target for dephosphorylation.  
 
4.2.1 PIP3, the key messenger at the membrane, is not affected by the decrease in 
the level of intracellular O2.- in MEFPTEN-/- cells 
 
The PIP3-mediated membrane translocation is crucial for Akt phosphorylation and 
activation. The PIP3 level is under direct regulation of PI3K and the lipid 
phosphatases. Alteration in Akt phosphorylation could therefore be due to changes in 
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the activity of PI3K and the lipid phosphatases. This mechanism is described in 
various cases such as in H2O2-induced Akt activation or in cells stimulated with 
insulin, PDGF and EGF. In H2O2-stimulated DT40 cells, the increase in PIP3 level 
was attributed to PI3K membrane recruitment to its substrate site instead of an 
increase in intrinsic PI3K activity (Qin and Chock, 2003). In addition, SHIP2, which 
catalyzes the dephosphorylation of PIP3 at the D5 position, was shown to play an 
important role in H2O2-induced PIP3 accumulation (Zhang et al., 2007). ROS or H2O2 
production upon EGF, PDGF, or insulin stimulation was shown to increase cellular 
levels of PIP3 via an oxidative inhibition of PTEN (Seo et al., 2005; Kwon et al., 
2004).  
 
In our project, the results from PIP3 measurement did not show any alterations upon 
the decrease in O2.- level by DPI or siNox4. Therefore, the involvement of the PI3-
kinase related elements acting upstream of PIP3 was eliminated.  
 
4.2.2 Membrane recruitment of Akt or PDK1 is not affected  
 
Alterations in the membrane localization of Akt or PDK1 are observed in studies 
when PI3K activity is disrupted. Inhibition of PI3K activity results in loss of PIP3, 
which will decrease membrane recruitment of Akt or PDK1, as PIP3 is the primary 
interacting partner for Akt and PDK1 to translocate to the membrane. Wu et al. 
showed that methylseleninic acid (MSA) decreased Akt phosphorylation in PC-3 cells 
via an inhibition in PI3K activity, which was accompanied by a decrease in the 
amount of Akt and PDK1 in the membrane fraction (Wu et al., 2006). In U87-MG 
cells, both overexpression of PTEN and incubation with LY294002 significantly 
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reduced the amount of Akt and PDK1 associated with the membrane. This was due to 
the loss of PIP3 induced by PTEN and LY294002 (Taylor et al., 2000). In the present 
study, we showed that membrane recruitment of Akt or PDK1 was not changed upon 
the  reduction in intracellular O2.- level by DPI or siNox4. This provides the evidence 
that the Akt dephosphorylation observed is not due to the disruptions in membrane 
recruitment of Akt or PDK1. In contrast, we showed that when the reduction in Akt 
phosphorylation was mediated by serum deprivation, a decrease in membrane 
translocation of both Akt and PDK1 were observed. Therefore, Akt 
dephosphorylation upon the reduction in the intracellular level of O2.- and upon serum 
deprivation are regulated by different mechanisms.      
 
It was noticed in un-treated cells that there was more Akt in the cytosolic fraction as 
compared to the membrane fraction when the same amount of protein from each 
fraction was loaded. This observation is consistent with the results obtained in 
previous reports (Filippa et al., 2000; Taylor et al., 2000). This might be due to the 
fact that Akt translocation to the membrane is a transient and dynamic process. 
Membrane recruitment is meant for Akt activation and the activated protein 
subsequently translocates back to the cytosol again, where the protein further 
translocates to other compartments like nucleus and mitochondria (Andjelković et al., 
1997). Therefore, it is a dynamic process for Akt to travel across the different 
compartments. At steady state, more of the Akt protein resides in the cytosol than at 
the membrane. The cytosolic pathway thus represents an important aspect in the 
regulation of Akt.  
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4.2.3 Cytosolic Akt is more sensitive to dephosphorylation than membrane Akt: 
localization matters 
 
Our data on membrane fractionation not only provide information on the localization 
of total Akt protein but also on the phosphorylation status of Akt in membrane versus 
cytosolic fractions. The results suggest that the dephosphorylation of Akt upon the 
decrease in intracellular O2.- level mainly occurs in the cytosol.    
 
In this project, we show for the first time that O2.- is involved in the cytosolic 
regulation of Akt phosphorylation. As the same protein molecule residing in distinct 
intracellular compartments is exposed to different subcellular environments, 
localization is a critical factor in determining the fate of the protein. Localization is 
especially important in the redox mediated regulations for several reasons. First, the 
effect of ROS is functionally localized. As the primary reactive oxygen species, O2.- is 
readily converted to other species like H2O2. In addition, O2.- is short lived and is poor 
in diffusibility. Therefore, the redox regulation mediated by O2.- is usually localized to 
the site of production. For species like H2O2, although it is membrane permeable, 
existence of specific scavengers in the local environment confines its effect to the 
nearby compartment as well. For the highly reactive species like hydroxyl radical, the 
high reactivity makes it react quickly with biomolecules close to it and therefore 
evoke a local event (Dröge, 2002). Secondly, studies on the subcellular redox 
characteristics suggest that the subcellular compartments exhibit non-equilibrium 
redox potentials. In particular, the redox potentials of the central thiol/disulfide redox 
couples (GSH/GSSG, thioredoxin-1, thioredoxin-2 and cysteine/cysteine) are 
different in cell compartments like mitochondria, nucleus and cytoplasm (Kemp et al., 
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2008; Go and Jones, 2008). The redox potential (electromotive force, Eh) is used as a 
measurement of the tendency of a chemical species to accept or donate electrons. For 
example, the Eh value estimated for the GSH/GSSG couple suggests that GSH/GSSG 
is maintained at a more reduced steady state in mitochondria than in the nucleus or 
cytoplasma (Kemp et al., 2008; Go and Jones, 2008). The redox sensitive molecules 
are thus exposed to and regulated by different redox environments in each 
compartment.     
 
In this study, the measurement of O2.- could only provide information on the changes 
in overall O2.- level without identifying the exact localization. However, we 
demonstrate that the O2.--dependent regulation is specifically on cytosolic Akt. As 
Nox4 has been identified in our cell system, the localization of Nox4 at the nucleus 
(Kuroda et al., 2005; Hilenski et al., 2004) and endoplasmic reticulum (Helmcke et al., 
2009; Ambasta et al., 2004) but not at the plasma membrane (Ambasta et al., 2004) 
might explain the specific effect on cytosolic Akt instead of membrane Akt by 
cytosolic O2.-.  
 
We have also provided evidence that the cytosolic regulation of Akt in the current 
system is dependent on the phosphatase PP2A, in particular the PP2A-B55α subunit. 
Although the phosphatase-mediated dephosphorylation process is less well 
understood than the kinase-mediated process, it is important for maintaining the 
phosphorylation level of Akt. The “off” signal must be kept low for Akt to maintain 
the phosphorylation level and, thus, the activity. The cytosolic regulation is then 
critical to determine the ability of the kinase to act on the downstream substrates.  
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4.3 Akt oxidation status is regulated by O2.-.  
 
Detection of Akt oxidation using AMS to modify free thiols was first introduced by 
Murata et al. (Murata et al., 2003). This assay allows the measurement of redox states 
of the Akt protein. A more recent paper also used the AMS method to detect oxidized 
Akt (Cao et al., 2009). However, studies on Akt oxidation status are not well 
established yet. In our project, we used the same AMS assay to distinguish between 
the reduced versus the oxidized form of Akt.  
 
4.3.1 Akt oxidation is reversely correlated with intracellular O2.- level in 
MEFPTEN-/- cells 
 
In previous papers where Akt oxidation was reported, Akt oxidation was detected 
after cells were exposed to H2O2 (Murata et al., 2003) or the ROS generating reagent 
4-HPR (Cao et al., 2009). In our project, we showed for the first time that intracellular 
O2.- level affects the Akt oxidation status. Akt oxidation level was negatively related 
to the level of O2.- in MEFPTEN-/- cells. An increase in the level of oxidized-Akt was 
observed upon the decrease in the level of O2.- by DPI, while a reduction in the 
percentage of oxidized-Akt was achieved after the restoration of O2.- level by DDC. 
Similarly, sustained reduction in the level of O2.- by siNox4 also resulted in an 
increase in the percentage of oxidized-Akt.  
 
In this project, we showed that the increase in intracellular O2.- level by DDC 
decreased the level of Akt oxidation. This reverse correlation of the level of 
intracellular O2.- and the level of oxidized-Akt is different from what has been 
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observed previously for H2O2. In the case of H2O2, Akt oxidation was induced after 
cells were exposed to H2O2 (Murata et al., 2003). Therefore, in contrast to the 
oxidizing power of H2O2, O2.- functionally presents a reducing power in the current 
system to reduce the level of Akt oxidation.   
 
4.3.2 The possible reducing/oxidation powers of O2.--mediated alteration in Akt 
oxidation: present and future works  
 
As O2.- is shown to regulate Akt oxidation status in our system, it should function 
through certain reducing or oxidizing machineries. In modulating the redox status on 
cellular proteins, the reduced glutathione (GSH), the glutaredoxins (Grxs) and the 
thioredoxins (Trxs) represent the major regulating systems.   
 
GSH 
Our results showed that the reduction in intracellular O2.- level by DPI was 
accompanied by a decrease in GSH level. Pullar and Hampton previously reported 
that DPI induced GSH efflux via a transport channel (Pullar and Hampton, 2002). 
This observation is in line with our results. However, it remains unclear whether the 
decrease in GSH level is independent of or is a consequence/cause of the reduction in 
O2.- level. In fact, we showed that restoration of the intracellular O2.- level by co-
incubation with DDC also recued the GSH level. This suggests that the GSH level 
could be modulated by the changes in O2.- level. Future works are needed to restore 
the GSH level in DPI-treated cells in order to elucidate the relationship between O2.-, 
GSH and Akt oxidation. On the other hand, the reduction of the intracellular O2.- level 
by siNox4 did not disturb the intracellular GSH level. GSH is, thus, not involved in 
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this case. The discrepancies observed for DPI and siNox4 might be due to differences 
in the nature of these two approaches. While the DPI studies showed the effect at the 
initial stage, silencing of Nox4 reflected the effect of reducing intracellular O2.- level 
for a prolonged period of time. 
 
Grxs/Trxs 
Glutaredoxins (Grxs) and thioredoxins (Trxs) represent two families of proteins 
regulating a broad range of target proteins by modifying the redox status. The main 
function of Grxs and Trxs is to reduce the target protein by breaking the 
intramolecular and intermolecular disulfide bridges or by removing the glutathione 
group in glutathionylated proteins (Franco et al., 2007). Grxs and Trxs thus play 
important roles in diverse forms of life from E. coli to mammals. 
 
In E. coli, requirement of Grxs and Trxs are reported in the reduction process of many 
proteins such as the ribonucleotide reductases (RNR) and arsenate reductase (Gon et 
al., 2006; Shi et al., 1999). Reduction of proteins is sometimes associated with 
changes in activity. Phosphoadenylylsulfate (PAPS) reductase is the key enzyme in 
sulphate assimilation in E. coli. PAPS reductase was inactivated by glutathionylation 
on Cys-239, and was reactivated by Grx-mediated reduction (Lillig et al., 2003). In 
contrast, the transcription factor OxyR was activated by disulfide bond formation. 
Enzymatic reduction by Grx1 thus inactivated OxyR (Zheng et al., 1998; Aslund et al., 
1999). In yeast, the transcription factor Yap1 was activated by disulfide bond 
formation upon H2O2-induced oxidation. Activated Yap1 was deactivated by 
enzymatic reduction by Trx (Delaunay et al., 2000). The functional role of Grxs in the 
yeast system is implicated in antioxidant defence, where Grx1 or Grx2 is sufficient to 
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defend against the oxidative stress induced by O2.- or H2O2 respectively (Luikenhuis 
et al., 1998). In mammalian cells, Trx was implicated in protein denitrosylation using 
caspase-3 as the sample protein (Benhar et al., 2008). Grx was shown to regulate the 
redox status of Akt and, thus, to protect cells from H2O2-induced apoptosis (Murata et 
al., 2003).  
 
As Grxs and Trxs are actively involved in redox modifications of the proteins, it will 
be interesting to investigate whether they play a role in our system to modulate Akt 
oxidation status. Future work in this regard will involve the examination of potential 
changes in Grx and Trx activity upon modulation of O2.- level. In addition, Trx 
oxidation is reported in several conditions. It could be induced by EGF (Halvey et al., 
2005), hexavalent chromium (Myers et al., 2008) or hypoxia (Muniyappa et al., 2009). 
Moreover, Trx was shown to be S-nitrosylated at cysteine 69 in human umbilical vein 
endothelial cells (HUVECs) at the basal level, and this modification was important for 
Trx activity (Haendeler et al., 2002). Therefore, investigation of Trx oxidation status 
will be another approach to assess the possible involvement of this protein.   
 
4.4 Regulation of Akt phosphorylation can be achieved via Akt 
oxidation  
 
In addition to the shift between reduced-Akt and oxidized-Akt, we also noticed that 
the phosphorylation level on the reduced-Akt and oxidized-Akt is different. The 
oxidized-Akt always exhibited a lower level of phosphorylation than the reduced-Akt 
after normalized to their respective amount of Akt in the oxidized or reduced form. 
The decreased level of phosphorylation on oxidized-Akt could be due to the lack of 
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efficiency in detection by the antibody. As suggested by a previous paper (Murata et 
al., 2003), Akt underwent disulfide bond formation between Cys297 and Cys311 in 
Akt2. The disulfide bond formation may cause a conformational change of the protein. 
This may mask the epitope for the antibody to recognize the phosphorylation, as the 
disulfide formation site is around the Thr308 phosphorylation site. However, in our 
experiments where H2O2 was applied to the cells, blotting the membrane with 
phospho-Akt (Thr308) antibody revealed a significant band at the size of the 
oxidized-Akt (Appendix B), suggesting that the antibody can detect the 
phosphorylation on oxidized-Akt. Moreover, the less abundance in Akt 
phosphorylation on oxidized-Akt was observed on Ser473 as well, which could not be 
explained by the hindrance of antibody recognition caused by the disulfide formation 
around Thr308. Therefore, the decreased level of phosphorylation on oxidized-Akt  
does not appear to be an artefact. This observation is further supported by the data 
obtained after the reduction in the level of O2.- . The phosphorylation on oxidized-Akt 
was not proportionally increased with the elevated level of the oxidized form of Akt. 
The phosphorylation is therefore lost when the protein is shifted from the reduced 
form to the oxidized form.    
 
Murata et al. showed that, besides inducing Akt oxidation, H2O2 also induced Akt 
interaction with the phosphatase PP2A, which was to dephosphorylate and inactivate 
Akt. This enhanced interaction of Akt and PP2A was proposed to be responsible for 
the transient dephosphorylation on Akt after exposure to H2O2 (Murata et al., 2003). 
In our project, we also showed an increase in Akt-PP2A interaction upon DPI 
treatment. This corresponds to the decreased level of Akt phosphorylation as well as 
the increased level of Akt oxidation. Therefore, our results are in agreement with the 
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model where the redox status of Akt might affect the phosphorylation status via the 
interaction with PP2A.  
 
The previous model on PKA, which is in the same AGC [cAMP-dependent protein 
kinase (PKA)/protein kinaseG/protein kinase C (PKC)] kinase family as Akt, suggests 
that oxidation of the cysteine residue located proximal to the threonine 
phosphorylation site might render the protein more susceptible for dephosphorylation 
(Humphries et al., 2005). It was shown that oxidation, such as glutathionylation or 
internal disulfide bond formation of the catalytic subunit of cAMP-dependent protein 
kinase (PKA) in vitro, could render the kinase more susceptible for dephosphorylation 
on Thr197, which is a critical site for optimal enzymatic activity of PKA. Moreover, 
in vivo treatment of PC12 cells with N-ethylmaleimide (NEM) resulted in PKA 
inactivation and dephosphorylation on Thr197. It was proposed that oxidation of the 
Cys199, located proximal to Thr197, was responsible for the enhanced availability of 
Thr197 for dephosphorylation. Although this is not reported on the Akt protein, Akt 
belongs to the same AGC kinase family as PKA. A sequence search on the three Akt 
isoforms showed that there is indeed a cysteine residue proximal to the threonine 
phosphorylation site in the activation loop (Table 7). In accordance with this model, 
intermolecular disulfide bond formation in the activation loop between Cys297 and 
Cys311 in Akt2 was observed by in vivo experiments after H2O2 treatment (Murata et 
al., 2003) as well as by a crystal structure study of Akt2 kinase domain (Akt2-KD) 
(Huang et al., 2003). The reported disulfide formation on Cys311, which is proximal 
to the Thr309 phosphorylation site, could therefore interfere with Akt phosphorylation 
on the threonine residue.    
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These two models suggest that cysteine oxidation (such as disulfide bond formation) 
in the activation loop could possibly lead to oxidative inactivation of the Akt kinase, 
which is dependent on the phosphatase-mediated dephosphorylation of Akt.   
 
  Sequence from 301-315 
Mouse/Human Akt1 kdgatmkt(308)fc(310)gtpey 
Mouse/Human Akt2 isdgatmkt(309)fc(311)gtpe 
Mouse/Human Akt3 atmkt(305)fc(307)gtpeylap 
Table 7: Sequence search on Akt isoforms 
 
In order to confirm the involvement of the cysteine residue in the case of                 
O2.--mediated regulation of Akt, more investigations are needed to identify the form 
of modification as well as the residues involved. Furthermore, mutational studies to 
replace the cysteine residue are needed to elucidate its effect on Akt phosphorylation. 
As the highly conserved cysteine residue is found around the threonine residue in the 
activation loop of other members of the AGC kinase family, the O2.--mediated 
regulation found on Akt might be applicable to other members of the family as well. 
One closely related candidate is p70S6K. The phosphorylation level of p70S6K was 
shown to follow a similar pattern to that of Akt upon the reduction in intracellular O2.- 
level by DPI or siNox4. This can be explained by the fact that p70S6K resides 
downstream of the Akt pathway. However, it could also be possible that p70S6K is a 
direct target under the redox regulation of O2.-. One experiment to do is to check the 
redox status of p70S6K in the basal condition as well as in conditions with altered 
intracellular O2.- level.   
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4.5 O2.- and Akt in cell proliferation and survival 
 
4.5.1 Pro-proliferation activities of O2.- 
 
The involvement of O2.- in cell proliferation and cell growth has been shown in 
different systems. In the development of Dictyostelium discoideum, O2.- production 
was detected during the transition to the multicellular phase of development and 
generation of  O2.- was required for the formation of multicellular aggregates 
(Bloomfield and Pears, 2003). In cell lines that exhibit density inhibition of growth, 
elevated MnSOD activity was observed by the time cells stopped proliferation 
(Oberley et al., 1995). This suggests that a decrease in O2.- might be needed for 
growth inhibition. A direct involvement of O2.- in promoting cell proliferation was 
demonstrated in NIH3T3 fibroblasts stably transfected with a constitutively active 
isoform of p21Ras. In this system, O2.- production in the transfected cells was proposed 
as the mediator of Ras-induced cell proliferation (Irani et al., 1997). Involvement O2.- 
was also implicated in Ras-induced transformation of non-malignant rat kidney 
epithelial cells (RECs), as evidenced by the inhibitory effect from MnSOD or 
Cu/ZnSOD overexpression (Yang et al., 2002).  
 
In line with the pro-proliferative role of O2.-, there is evidence pointing to the anti-
apoptotic role of O2.-. The decrease in O2.- level after Sindbis virus (SV) infection was 
shown to be necessary for SV-induced apoptosis, as the potentiation of SV-induced 
apoptosis by expression of Cu/ZnSOD was dependent on the SOD activity to 
scavenge O2.- instead of the activity to produce H2O2 (Lin et al., 1999). Moreover, our 
group has shown that an increase in intracellular O2.- protected cells from various 
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apoptotic triggers. In human melanoma M14 cells sensitive to Fas-mediated cell death, 
an increase in O2.- could inhibit Fas-mediated apoptosis while a decrease in O2.- 
sensitized originally Fas-resistant cells (Clément and Stamenkovic, 1996). Scavenging 
intracellular O2.-  also rendered the M14 cells more sensitive to  anti-cancer drugs 
such as daunorubicin, etoposide and pMC540 (Pervaiz et al., 1999). In addition, Rac-
dependent O2.- production was related to the  increased apoptotic resistance of cells 
(Pervaiz et al., 2001).    
 
In this project, we showed that sustained reduction in intracellular O2.- level by DPI 
resulted in a decreased rate of cell proliferation without inducing significant increase 
in the subG1 population. Although these data are preliminary in specifying the 
involvement of O2.- in cell proliferation, it demonstrates that O2.- indeed plays a part in 
maintaining cell proliferation in our system.  
. 
4.5.2 O2.- mediated regulation of Akt 
 
Our group has previously shown that Akt activation was induced by an increase in 
O2.- level in MEFs (Lim and Clément, 2007). In understanding how O2.--dependent 
Akt phosphorylation was achieved, Lim and Clement showed that inhibition of PTEN 
via O2.--mediated oxidation of the phosphatase was responsible for it. Oxidation of 
PTEN is related to the functional inhibition of the phosphatase. Therefore, an increase 
in PIP3 level was observed after the increase in O2.- level. These results suggest that 
O2.- interferes with the membrane-associated process for Akt activation which is 
dependent on PIP3 level.  
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In the current project, we have proposed an additional mechanism of O2.--mediated 
regulation of Akt. The MEFPTEN-/- cells used in this project serves as a good system to 
avoid the interference from the PTEN-dependent regulation as previously reported. In 
the MEFPTEN-/- cells, we have demonstrated that O2.- regulates Akt in a cytosolic 
pathway which is related to the oxidation status of Akt and the Akt-PP2A interaction.  
 
Therefore, in cells with functional PTEN, O2.- could regulate Akt in two distinct ways 
(Figure B). One is dependent on oxidation of PTEN which is located at the membrane. 
The other resides in the cytosol which is dependent on oxidation of Akt as well as 
Akt-PP2A complex formation. However, it remains unclear the relative abundance of 
these two pathways in various physiological conditions. Incorporation of the two 
proposed pathways in a biological process will determine the fate of the Akt kinase. 
The complexity is dependent on how the components in each pathway interact with 
each other both spatially and temporally. Therefore, we would like to incorporate the 
computational modelling method in future work to decipher the importance of these 
two regulatory pathways.  
 
 






















Figure B: Proposed model of the O2.- dependent membrane and cytosolic 
regulation pathways of Akt phosphorylation 
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4.5.3 Possible implication of O2.- dependent Akt regulation in tumour cells    
 
In agreement with the proposed cytosolic pathway in MEFPTEN-/- cells, the decrease in 
Akt phosphorylation and the increase in Akt oxidation were also observed in the 
androgen-sensitive human prostate cancer cell LNCaP after the decrease in O2.-. 
LNCaP cells have a similar background of dysfunctional PTEN as MEFPTEN-/- cells. 
However, in MEFWT cells, reduction of intracellular O2.- level by DPI failed to induce 
Akt oxidation or to decrease Akt phosphorylation.  In fact, measurement the basal O2.- 
level in MEFPTEN-/-  and MEFWT cells showed that O2.- level was higher in MEFPTEN-/- 
cells. With the long term exposure to higher O2.- level, the molecules in MEFPTEN-/- 
cells might develop regulation properties that are dependent on O2.-, such as the 
cytosolic regulation pathway  proposed for Akt. These molecules (like Akt) are 
therefore sensitive to O2.- withdrawal in  MEFPTEN-/- cells but not in MEFWT cells 
where the same dependency is not developed. To really understand these different 
observations in different cell lines, we need to first identify the mediators connecting 
O2.- and Akt oxidation.   
 
It is evident that ROS plays important roles in cancer cells. Many tumour cells exhibit 
high level of ROS, and they use ROS in many signalling pathways such as to promote 
proliferation, metastasis, angiogenesis and to suppress apoptosis (Pelicano et al., 2004; 
Storz, 2005; Mori et al., 2004; Toyokuni et al., 1995). Involvement of O2.- in 
carcinogenesis was supported by the observation that overexpression of the O2.- 
producing NADPH oxidase Nox1 induced transformation in  NIH3T3 cells (Suh et al., 
1999). Moreover, knockout of Cu/ZnSOD in mice models resulted in increased rate of 
liver cancer development (Elchuri et al., 2005). The role of O2.- in tumour cells is also 
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supported by experiments showing that reduction in intracellular O2.- level can revert 
the malignant features of cancer cells. In this regard, the effect of Cu/ZnSOD and 
MnSOD as tumour suppressor proteins is widely reported. Overexpression of these 
enzymes results in reduction in O2.- level as well as tumour suppression (Weydert et 
al., 2006; Oberley, 2005). Experiments in cultured cells also showed increased 
resistance to apoptotic triggers upon elevation in O2.- level (Pervaiz et al., 1999; 
Clément and Stamenkovic, 1996; Pervaiz et al., 2001). The dependency on ROS of 
tumour cells makes us interested to investigate whether there is a different 
dependency on the cytosolic Akt regulation pathway in tumour cells as compared to 
normal cells. This is inspired by our observation that MEFPTEN-/- cells, which are 
dependent on the cytosolic pathway for Akt regulation, exhibits higher O2.-  level than 
MEFWT cells, which are insensitive to the decrease in the intracellular level of O2.- .   
 
4.6 Scaffolding functionality of NHE1 in relation to Akt 
 
Among the two functional domains of NHE1, the N-terminal transmembrane domain 
is responsible for ion transport, and the C-terminal cytosolic domain is the regulatory 
domain associated with a number of binding proteins (Slepkov et al., 2007). 
Interaction of the C-terminal tail with other proteins has two important functions. First, 
regulation of NHE1 activity or localization is facilitated by a list of C-terminal 
interacting proteins. The regulation is dependent on interaction with calcineurin 
homologous protein 1 (CHP1), calmodulin, carbonic anhydrase II and tescalcin, or on 
phosphorylation of NHE1 by p90RSK, Nck-interacting kinase (NIK) and Rho kinase 
1 (ROCK1) (Malo and Fliegel, 2006). Second, NHE1 interacting partners are 
clustered at the C-terminal, which allows formation of complexes that could be 
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functionally important. Therefore, in addition to its conventional role as a pH 
regulator, NHE1 also serves as a scaffold for the assembly of signalling complexes at 
the plasma membrane (Wu et al., 2004). Figure C shows the major regulatory 




Figure C: Topology of NHE-1 and its regulatory elements. 
Diagram taken from (Malo and Fliegel, 2006). 
Abbreviations: CHP, calcineurin homologous protein; CaM, calmodulin; CAII, 
carbonic anhydrase isoform II; NIK, Nck-interacting kinase; ERM, 
ezrin/radixin/moesin proteins; PIP2, phosphatidylinositol bisphosphate. 
 
 
For our particular interest, NHE1 is shown to be involved in cell survival, which is 
dependent on NHE1-ERM interaction and the related regulation on Akt (Wu et al., 
2004). Wu et al. showed that NHE1 activation was linked to Akt phosphorylation. 
Mutant studies suggested that the ability of NHE1 to interact with the 
ezrin/radixin/moesin (ERM) proteins was essential for Akt activation. Moreover, 
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NHE1-ERM complex formation was shown to protect cells from hypertonicity or 
staurosporine induced apoptosis, in which process PI3K-binding ability of ERM was 
essential. As Akt activation is under the regulation of PI3K pathway, the author 
proposed a model where Akt is the functional mediator in the survival pathway that is 
dependent on the complex formation of NHE1, ERM and PI3K (Wu et al., 2004).  
 
In the current project, we have demonstrated a novel model on how NHE1 is involved 
in Akt regulation. NHE1 was shown to regulate Akt phosphorylation and to interact 
directly with Akt. NHE1 is thus proposed to serve as an additional anchor point for 
Akt recruitment to the membrane and therefore modulate the membrane-associated 
process in Akt activation. The direct interaction reported in this project is in 
agreement with the fact that NHE1 is phosphorylated by Akt as reported by two 
groups (Snabaitis et al., 2008; Meima et al., 2009). To allow phosphorylation, it is 
rationale that the kinase Akt should interact with the substrate NHE1, although the 
interaction could be transient.  
 
To promote Akt phosphorylation, it is essential to bring Akt into close proximity with 
the upstream kinases. Therefore, interaction of NHE1 with PDK1 or rictor-mTOR 
will be investigated in future work.  The possible role of the ERM proteins is also 
worth investigating. As NHE1 is binding with PIP2 (Aharonovitz et al., 2000) and 
ERM is interacting with PI3K (Gautreau et al., 1999), the theoretical model could be 
that assembly of the PIP2-NHE1-ERM-PI3K signalling cascade facilitates PIP3 
formation at the site of NHE1. Interaction of Akt with NHE1 therefore brings Akt 
together with PDK1 which can be recruited to the NHE1 site via PIP3. In this case, 
direct interaction between PDK1 and NHE1 is not necessary. Nevertheless, this is just 
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hypothetical and more investigations are needed to explore the roles of NHE1 in Akt 




In this project, we have identified O2.- as another factor contributing to the 
hyperphosphorylation of Akt in MEF cells lacking PTEN. The hyperphosphorylation 
of Akt in the background of dysfunctional PTEN is conventionally attributed to the 
PIP3 accumulation due to absence of PTEN. In our system, we have shown that 
reduction in intracellular O2.- level could decrease Akt hyperphosphorylation without 
affecting the PIP3 level. This suggests that in addition to be due to the elevated level 
of PIP3, hyperphosphorylation of Akt in PTEN defective cells could be dependent on 
intracellular O2.- level as well.  
 
In understanding how O2.- regulates Akt phosphorylation in our system, we have 
proposed a cytosolic regulation pathway. Firstly, cytosolic Akt is the main target in 
this system. Secondly, the regulation is through the PP2A-dependent 
dephosphorylation process, which is less well characterized as compared to the kinase 
mediated phosphorylation process of Akt. Although we have not exhaustively 
investigated all the possible regulatory subunits involved in this regulation, we have 
identified the role of B55α subunit in this event. We have also provided evidence that 
Akt oxidation status is reversely correlated with O2.- level. The proposed cytosolic 
regulation of Akt phosphorylation by O2.- is possibly dependent on the shift between 
reduced-Akt and oxidized-Akt, which is related to the susceptibility of Akt to the 
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phosphatase. This model therefore represents new insights in understanding the role 
of O2.- in cell signalling processes.     
 
Last but not least, we have reported NHE1 as a regulator of Akt phosphorylation at 
the membrane. We showed for the first time that NHE1 interacts directly with Akt. 
This interaction allows NHE1 to serve as an additional anchor point for Akt 
recruitment to the membrane. Interestingly, reduction in intracellular O2.- level could 
disrupt the complex formation between NHE1 and Akt. This further illustrates the 
importance of O2.- in regulating Akt phosphorylation, but this time at the membrane 
instead of in the cytosol.           
 
To summarize the key findings of this project, we proposed a model to elaborate how  
O2.- could affect Akt phosphorylation in the MEFPTEN-/- cells (Figure D). The model 
will provide ideas in understanding the regulation of the hyperphosphorylated Akt in 
the background of dysfunctional PTEN, which is observed in many cancer cells. It 
will also provide insights in understanding the pro-proliferation role of O2.-, especially 
in tumour cells with elevated ROS level. As different cellular environment may 
render the cells to respond very differently to the changes in O2.-, we would like to test 
this model in other cell systems as well, in particular in normal cells compared to 
tumour cells.    
 






































 cells grown in DMEM/10%FBS were transfected with siRNA for Nox4 
(siNox4) or control (sico). Membrane fractionation was performed 48 hours post 
transfection. Same amount of samples from cytosolic (S100) and membrane (P100) 


































 cells (WT) cells were serum starved in DMEM/0.5%FBS for 24 hours before 
treated with nothing or 2mM H2O2 for 1 hour. The cells were then harvested for AMS 
assay. The Lysates were incubated with or without DTT before the AMS modification 
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